<SEC-DOCUMENT>0001213900-26-003910.txt : 20260113
<SEC-HEADER>0001213900-26-003910.hdr.sgml : 20260113
<ACCEPTANCE-DATETIME>20260113160503
ACCESSION NUMBER:		0001213900-26-003910
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		8
CONFORMED PERIOD OF REPORT:	20260113
FILED AS OF DATE:		20260113
DATE AS OF CHANGE:		20260113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			China SXT Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001723980
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38773
		FILM NUMBER:		26530105

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		178 TAIDONG ROAD NORTH
		CITY:			TAIZHOU
		PROVINCE COUNTRY:   	F4
		BUSINESS PHONE:		8652386298290

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		178 TAIDONG ROAD NORTH
		CITY:			TAIZHOU
		PROVINCE COUNTRY:   	F4
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0272506-6k_chinasxt.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16 UNDER<BR>
THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the month of January 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File Number: 001-38773</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CHINA SXT PHARMACEUTICALS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">178 Taidong Rd North, Taizhou</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Jiangsu, China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT>
&nbsp;&nbsp;&nbsp;Form 40-F <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>INFORMATION CONTAINED IN THIS FORM 6-K REPORT
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 9, 2026, China SXT Pharmaceuticals,
Inc. (the &ldquo;Company&rdquo;) entered into a securities purchase agreement (the &ldquo;Securities Purchase Agreement&rdquo;) with certain
institutional investor (&ldquo;Purchaser,&rdquo; together with the Company, the &ldquo;Parties&rdquo;) in connection with a registered
direct offering for the offer and sale of 12,000,000 Class A ordinary shares of the Company, no par value (&ldquo;Class A Ordinary Shares&rdquo;)
and pre-funded warrants to purchase 54,666,666 Class A Ordinary Shares (&ldquo;Pre-Funded Warrants&rdquo;), in the aggregate (such offering,
the &ldquo;Offering&rdquo;). Pursuant to the Securities Purchase Agreement, the Company also agreed to, amongst other things, adjustment
terms in the Pre-Funded Warrants, issuance of the shares underlying the Pre-Funded Warrants upon the exercise of the Pre-Funded Warrants,
in accordance with the terms of the Pre-Funded Warrants, and the Parties agreed to customary representations and warranties and agreements
and indemnification rights and obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Pre-Funded Warrants have an exercise price
of $0.001 per share, and each Pre-Funded Warrant is exercisable for one Class A Ordinary Share (the shares underlying the Pre-Funded Warrants,
the &ldquo;Warrant Shares&rdquo;). A holder of the Pre-Funded Warrants (&ldquo;Holder&rdquo;) will not have the right to exercise any
portion of its Pre-Funded Warrants if the Holder, together with its affiliates, would beneficially own in excess of 9.99% of the number
of Class A Ordinary Shares outstanding immediately after giving effect to such exercise. The Pre-Funded Warrants will be immediately exercisable
(subject to the aforementioned beneficial ownership limitation) and may be exercised at any time until all of the Pre-Funded Warrants
are exercised in full. The Pre-Funded Warrant may be exercised, in whole or in part, at such time by means of a cashless exercise, under
which cashless exercise the Holder is entitled to receive a number of Warrant Shares under the terms of the Pre-Funded Warrants. The exercise
price of the Pre-Funded Warrants is subject to adjustment for stock splits, stock dividends, stock combinations, and similar capital transactions
or such other event as further described in the Pre-Funded Warrants. As more fully described in the Securities Purchase Agreement, Holders
are also entitled to acquire Purchase Rights (as defined in the Pre-Funded Warrants) upon subsequent rights offerings conducted by the
Company, are entitled to certain pro rata distributions, and may be issued shares of Common Stock upon the occurrence of a Fundamental
Transaction (as defined in the Pre-Funded Warrants).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Class A Ordinary Shares, the Pre-Funded Warrants,
and the Warrant Shares were offered pursuant to the (i) registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1723980/000121390025108285/ea0264327-f3_chinasxt.htm">Form F-3</A> (File No. 333-291428) filed with the U.S. Securities
and Exchange Commission (&ldquo;SEC&rdquo;) on November 10, 2025 and became effective by the SEC on December 1, 2025, and the (ii) prospectus
supplement filed with the SEC on January 12, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Offering was consummated on January 13, 2026.
The Company received net proceeds of approximately $9,110,000 from the Offering, after deducting offering expenses payable by the Company,
including placement agent fees, legal fees, and clearing fees. The Company intends to use the net proceeds from the Offering for general
corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Offering, the Company entered
into a Placement Agency Agreement (the &ldquo;Placement Agency Agreement&rdquo;) on January 9, 2026 with Univest Securities, LLC (&ldquo;Univest&rdquo;),
pursuant to which Univest agreed to act as the exclusive placement agent in connection with the Offering. As compensation to Univest,
the Company paid Univest a cash fee of 7.0% of the aggregate gross proceeds raised in the Offering, a non-accountable expense reimbursement
in an amount equal to half percent (0.5%) of the gross proceeds of the Offering, and out-of-pocket expenses, including legal counsel fees
and disbursements, in an amount not to exceed an aggregate of $100,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summaries of the Securities Purchase
Agreement, Pre-Funded Warrant, and Placement Agency Agreement do not purport to be complete and are subject to and are qualified in their
entirety by copies of such documents filed as Exhibits 10.1, 4.1, and 10.2, respectively to this Current Report on Form 6-K (&ldquo;Form
6-K&rdquo;) and are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company issued a press release announcing
the Offering on January 9, 2026. A copy of the press release is filed herein as Exhibit 99.1 and is incorporated by reference.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 90%"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea027250601ex4-1_chinasxt.htm"><FONT STYLE="font-size: 10pt">Form of Pre-Funded
    Warrant</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">5.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea027250601ex5-1_chinasxt.htm">Opinion of Campbells</A></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea027250601ex10-1_chinasxt.htm"><FONT STYLE="font-size: 10pt">Securities Purchase Agreement</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">10.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea027250601ex10-2_chinasxt.htm"><FONT STYLE="font-size: 10pt">Placement Agency Agreement</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea027250601ex99-1_chinasxt.htm">Press Release dated January 9, 2026</A></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">104</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Cover Page Interactive Data File (formatted in Inline XBRL).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: January 13, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">China SXT Pharmaceuticals, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Feng Zhou</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Feng Zhou</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Co-Chief Executive Officer </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%"><FONT STYLE="font-size: 10pt"><I>/s/ Simon Lim Sze Beng</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Simon Lim Sze Beng</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Co-Chief Executive Officer </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea027250601ex4-1_chinasxt.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CHINA SXT PHARMACEUTICALS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 35%; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">Warrant Shares: [____]</FONT></TD>
    <TD STYLE="width: 65%; text-align: right; font-size: 10pt"><FONT STYLE="font-size: 10pt">Issuance Date: [_____], 2026</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS PRE-FUNDED ORDINARY
SHARE PURCHASE WARRANT (the &ldquo;<B>Warrant</B>&rdquo;) certifies that, for value received, [______________] or its assigns (the &ldquo;<B>Holder</B>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth at any time on or after
the Issuance Date (such date, the &ldquo;<B>Initial Exercise Date</B>&rdquo;) and until exercised in full (the &ldquo;<B>Termination Date</B>&rdquo;)
but not thereafter, to subscribe for and purchase from China SXT Pharmaceuticals, Inc., a BVI business company incorporated in the British
Virgin Islands (the &ldquo;<B>Company</B>&rdquo;), up to [___] class A ordinary shares (the &ldquo;<B>Warrant Shares</B>&rdquo;), no par
value per share, of the Company (&ldquo;<B>Ordinary Shares</B>&rdquo;), subject to adjustment hereunder. The purchase price of one Ordinary
Share under this Warrant shall be equal to the Exercise Price, as defined in <U>Section 2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this <U>Section 1</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<B>Purchase Agreement</B>&rdquo;), dated January 9, 2026, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls, or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Alternate
Consideration</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Attribution
Parties</B>&rdquo; shall have the meaning set forth in <U>Section 2(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Beneficial Ownership
Limitation</B>&rdquo; shall have the meaning set forth in <U>Section 2(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bid
Price</B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (i) if the Ordinary Share
is then listed or quoted on a Trading Market, the bid price of the Ordinary Share for the time in question (or the nearest preceding date)
on the Trading Market on which the Ordinary Share is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York, New York time) to 4:02 p.m. (New York, New York time)), (ii) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Ordinary Share for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (iii) if the Ordinary
Share is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Share are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per Ordinary Share
so reported, or (iv) in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser selected
in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg L.P., or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Board
of Directors</B>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday, or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Buy-In</B>&rdquo;
shall have the meaning set forth in <U>Section 2(d)(iv)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company</B>&rdquo;
shall have the meaning set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Distribution</B>&rdquo;
shall have the meaning set forth in <U>Section 3(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>DWAC</B>&rdquo;
shall have the meaning set forth in <U>Section 2(d)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exchange
Ac</B>t&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exercise
Price</B>&rdquo; shall have the meaning set forth in <U>Section 2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Fundamental
Transaction</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Holder</B>&rdquo;
shall have the meaning set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Initial Exercise
Date</B>&rdquo; shall have the meaning set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Issuance
Date</B>&rdquo; means the issuance date of this Warrant as set forth on the first page hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Notice of Exercise</B>&rdquo;
shall have the meaning set forth in <U>Section 2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Ordinary
Share</B>&rdquo; means the class A ordinary share of the Company, no par value per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Ordinary
Share Equivalents</B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Ordinary Shares, including, without limitation, any debt, preferred shares, right, option, warrant, or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof), or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Placement
Agency Agreement</B>&rdquo; means the placement agency agreement, dated as of January 9, 2026, by and between the Company and Univest
Securities, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Purchase
Agreement</B>&rdquo; shall have the meaning set forth in <U>Section 1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Purchase
Rights</B>&rdquo; shall have the meaning set forth in <U>Section 3(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Registration
Statement</B>&rdquo; means the Company&rsquo;s registration statement on Form F-3 (File No. 333-291428).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>SEC</B>&rdquo;
means the United States Securities and Exchange Commission.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Standard Settlement
Period</B>&rdquo; shall have the meaning set forth in <U>Section 2(d)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsidiary</B>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Successor
Entity</B>&rdquo; shall have the meaning set forth in <U>Section 3(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Termination Date</B>&rdquo;
shall have the meaning set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading
Day</B>&rdquo; means a day on which the Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Ordinary Share is listed or quoted for trading on the date
in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, or the
NYSE American, (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transfer
Agent</B>&rdquo; means Transhare Corporation, the current transfer agent of the Company, with a mailing address of 17755 US Hwy 19 N,
Clearwater, FL 33764 and an email address of kwhiteside@transhare.com, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (i) if the Ordinary Share is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Ordinary Share for such date (or the nearest preceding date)
on the Trading Market on which the Ordinary Share is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York, New York time) to 4:02 p.m. (New York, New York time)), (ii) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Ordinary Share for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (iii) if the Ordinary
Share is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Share are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the
Ordinary Share so reported, or (iv) in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrants</B>&rdquo;
means this Warrant and other Pre-Funded Ordinary Share purchase warrants issued by the Company pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrant
Register</B>&rdquo; shall have the meaning set forth in <U>Section 4(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrant Share Delivery
Date</B>&rdquo; shall have the meaning set forth in <U>Section 2(d)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrant Shares</B>&rdquo;
shall have the meaning set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><U>Exercise of Warrant</U>.&nbsp; Subject to the terms and conditions hereof, exercise of the purchase
rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on
or before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail
attachment) of the Notice of Exercise substantially in the form attached hereto as <U>Exhibit A</U> (the &ldquo;<B>Notice of Exercise</B>&rdquo;).&nbsp;
Within the earlier of (i) one (1) Trading Day and (ii) such earlier time comprising the Standard Settlement Period (as defined in <U>Section
2(d)(i)</U> herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the number
of Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in <U>Section 2(c)</U> below is applicable and specified in the attached Notice of Exercise.
The Company shall have no obligation to inquire with respect to or otherwise confirm the authenticity of the signature(s) contained on
any Notice of Exercise nor the authority of the person so executing such Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.&nbsp;
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in
an amount equal to the applicable number of Warrant Shares purchased.&nbsp; The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Trading Day of receipt of such notice.&nbsp; <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><U>Exercise Price</U>.&nbsp; The aggregate exercise price of this Warrant, except for a nominal exercise
price of $0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional
consideration (other than the nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person
to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid
aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been
exercised prior to the Termination Date. The remaining unpaid exercise price per Ordinary Share under this Warrant shall be $0.001, subject
to adjustment hereunder (the &ldquo;<B>Exercise Price</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><U>Cashless Exercise</U>. This Warrant may be exercised, in whole or in part, at such time by means of
a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained
by dividing [(A-B) (X)] by (A), where:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; padding-right: 0.8pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 0.5in; padding-right: 0.8pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">(A) =</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.5in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-size: 10pt">(B) =</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-size: 10pt">the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.5in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-size: 10pt">(X) =</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-size: 10pt">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The Company agrees not to
take any position contrary to this <U>Section 2(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">d)</TD><TD STYLE="text-align: justify"><U>Mechanics of Exercise</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">i. </FONT><U>Delivery
of Warrant Shares Upon Exercise</U>.&nbsp; The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<B>DWAC</B>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is
the earliest of (i) one (1) Trading Day after the delivery of the Notice of Exercise to the Company and payment of exercise price, (ii)
one (1) Trading Day after delivery of the aggregate Exercise Price to the Company, and (iii) the number of days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;)
provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company by
such date. For corporate and BVI law purposes, the Holder shall become the registered holder of the Warrant Shares upon entry of its (or
its nominee&rsquo;s) name in the Company&rsquo;s BVI register of members. Settlement through DWAC or delivery of certificates shall be
without prejudice to this requirement, and the Company shall promptly procure such register update. Upon delivery of the Notice of Exercise,
the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise
Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date.&nbsp; If the Company fails for any
reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, provided that payment
of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company by such date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Ordinary Share on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date
until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant
in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<B>Standard Settlement Period</B>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Ordinary Share as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any
Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York, NY time) on the Initial Exercise Date, which may be delivered at
any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s)
by 4:00 p.m. (New York, NY time) on the date following the Initial Exercise Date if it is a Trading Day and the Initial Exercise Date
shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in
the case of a cashless exercise) is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">ii. </FONT><U>Delivery
of New Warrants Upon Exercise</U>.&nbsp; If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: 48.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">iii. </FONT><U>Rescission
Rights</U>.&nbsp; If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section
2(d)(i)</U> by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written notice
to the Company at any time prior to the delivery of such Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">iv. </FONT><U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of <U>Section
2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, (other than a failure caused by incorrect or incomplete
information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase (in an open
market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Ordinary Shares to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the Ordinary Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant
Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the
sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of
the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed
rescinded) or deliver to the Holder the number of Ordinary Shares that would have been issued had the Company timely complied with its
exercise and delivery obligations hereunder. For example, if the Holder purchases Ordinary Shares having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of Warrants with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver Ordinary Shares upon exercise of the Warrant as required pursuant to the terms hereof.
The obligation of the Company to pay compensation for Buy-In under this <U>Section 2(d)(iv)</U> is subject to delivery by the Holder of
the aggregate Exercise Price in accordance with the terms of <U>Section 2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.8in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.8in; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.8in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">v. </FONT><U>No
Fractional Shares or Scrip</U>.&nbsp; No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
this Warrant.&nbsp; As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: 48.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">vi. </FONT><U>Charges,
Taxes and Expenses</U>.&nbsp; Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the assignment form attached hereto as <U>Exhibit B</U> duly executed by the Holder and
the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&nbsp;
The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">vii. </FONT><U>Closing
of Books</U>.&nbsp; The Company will not close its register of members or records in any manner which prevents the timely exercise of
this Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">e)</FONT></TD><TD STYLE="text-align: justify"><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to <U>Section 2</U> or otherwise, to the extent
that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with
the Holder&rsquo;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates
(such Persons, &ldquo;<B>Attribution Parties</B>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as
defined below).&nbsp; For purposes of the foregoing sentence, the number of Ordinary Shares beneficially owned by the Holder and its Affiliates
and Attribution Parties shall include the number of Ordinary Shares issuable upon exercise of this Warrant with respect to which such
determination is being made, but shall exclude the number of Ordinary Shares which would be issuable upon (i) exercise of the remaining,
nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise
or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other&nbsp;Ordinary
Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by
the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this
<U>Section 2(e)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is
in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance
therewith.&nbsp;To the extent that the limitation contained in this <U>Section 2(e)</U> applies, the determination of whether this
Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and
of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise
shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by
the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for exercises of the Warrant that are not in compliance with the Beneficial Ownership Limitation, except to
the extent the Holder relies on a number of outstanding Ordinary Shares that was provided by the Company.&nbsp;In addition, a determination
as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder, and the Company shall have no obligation to verify or confirm the accuracy of such determination and
shall have no liability for exercises of the Warrant that are not in compliance with the Beneficial Ownership Limitation, except to the
extent the Holder relies on the number of outstanding Ordinary Shares that was provided by the Company.&nbsp; For purposes of this <U>Section
2(e)</U>, in determining the number of outstanding Ordinary Shares, a Holder may rely on the number of outstanding Ordinary Shares as
reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the SEC, as the case may be, (B) a more recent public
announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of Ordinary
Shares outstanding.&nbsp; Upon the written request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing
to the Holder the number of Ordinary Shares then outstanding.&nbsp; In any case, the number of outstanding Ordinary Shares shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding Ordinary Shares was reported.&nbsp; The &ldquo;<B>Beneficial
Ownership Limitation</B>&rdquo; shall be 9.99% of the number of Ordinary Shares outstanding immediately after giving effect to the issuance
of Ordinary Shares issuable upon exercise of this Warrant. The Holder, upon written notice to the Company, may increase or decrease the
Beneficial Ownership Limitation provisions of this <U>Section 2(e)</U>, provided that the Beneficial Ownership Limitation in no event
exceeds 9.99% of the number of Ordinary Shares outstanding immediately after giving effect to the issuance of Ordinary Shares upon exercise
of this Warrant held by the Holder and the provisions of this <U>Section 2(e)</U> shall continue to apply.&nbsp; Any increase in the Beneficial
Ownership Limitation will not be effective until the sixty-first (61st) day after such notice is delivered to the Company.&nbsp; The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section
2(e)</U> to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant. If the Warrant is unexercisable as a result of the Holder&rsquo;s
Beneficial Ownership Limitation, no alternate consideration is owing to the Holder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><U>Share Dividends and Splits</U>. Subject to the Company&rsquo;s
M&amp;A and the BVI Business Companies Act (as revised), the following adjustments shall apply. If the Company, at any time while this
Warrant is outstanding: (i) pays a share dividend or otherwise makes a distribution or distributions on its Ordinary Shares or any other
equity or equity equivalent securities payable in Ordinary Shares (which, for avoidance of doubt, shall not include any Ordinary Shares
issued by the Company upon exercise of this Warrant), (ii) subdivides its outstanding Ordinary Shares into a larger number of shares,
(iii) combines (including by way of consolidation/reverse share split) outstanding Ordinary Shares into a smaller number of shares, or
(iv) issues by reclassification of the Ordinary Shares any shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares (excluding treasury shares, if any) outstanding
immediately before such event and of which the denominator shall be the number of Ordinary Shares outstanding immediately after such
event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise
Price of this Warrant shall remain unchanged.&nbsp; Any adjustment made pursuant to this <U>Section 3(a) </U>shall become effective immediately
after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><U>Subsequent Rights Offerings</U>.&nbsp; In addition to any adjustments pursuant to <U>Section 3(a)</U>
above, if at any time while this Warrant is outstanding the Company grants, issues or sells any Ordinary Share Equivalents or rights to
purchase shares, warrants, securities or other property pro rata to all of the record holders of any class of Ordinary Shares (the &ldquo;<B>Purchase
Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase
Rights which the Holder could have acquired if the Holder had held the number of Ordinary Shares acquirable upon complete exercise of
this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record
is taken, the date as of which the record holders of Ordinary Shares are to be determined for the grant, issue or sale of such Purchase
Rights (<I>provided</I>, <I>however</I>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would
result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase
Right to such extent (or beneficial ownership of such Ordinary Shares as a result of such Purchase Right to such extent) and such Purchase
Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such grant, issuance or sale of the Purchase Rights, such Purchase Rights shall be held in abeyance for the benefit of the Holder
until the Holder has exercised this Warrant; provided, however, that to the extent such Purchase Rights expire for the shareholders of
the Company if not exercised, or the Warrant has not been exercised prior to the Termination Date, the Purchase Rights will also expire
for the Holder as of such date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><U>Pro Rata Distributions</U>.&nbsp; During such time as
this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire
its assets) to holders of Ordinary Shares, by way of return of capital or otherwise (including, without limitation, any distribution
of cash, shares or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme
of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after the issuance of this Warrant, then,
in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated
therein if the Holder had held the number of Ordinary Shares acquirable upon complete exercise of this Warrant (without regard to any
limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which
a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Ordinary Shares are
to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any Ordinary Shares as a
result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder
until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). To the
extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion of the Distribution
shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant or the Warrant has been terminated.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><U>Fundamental Transaction</U>. If, at any time while this
Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation
of the Company with or into another Person whereby such other Person or group acquires greater than 50% of the voting power of the shares
of the Company, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other
disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase
offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Ordinary Shares
are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
greater than 50% of the voting power of the shares of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share exchange pursuant to
which the Ordinary Shares are effectively converted into or exchanged for other securities, cash or property (other than a share split
or share dividend), or (v) the Company, directly or indirectly, in one or more related transactions consummates a share purchase agreement
or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement
(other than a share split or share dividend)) with another Person or group of Persons whereby such other Person or group acquires greater
than 50% of the voting power of the shares of the Company (each a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such
exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation
in <U>Section 2(e)</U> on the exercise of this Warrant), the number of Ordinary Shares of the successor or acquiring corporation or of
the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<B>Alternate Consideration</B>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary Shares for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one Ordinary Share in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Ordinary Shares are given any choice as to the securities,
cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<B>Successor Entity</B>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this <U>Section
3(d)</U> pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without
unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for
this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the Ordinary Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares
of capital stock (but taking into account the relative value of the Ordinary Shares pursuant to such Fundamental Transaction and the
value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to
the term &ldquo;Company&rdquo; under this Warrant and the other Transaction Documents (so that from and after the occurrence or consummation
of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity, or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
<U>Section 3(d)</U> regardless of (i) whether the Company has sufficient authorized Ordinary Shares for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">e)</TD><TD STYLE="text-align: justify"><U>Calculations</U>. All calculations under this <U>Section
3</U> shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this <U>Section 3</U>,
the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares
(excluding treasury shares, if any) issued and outstanding.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">f)</TD><TD STYLE="text-align: justify"><U>Notice to Holder</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">(i) <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">(ii) <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form other than a
share split or share dividend) on the Ordinary Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption
of the Ordinary Shares (excluding any granting or issuance of rights to all of the Company&rsquo;s shareholders pursuant to a shareholder
rights plan), (C) the Company shall authorize the granting to all holders of the Ordinary Shares rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights, (D) the approval of any shareholders of the Company shall be required
in connection with any reclassification of the Ordinary Shares, any consolidation or merger to which the Company is a party, any sale
or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Ordinary Shares are
converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its
last email address as it shall appear upon the Warrant Register of the Company, at least ten (10) calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Ordinary
Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Ordinary Shares of record shall be entitled to exchange their Ordinary Shares for
securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided
that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate
action required to be specified in such notice.&nbsp; To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the SEC pursuant to a Report on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">g)</TD><TD STYLE="text-align: justify"><U>Voluntary Adjustment by Company</U>. Subject to the rules
and regulations of the Trading Market, the Company may at any time during the term of this Warrant reduce the then current Exercise Price
to any amount and for any period of time deemed appropriate by the Board of Directors.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 33.75pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify"><U>Transferability</U>.&nbsp; Subject to compliance with
any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto as <U>Exhibit B</U> duly executed by the Holder or its agent or
attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&nbsp; Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&nbsp; Notwithstanding anything herein to the
contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant
in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the
Holder delivers an assignment form to the Company assigning this Warrant in full.&nbsp; The Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><U>New Warrants</U>. This Warrant may be divided or combined
with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names
and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&nbsp; Subject to compliance
with <U>Section 4(a)</U>, as to any transfer which may be involved in such division or combination, the Company shall execute and deliver
a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants
issued on transfers or exchanges shall be dated the Issuance Date of this Warrant and shall be identical with this Warrant except as
to the number of Warrant Shares issuable pursuant thereto.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><U>Warrant Register</U>. The Company shall register this
Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<B>Warrant Register</B>&rdquo;), in the name of the
record Holder hereof from time to time.&nbsp; The Company may deem and treat the registered Holder of this Warrant as the absolute owner
hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to
the contrary.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. &nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><U>No Rights as Shareholder Until Exercise; No Settlement
in Cash</U>.&nbsp; This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a shareholder of the Company
prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U> and the Holder is entered in the register of members, except as expressly
set forth in <U>Section 3</U>.&nbsp; Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to <U>Section 2(c)</U> or to receive cash payments pursuant to <U>Section 2(d)(i)</U> and <U>Section 2(d)(iv)</U> herein, in
no event shall the Company be required to net cash settle an exercise of this Warrant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><U>Loss, Theft, Destruction or Mutilation of Warrant</U>.
The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation
of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security
reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and
cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share certificate
of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><U>Saturdays, Sundays, Holidays, etc</U>. If the last or
appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then
such action may be taken or such right may be exercised on the next succeeding Business Day.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><U>Authorized Shares</U>. The Company covenants that, during
the period the Warrant is outstanding, it will reserve from its authorized and unissued Ordinary Shares a sufficient number of Ordinary
Shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of completing
the issuance of the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such
reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable
law or regulation, or of any requirements of the Trading Market upon which the Ordinary Shares may be listed.&nbsp; The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 40.5pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its second
amended and restated memorandum and articles of association or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such
actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment (it being understood
that this Warrant shall not in any case prevent the Company from effecting any such amendment, reorganization, transfer, consolidation,
merger, dissolution, issuance or sale).&nbsp; Without limiting the generality of the foregoing, the Company will (i) not increase the
par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value (except
that the Company may undertake a reverse share split that is required, in the good faith determination of the Board of Directors, to maintain
the listing of the Ordinary Shares on the Trading Market), (ii) take all such action as may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use
commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction
thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Before taking any
action, which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Governing
Law; Exclusive Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be determined in accordance with the provisions of the Purchase Agreement, and any action relating to this Warrant shall only be brought
as provided in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.&nbsp;
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and no exemption is available,
will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right to
exercise this Warrant terminates on the Termination Date.&nbsp; Without limiting any other provision of this Warrant, if the Company willfully
and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall
pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo;
fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing
any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">h) </FONT><U>Notices</U>.&nbsp;
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">i) </FONT><U>Limitation
of Liability</U>.&nbsp; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for
the purchase price of any Ordinary Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by
creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">j) </FONT><U>Remedies</U>.&nbsp;
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant.&nbsp; The Company agrees that monetary damages would not be adequate compensation for any
loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in
any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">k) </FONT><U>Successors
and Assigns</U>.&nbsp; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure
to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of
Holder.&nbsp; The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">l) </FONT><U>Amendment
and Waiver</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the
one hand, and the Holder or the beneficial owner of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">m) </FONT><U>Severability</U>.&nbsp;
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">n) </FONT><U>Headings</U>.&nbsp;
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>China SXT Pharmaceuticals, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.8pt; width: 60%">&nbsp;</TD>
    <TD STYLE="padding-right: 1.8pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 1.8pt; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding-right: 1.8pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feng Zhou</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="padding-right: 1.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: CHINA SXT PHARMACEUTICALS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) The undersigned hereby
elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) Payment shall take the
form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in; text-align: justify">&#9744;  in lawful money of the United States;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in; text-align: justify">&#9744; if permitted the cancellation of
such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with
respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ___________________________________________________________________________<BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>EXHIBIT B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 55%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Please Print)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: _______________ __, ______</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holder&rsquo;s Signature:<BR>
 ___________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holder&rsquo;s Address: <BR>
____________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ea027250601ex5-1_chinasxt.htm
<DESCRIPTION>OPINION OF CAMPBELLS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; margin-top: 9.75pt; margin-bottom: 3.75pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Courier New, Courier, Monospace; width: 70%"><IMG SRC="ex5-1_001.jpg" ALT=""></TD>
    <TD STYLE="padding-left: 0in; width: 30%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt">Campbells Legal (BVI) Limited</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt">Floor 4, Banco Popular Building</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt">PO Box 4467</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt">Road Town, Tortola VG-1110</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt">British Virgin Islands</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">China SXT Pharmaceuticals, Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">178 Taidong Road North, Taizhou</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jiangsu</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">People&rsquo;s Republic of China</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -2.5pt"><B>&nbsp;</B></P></TD>
    <TD STYLE="padding-left: 0in">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt"><B>T</B> +1 284 852 4823</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt"><B>E</B> gwilliamson@campbellslegal.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt">campbellslegal.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">13 January 2026</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="padding-left: 0in">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt">Our Ref: 16578-45953</P>
    <P STYLE="font: 10pt Courier; margin: 0pt 0 0pt 0in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Sirs</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -2.5pt"></P></TD>
    <TD STYLE="padding-left: 0in">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt">BVI <B>| </B>CAYMAN <B>| </B>HONG KONG</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: -2.5pt"></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Re: China SXT Pharmaceuticals, Inc. (the &ldquo;Company&rdquo;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as British Virgin Islands counsel
to the Company, a company limited by shares incorporated in the British Virgin Islands, and have been requested to provide this legal
opinion in connection with the Company&rsquo;s registration statement on Form F-3 (File No. 333-291428) filed on 10 November 2025 and
became effective on 1 December 2025 (the &ldquo;<B>Registration Statement</B>&rdquo;), and the prospectus supplement relating to the offering,
filed with the Commission on Form 6-K on 12 January 2026 (together with the base prospectus, the &ldquo;<B>Prospectus</B>&rdquo;) including
all amendments or supplements thereto, relating to the offering and sale by the Company of up to an aggregate of approximately US$10,000,000
of securities directly to an investor through Univest Securities, LLC, as placement agent, consisting of class A ordinary shares of the
Company, no par value each (the &ldquo;<B>Class A Ordinary Shares</B>&rdquo;) and/or pre-funded warrants to purchase Class A Ordinary
Shares (the &ldquo;<B>Pre-Funded Warrants</B>&rdquo;) and the Class A Ordinary Shares issuable upon exercise of the Pre-Funded Warrants,
as the applicable investor may elect.&nbsp; We are furnishing this opinion as Exhibit 5.1 to the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are Attorneys-at-Law in the British Virgin
Islands and express no opinion as to any laws other than the laws of the British Virgin Islands in force and as interpreted at the date
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1</TD><TD STYLE="text-align: justify">Documents Reviewed</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have reviewed originals, copies, drafts or
conformed copies of the following documents and such other documents or instruments as we deem necessary:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">the unanimous written resolutions of the directors of the Company dated 6 November 2025 and 9 January
2026 (the &ldquo;<B>Resolutions</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">a certified copy of the register of directors of the Company, dated 5 November 2025, issued by Vistra
(BVI) Limited, the Company&rsquo;s registered agent (the &ldquo;<B>ROD</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.3</TD><TD STYLE="text-align: justify">a copy of the register of members of the Company, dated 31 December 2025, issued by Transhare Corp (together
with the ROD, the &ldquo;<B>Registers</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.4</TD><TD STYLE="text-align: justify">the information revealed by our search of the Company&rsquo;s public records on file and available for
public inspection at the British Virgin Islands Registry of Corporate Affairs (the &ldquo;<B>Registry of Corporate Affairs</B>&rdquo;)
at the time of our searches on 12 January 2026 including:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.1</TD><TD>the Company&rsquo;s certificate of incorporation dated 4 July 2017; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">the Company&rsquo;s amended and restated memorandum and articles of association (the &ldquo;<B>Memorandum and Articles of Association</B>&rdquo;)
dated 30 July 2025;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.5</TD><TD STYLE="text-align: justify">the information revealed by our searches of the Company&rsquo;s records of proceedings on file with and
available for inspection at the British Virgin Islands High Court Registry at the time of our searches on 12 January 2026;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.6</TD><TD STYLE="text-align: justify">a copy of the Certificate of Good Standing in respect of the Company, issued by the BVI Registrar of Corporate
Affairs, dated 9 January 2026 (the &ldquo;<B>Certificate of Good Standing</B>&rdquo;); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.7</TD><TD STYLE="text-align: justify">a copy of the Registration Statement and Prospectus.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2</B></TD><TD STYLE="text-align: justify"><B>Assumptions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following opinions are given only as to, and
based on, circumstances and matters of fact existing and known to us on the date of this opinion. This opinion only relates to the laws
of the British Virgin Islands which are in force on the date of this opinion. In giving this opinion we have relied (without further verification)
upon the completeness and accuracy of the factual confirmations contained in the Registers and the Certificate of Good Standing. We have
also relied upon the following assumptions, and the assumptions set out in Schedule 1 hereto, which we have not independently verified:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.1</TD><TD STYLE="text-align: justify">copies of documents, conformed copies or drafts of documents provided to us are true and complete copies
of, or in the final forms of, the originals, and translations of documents provided to us are complete and accurate;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.2</TD><TD STYLE="text-align: justify">all signatures, initials and seals are genuine;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.3</TD><TD STYLE="text-align: justify">there is nothing under any law (other than the laws of the British Virgin Islands) which would or might
affect the opinions expressed herein;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.4</TD><TD STYLE="text-align: justify">the shares to be issued by the Company pursuant to the Registration Statement will be issued by the Company
against payment in full of the consideration, and that such shares will be duly registered in the Company&rsquo;s register of members;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.5</TD><TD STYLE="text-align: justify">the minute book and corporate records of the Company, whether maintained at its registered office in the
British Virgin Islands or otherwise, which we have specifically not reviewed, do not disclose anything which would affect any opinion
given herein;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.6</TD><TD STYLE="text-align: justify">the Resolutions remain in full force and effect; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.7</TD><TD STYLE="text-align: justify">there is no contractual or other prohibition (other than as arising under British Virgin Islands law)
binding on the Company prohibiting it from entering into and performing its obligations under the Registration Statement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3</TD><TD STYLE="text-align: justify">Opinions</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon, and subject to, the foregoing assumptions
and the qualifications set out below, and having regard to such legal considerations as we deem relevant, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">The Company was incorporated in the British Virgin Islands under the BVI Business Companies Act (As Revised)
on 4 July 2017, with company number 1949664, is a company limited by shares, is in good standing at the Registry of Corporate Affairs
and is validly existing under the laws of the British Virgin Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify">The Company is authorised to issue an unlimited number of shares divided into Class A Ordinary Shares
of no par value each and Class B Ordinary Shares of no par value each.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.3</TD><TD STYLE="text-align: justify">When issued and paid for in the manner described in the Registration Statement and in accordance with
the Resolutions, the Class A Ordinary Shares and the Class A Ordinary Shares to be issued pursuant to the Pre-Funded Warrants (if any)
will be validly issued, fully paid and non-assessable. As a matter of British Virgin Islands law, a share is only issued when it has been
entered in the register of members (or shareholders).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4</TD><TD STYLE="text-align: justify">Qualifications</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as explicitly stated herein, we make no
comment with respect to any representations and warranties which may be made by or with respect to the Company in any of the documents
or instruments cited in this opinion or otherwise with respect to the commercial terms of the transactions the subject of this opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this opinion, the phrase &ldquo;non-assessable&rdquo;
means, with respect to the Class A Ordinary Shares, that a shareholder shall not, solely by virtue of its status as a shareholder, be
liable for additional assessments or calls on the shares by the Company or its creditors (except in exceptional circumstances, such as
involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstance in which a court
may be prepared to pierce or lift the corporate veil).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To maintain the Company in good standing under
the laws of the British Virgin Islands, annual filing fees must be paid as and when due to, and a copy of the Company&rsquo;s register
of directors filed with, the Registry of Corporate Affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion is provided solely for your benefit
and use and may not be quoted in whole or in part or otherwise referred to or filed with any government agency or any other person without
our prior express written consent, and no person other than the Company is entitled to rely on this opinion. Notwithstanding the foregoing,
we hereby consent to the filing of this opinion as an exhibit to the Registration Statement and the Prospectus and to the reference to
our name in the Registration Statement. In giving our consent, we do not thereby admit that we are in the category of persons whose consent
is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion is limited to the matters detailed
herein and is not to be read as an opinion with respect to any other matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yours faithfully</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>/s/ Campbells Legal (BVI) Limited </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Campbells Legal (BVI) Limited </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ea027250601ex10-1_chinasxt.htm
<DESCRIPTION>SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITIES PURCHASE AGREEMENT
(this &ldquo;<U>Agreement</U>&rdquo;) is entered into and made effective as of January 9, 2026, between China SXT Pharmaceuticals, Inc.,
a BVI business company incorporated in the British Virgin Islands with company number 1949664 (the &ldquo;<U>Company</U>&rdquo;), and
each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act of 1933, as amended
(the &ldquo;<U>Securities Act</U>&rdquo;) as to the Shares, and/or the Pre-Funded Warrants (each as defined herein) (collectively, the
&ldquo;<U>Securities</U>&rdquo;), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly,
desires to purchase from the Company, the Securities of the Company as provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and sufficiency of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE I.<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&nbsp;<U>Definitions</U>.
In addition to the words and terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following words and terms
have the meanings set forth in this&nbsp;<U>Section 1.1</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Agreement</U>&rdquo;
shall have the meaning ascribed to such term in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>BSA/PATRIOT
Act</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.2(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>BVI Counsel</U>&rdquo;
means Campbells, British Virgin Islands legal counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to&nbsp;<U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first (1st) Trading
Day following the date hereof (or the second (2nd) Trading Day following the date hereof if this Agreement is signed on a day that is
not a Trading Day or after 4:00 p.m. (New York, NY time) and before midnight (New York, NY time) on a Trading Day).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company</U>&rdquo;
shall have the meaning ascribed to such term in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Loeb &amp; Loeb LLP, U.S. counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Control</U>&rdquo;
(including the terms &ldquo;<U>controlled by</U>&rdquo; and &ldquo;<U>under common control with</U>&rdquo;) means the possession, directly
or indirectly, of the power to direct or cause the direction of the management and policies of a person, whether through the ownership
of voting securities, as trustee or executor, by contract or otherwise, including the ownership, directly or indirectly, of securities
having the power to elect a majority of the board of directors or similar body governing the affairs of such person or securities that
represent a majority of the outstanding voting securities of such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York, NY time) and before
midnight (New York, NY time) on any Trading Day, 9:01 a.m. (New York, NY time) on the Trading Day immediately following the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York,
NY time) and 9:00 a.m. (New York, NY time) on any Trading Day, no later than 9:01 a.m. (New York, NY time) on the date hereof, unless
otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>DVP</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>DWAC</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section 2.2(a)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>EDGAR</U>&rdquo;
means the Electronic Data Gathering, Analysis, and Retrieval System.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>ERISA</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section 3.2(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(r)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (i) Ordinary Shares, restricted share units, or options, including the Ordinary Shares underlying
the restricted share units or options, to employees, officers, directors, or consultants of the Company pursuant to any share or option
plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of
a committee of non-employee directors established for such purpose for services rendered to the Company, provided that any issuances to
consultants of the Company are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights
that require or permit the filing of any registration statement in connection therewith during the prohibition period in <U>Section 4.11(a)</U>
herein, (ii) Ordinary Shares issued upon the exercise or exchange of or conversion of any Pre-Funded Warrants issued hereunder and/or
other securities exercisable or exchangeable for or convertible into Ordinary Shares issued and outstanding on the date of this Agreement,&nbsp;<I>provided</I>&nbsp;that
such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise
price, exchange price, or conversion price of such securities (other than in connection with share splits or combinations) or to extend
the term of such securities, (iii) securities (including Ordinary Shares and Ordinary Share Equivalents) issued pursuant to merger, acquisition,
or strategic transactions approved by a majority of the disinterested directors of the Company,&nbsp;<I>provided</I>&nbsp;that such securities
are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the
filing of any registration statement in connection therewith during the prohibition period in&nbsp;<U>Section 4.11(a)</U>&nbsp;herein,
and&nbsp;<I>provided</I>,&nbsp;<I>further</I>&nbsp;that any such issuance shall only be to a Person that (or to the equity holders of
a Person) which is, itself or through its subsidiaries, an operating company, or an owner of an asset in a business synergistic with or
relates to the business of the Company and in which the Company receives benefits in addition to any investment of funds, but shall not
include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary
business is investing in securities, and (iv) securities (including Ordinary Shares and Ordinary Share Equivalents) for settlement of
outstanding payables or liabilities,&nbsp;<I>provided</I>&nbsp;that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the prohibition period in&nbsp;<U>Section 4.11(a)</U>&nbsp;herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Federal
Reserve</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 2.2(a)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FTC</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(l)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(z)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Issuer
Free Writing Prospectus</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(f)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>IT Systems
and Data</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(mm)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(o)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Placement Agent and the directors, officers,
and 5% shareholders of the Company, substantially in the form of&nbsp;<U>Exhibit A</U>&nbsp;attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in&nbsp;<U>Section 3.1(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(m)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Misconduct</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(k)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Money
Laundering Laws</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(jj)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Non-cooperative
Jurisdiction</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.2(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>OFAC</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(gg)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Offering</U>&rdquo;
shall mean the offering of the Securities contemplated by this Agreement and the other Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Ordinary
Shares</U>&rdquo; means the Class A ordinary shares of the Company, no par value per share and any other class of securities into which
such shares may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Ordinary
Share Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Ordinary Shares, including, without limitation, any debt, preferred shares, right, option, warrant or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $0.15, subject to adjustment for reverse and forward share splits, share dividends, share combinations
and other similar events with respect to Ordinary Shares that occur after the date of this Agreement and prior to the Closing;&nbsp;<I>provided</I>&nbsp;that
the purchase price per Pre-Funded Warrant i shall be the Per Share Purchase Price minus $0.001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint share company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Personal
Data</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(nn)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the Placement Agency Agreement by and between the Company and the Placement Agent dated as of January
9, 2026, as it may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Univest Securities, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Policies</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(nn)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>PRC Counsel</U>&rdquo;
means Beijing W&amp;H(Taizhou) Firm, PRC counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means the Pre-Funded Ordinary Share Purchase Warrants delivered to certain of the Purchasers at the Closing in accordance
with&nbsp;<U>Section 2.2(a)(iii)</U>&nbsp;hereof to the extent any Purchasers elect to receive Pre-Funded Warrants in lieu of Shares,
which Pre-Funded Warrants shall be exercisable into Ordinary Shares and shall be in the form of&nbsp;<U>Exhibit B</U>&nbsp;attached hereto,
which Pre-Funded Warrants shall be exercisable beginning on the Initial Exercise Date (as defined therein) until all of the Pre-Funded
Warrants have been exercised, and shall be exercisable at an exercise price of $0.001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Settlement
Period</U>&rdquo; shall have the meaning set forth in&nbsp;<U>Section 5.21</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Settlement
Shares</U>&rdquo; shall have the meaning set forth in&nbsp;<U>Section 5.21</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Privacy
Laws</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(nn)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, a preliminary inquiry, an informal investigation
or a partial proceeding, such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the SEC
and delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser</U>&rdquo;
shall have the meaning ascribed to such term in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 4.8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form F-3 filed with the SEC, as amended (File No. 333-291428), which
registers the sale of the Securities to the Purchasers, and shall include the Rule 462(b) Registration Statement, if applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or
any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or
any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 462(b)
Registration Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Securities, which was
filed with the SEC on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated by the SEC pursuant
to the Securities Act, if applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC</U>&rdquo;
means the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in&nbsp;<U>Section 3.1(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Pre-Funded Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the Ordinary Shares issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shell
Bank</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 3.2(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing Ordinary Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Securities purchased hereunder as specified below
such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United
States dollars and in immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded
Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
of any person means any corporation, partnership, limited liability company, joint stock company, joint venture or other organization
or entity, whether incorporated or unincorporated, which is Controlled by such Person, and shall, where applicable, also include any direct
or indirect subsidiary or VIE of the Company formed or acquired after the date of this Agreement. For the avoidance of doubt, &ldquo;Subsidiary&rdquo;
shall be deemed to include any VIE that is consolidated in the Company&rsquo;s financial statements in accordance with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Ordinary Shares are listed or quoted for trading on the
date in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, or
the NYSE American (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Lock-Up Agreements, the Pre-Funded Warrants, all exhibits and schedules thereto and hereto
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Transhare Corporation, the current transfer agent of the Company, with a mailing address of 17755 NORTH US HIGHWAY
19 SUITE 140, CLEARWATER, FL 33764 and an email address of kwhiteside@transhare.com, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in&nbsp;<U>Section 4.11(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VIE</U>&rdquo;
means variable interest entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (i) if the Ordinary Shares are then listed
or quoted on a Trading Market, the daily volume weighted average price of an Ordinary Share for such date (or the nearest preceding date)
on the Trading Market on which the Ordinary Shares are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from
9:30 a.m. (New York, NY time) to 4:02 p.m. (New York, NY time)), (ii) if the OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of an Ordinary Share for such date (or the nearest preceding date) on the OTCQB or OTCQX, (iii) if Ordinary Shares are not
then listed or quoted for trading on the OTCQB or OTCQX and if prices for Ordinary Shares are then reported in the &ldquo;Pink Sheets&rdquo;
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent
bid price per Ordinary Share so reported, or (iv) in all other cases, the fair market value per Ordinary Share as determined by an independent
appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the Ordinary Shares issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE II.<BR>
PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;<U>Closing</U>. On
the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
up to an aggregate of $10,000,000 Shares and/or Pre-Funded Warrants subscribed for by such Purchaser. Notwithstanding anything herein
to the contrary, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser&rsquo;s Subscription Amount (together
with such Purchaser&rsquo;s Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s
Affiliates) would cause such Purchaser&rsquo;s beneficial ownership of the Ordinary Shares to exceed the Beneficial Ownership Limitation,
or as such Purchaser may otherwise choose, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of the Shares as determined
pursuant to&nbsp;<U>Section 2.2(a)</U>. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, with respect to each
Purchaser, at the election of the Purchaser at Closing, 9.99%) of the number of Ordinary Shares outstanding immediately after giving effect
to the issuance of the Shares on the Closing Date. In each case, the election to receive Pre-Funded Warrants is solely at the option of
the Purchaser. Unless otherwise directed by the Placement Agent, each Purchaser shall deliver, via wire transfer, immediately available
funds equal to its Subscription Amount pursuant to Section 2.2(b)(ii). Each Purchaser&rsquo;s Subscription Amount as set forth on the
signature page hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;)
settlement with the Company or its designee. The Company shall deliver to each Purchaser its respective Shares and/or Pre-Funded Warrants,
, as applicable to such Purchaser and as indicated on such Purchaser&rsquo;s signature page hereto and determined based on its respective
Subscription Amount and election for Shares and/or Pre-Funded Warrants, and the Company and each Purchaser shall deliver the other items
set forth in&nbsp;<U>Section 2.2</U>&nbsp;deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in&nbsp;<U>Sections
2.2</U>&nbsp;and&nbsp;<U>2.3</U>, the Closing shall occur remotely by electronic transfer of the Transaction Documents and other items
deliverable hereunder. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via DVP (i.e., on the Closing
Date, the Company shall issue the Securities registered in the Purchasers&rsquo; names and addresses, and the Shares shall be released
by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the
Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the
Placement Agent (or its clearing firm) by wire transfer to the Company). Notwithstanding the foregoing, with respect to any Notice(s)
of Exercise (as defined in the Pre-Funded Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Closing Date, which
may be delivered at any time after the time of execution of this Agreement, the Company agrees to deliver the Warrant Shares subject to
such notice(s) by 4:00 p.m. (New York City time) on the date following the Closing Date if it is a Trading Day and the Closing Date shall
be the Warrant Share Delivery Date (as defined in the Pre-Funded Warrants) for purposes hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;<U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) On or prior to the Closing
Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) this Agreement duly executed
by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) subject to the last sentence
of&nbsp;<U>Section 2.1</U>, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on
an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) Shares equal
to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price (minus the number of Ordinary Shares issuable upon
exercise of such Purchaser&rsquo;s Pre-Funded Warrant, if applicable), registered in the name of such Purchaser; For the avoidance of
doubt, legal title to the Shares shall be evidenced by entry on the Company&rsquo;s register of members;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) duly executed Pre-Funded
Warrants, if any, registered in the name of such Purchaser, as applicable to such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv) legal opinions of Company
Counsel, BVI Counsel and PRC Counsel, each in a form reasonably acceptable to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v) a good standing certificate
or its equivalent of the Company in each such entity&rsquo;s jurisdiction of incorporation or formation issued by the relevant competent
state or local government authority or registrar of companies or entities as applicable, dated as of a date within ten (10) days of the
Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vi) a certificate executed
by the Chief Executive Officer of the Company, in form and substance reasonably satisfactory to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vii) a certificate executed
by the secretary of the Company, in form and substance reasonably satisfactory to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(viii) a certificate executed
by the Chief Financial Officer of the Company, in form and substance reasonably satisfactory to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ix) Lock-up Agreements, in
form and substance reasonably acceptable to the Placement Agent, executed by the Company and each officer, director and greater than five
percent (5%) shareholders of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x) the Company&rsquo;s wire
instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xi) the Prospectus and the
Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) On or prior to the Closing
Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) this Agreement duly executed
by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) such Purchaser&rsquo;s
Subscription Amount (minus, if applicable, a Purchasers aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid
as and when such Pre-Funded Warrants are exercised for cash), which shall be made available for DVP settlement with the Company or its
designees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3&nbsp;<U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) Subject to&nbsp;<U>Section
5.21</U>&nbsp;below, as applicable, the obligations of the Company hereunder in connection with the Closing are subject to the following
conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the accuracy in
all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all
respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless such representation
or warranty is as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations
or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all obligations,
covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the delivery
by each Purchaser of the items set forth in&nbsp;<U>Section 2.2(b)</U>&nbsp;of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) Subject to&nbsp;<U>Section
5.21</U>&nbsp;below, as applicable, the respective obligations of the Purchasers hereunder in connection with the Closing are subject
to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the accuracy in
all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all
respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless such representation
or warranty is as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations
or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all obligations,
covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the delivery
by the Company of the items set forth in&nbsp;<U>Section 2.2(a)</U>&nbsp;of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv) there shall have
been no Material Adverse Effect with respect to the Company since the date of this Agreement and to the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) the Shares and
Warrant Shares shall have been approved for listing on the Trading Market, subject to official notice of issuance, from the date of this
Agreement to the Closing Date, trading in the Ordinary Shares shall not have been suspended by the SEC or any Trading Market, and, at
any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited,
or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor
shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred
any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or
any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable
or inadvisable to purchase the Securities at the Closing; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi) no stop order
suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE III.<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&nbsp;<U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser as of the date hereof
and as of the Closing Date (unless as of a specific date therein, in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Subsidiaries</U>.
All of the direct and indirect Subsidiaries of the Company and their respective jurisdictions of incorporation are set forth in the SEC
Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear
of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid,
non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse
effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries,
taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis
its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;Material Adverse Effect&rdquo;) and no Proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s shareholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party has
been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof,
will constitute the valid and binding obligations of the Company enforceable against the Company in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, liquidation, possessory liens, rights of set off,
merger, consolidation, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights
generally as well as applicable international sanctions, (ii) as limited by laws relating to the statutory limitation of the time within
which proceedings may be brought or availability of specific performance, injunctive relief or other equitable remedies, (iii) insofar
as indemnification and contribution provisions may be limited by applicable law and (iv) that such obligations (a) may not be given effect
to by a British Virgin Islands court if and to the extent they constitute the payment of an amount which is in the nature of a penalty
and (b) may not be given effect by a British Virgin Islands court to the extent that they are to be performed in a jurisdiction outside
the British Virgin Islands and such performance would be illegal under the laws of that jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>No Conflicts</U>.
The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the
issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not
(i) conflict with or violate any provision of the Company&rsquo;s amended and restated memorandum and articles of association or any Subsidiary&rsquo;s
organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or
both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary,
or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of,
any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding
to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected,
or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction,
decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal
and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except
in the case of clause (ii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant
to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement (iii) application(s) to each applicable
Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby and such filings
as are required to be made under applicable state securities laws (collectively, the &ldquo;Required Approvals&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Issuance
of the Securities; Registration</U>. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company. The Pre-Funded
Warrants are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will constitute valid
and legally binding obligations of the Company, enforceable against the Company in accordance with their terms. The Warrant Shares are
duly authorized and, when issued in accordance with the terms of the Pre-Funded Warrants against payment therefor as provided therein,
will be validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company. The Company has reserved from
its duly authorized share capital the maximum number of Ordinary Shares issuable pursuant to this Agreement and the Pre-Funded Warrants
(without taking into account any limitations on the exercise of the Pre-Funded Warrants set forth therein). The Company has prepared and
filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on December 1, 2025,
including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration
Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement
or suspending or preventing the use of the Prospectus has been issued by the SEC and no Proceedings for that purpose have been instituted
or, to the knowledge of the Company, are threatened by the SEC. The Company, if required by the rules and regulations of the SEC, shall
file the Prospectus with the SEC pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective,
at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform
in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and
the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued
and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and
will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the Shelf Registration
Statement eligible to use Form F-3. The Company is eligible to use Form F-3 under the Securities Act and it meets the transaction requirements
as set forth in General Instruction I.B.1 of Form F-3 with respect to the aggregate market value of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Any &ldquo;issuer
free writing prospectus&rdquo; (as defined in Rule 433 under the Securities Act) relating to the Securities is hereafter referred to as
an &ldquo;<U>Issuer Free Writing Prospectus</U>.&rdquo; Any reference herein to the Prospectus shall be deemed to refer to and include
the documents incorporated by reference therein as of the date of filing thereof; and any reference herein to any &ldquo;amendment&rdquo;
or &ldquo;supplement&rdquo; with respect to the Prospectus shall be deemed to refer to and include (i) the filing of any document with
the SEC incorporated or deemed to be incorporated therein by reference after the date of filing of such Prospectus and (ii) any such document
so filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">All references in this Agreement to
the Registration Statement, the Prospectus, or any Issuer Free Writing Prospectus, or any amendments or supplements to any of the foregoing,
shall be deemed to include any copy thereof filed with the SEC on EDGAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on Schedule 3.1(g). The number of Ordinary Shares owned beneficially,
and of record, by Affiliates of the Company as of the date hereof is set forth in the Prospectus. Except as set forth on Schedule 3.1(g),
the Company has not issued any Ordinary Shares or other shares of capital stock since the filing of its most recently filed periodic report
under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the
issuance of Ordinary Shares to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion
and/or exercise of Ordinary Share Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange
Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as set forth on Schedule 3.1(g), there are no outstanding options, warrants, scrip rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or
exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any Ordinary Shares or the capital stock
of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound
to issue additional Ordinary Shares or Ordinary Share Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities
will not obligate the Company or any Subsidiary to issue Ordinary Shares or other securities to any Person (other than the Purchasers).
Except as set forth on Schedule 3.1(g), there are no outstanding securities or instruments of the Company or any Subsidiary with any provision
that adjusts, and the issuance and sale of the Securities will not result in a right of any holder of Company securities to adjust the
exercise, conversion, exchange or reset price under any of such securities upon an issuance of securities by the Company or any Subsidiary.
Except as set forth on Schedule 3.1(g), there are no outstanding securities or instruments of the Company or any Subsidiary that contain
any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or
any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding Ordinary Shares and
any other shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in
compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights
or similar rights to subscribe for or purchase securities. No further approval or authorization of any shareholder, the Board of Directors
or others is required for the issuance and sale of the Securities. There are no shareholders agreements, voting agreements or other similar
agreements with respect to the Company&rsquo;s Ordinary Shares or other shares of capital stock to which the Company is a party or, to
the knowledge of the Company, between or among any of the Company&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus
Supplement, being collectively referred to herein as the &ldquo;SEC Reports&rdquo;) on a timely basis or has received a valid extension
of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates,
the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and
none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to
be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. Additionally, any further documents so filed and incorporated by reference in the Prospectus and Prospectus Supplement,
when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and the
applicable rules and regulations, as applicable, and will not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein, in light of the circumstances under which they were made not misleading. No post-effective
amendment to the Registration Statement reflecting any facts or events arising after the date thereof which represent, individually or
in the aggregate, a fundamental change in the information set forth therein is required to be filed with the Commission. The Company has
not been an issuer subject to Rule 144(i) under the Securities Act. As of their respective dates, the financial statements of the Company
included in the SEC Reports the Registration Statement and the Prospectus complied in all material respects with applicable accounting
requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements
have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the
periods involved (&ldquo;GAAP&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements
and documents described in the Registration Statement, the Prospectus, the Prospectus Supplement, and the SEC Reports conform in all material
aspects to the descriptions thereof contained therein and there are no agreements or other documents required by the Securities Act and
the rules and regulations thereunder to be described in the Registration Statement, the Prospectus, the Prospectus Supplement, or the
SEC Reports or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described or filed. Each
agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound or
affected and (i) that is referred to in the Registration Statement, the Prospectus, the Prospectus Supplement, or the SEC Reports, or
(ii) is material to the Company&rsquo;s business (each, a &ldquo;Material Agreement&rdquo;), has been duly authorized and validly executed
by the Company, is in full force and effect in all material respects and is enforceable against the Company and, to the Company&rsquo;s
knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency,
reorganization or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability of any indemnification or contribution
provision may be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and
other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding
therefore may be brought. No Material Agreement has been assigned by the Company, and neither the Company nor, to the best of the Company&rsquo;s
knowledge, any other party is in default thereunder and, to the best of the Company&rsquo;s knowledge, no event has occurred that, with
the lapse of time or the giving of notice, or both, would constitute a default thereunder that has had or that could reasonably be expected
to result in a Material Adverse Effect. To the best of the Company&rsquo;s knowledge, performance by the Company of the material provisions
of the Material Agreements will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree
of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including,
without limitation, those relating to environmental laws and regulations. The other financial and statistical information included in
the SEC Reports, the Registration Statement and the Prospectus present fairly, in all material respects, the information included therein
and have been prepared on a basis consistent with that of the financial statements that are included in the SEC Reports the Registration
Statement and the Prospectus and the books and records of the respective entities presented therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, the Registration Statement, the Prospectus and the Prospectus Supplement, except as set forth on Schedule 3.1(i), (i)
there has been no event, occurrence or development, including changes generally affecting the Company&rsquo;s or Subsidiaries&rsquo; industries,
that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with
past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed
in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or
made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential
treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on Schedule 3.1(i),
no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist
with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial
condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made
or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made. Other than
as set forth on Schedule 3.1(i), the Company has not: (i) issued any securities or incurred any liability or obligation, direct or contingent,
for borrowed money; or (ii) declared or paid any dividend or made any other distribution on or in respect of its capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Litigation</U>.
Except as set forth on Schedule 3.1(j), there has not been, and to the knowledge of the Company, there is not pending or contemplated,
any action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against
or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative
agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;Action&rdquo;). None of the Actions
set forth on Schedule 3.1(j), the Registration Statement, the Prospectus and the Prospectus Supplement adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities, (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect or (iii) are not expected to have a Material Adverse Effect.
Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim
of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to
the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current
or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Labor
Relations</U>. The Company and each of its Subsidiaries is, and has been, in material compliance with all applicable laws respecting labor,
employment and employment practices, terms and conditions of employment, wages and hours, including the classification of independent
contractors and has not received any notice from any governmental authority in Canada or any other country disputing such classification
Except as set forth on Schedule 3.1(k), no labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of
the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or
its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary,
and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries
believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or
any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor
of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal,
state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and
wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Compliance</U>.
Except as set forth on Schedule 3.1(l), neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event
has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary
under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any
indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties
is bound (whether or not such default or violation has been waived); (ii) is in violation of any judgment, decree or order of any court,
arbitrator or other governmental authority; or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any
governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection,
occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or
reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations, approvals, orders, licenses and permits issued
by the appropriate federal, state, local or foreign regulatory authorities, or by any foreign, federal, state or local governmental, judicial
or regulatory authority necessary to conduct their respective businesses as described in the SEC Reports, the Registration Statement and
the Prospectus (each, a &ldquo;Material Permit&rdquo;), to own, lease and operate its properties and conduct their respective businesses
as they are now being conducted or, except as disclosed in the Registration Statement and the Prospectus, proposed to be conducted, in
each case as disclosed in the Registration Statement and the Prospectus, and each such Material Permit is valid, existing, in good standing
and in full force and effect, except in each case as would not have a Material Adverse Effect. Neither the Company nor any Subsidiary
has received any notice of investigation or proceedings relating to the revocation or modification of any Material Permit. The Company
and each Subsidiary are in compliance with the terms and conditions of all such Material Permits, except where the failure to so comply
would not, individually or in the aggregate, have a Material Adverse Effect. The disclosures in the Registration Statement concerning
the effects of federal, state, local and all foreign regulation on the business of the Company and its Subsidiaries as currently contemplated
are correct in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to or have valid and marketable rights to
lease or otherwise use all real property and all personal property owned or used by them that is material to the business of the Company
and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii)
Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP
and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company
and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in
compliance except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports, the Registration Statement
and the Prospectus and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;Intellectual Property
Rights&rdquo;). The SEC Reports set forth all of the Intellectual Property Rights that the Company and its Subsidiaries own or have the
rights to use. Neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property
Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the
date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements
included within the SEC Reports, the Registration Statement and the Prospectus, a written notice of a claim or otherwise has any knowledge
that the operation of their respective businesses violate or infringe upon the intellectual property rights of any Person, except as could
not have or reasonably be expected to have a Material Adverse Effect. . To the knowledge of the Company, all such Intellectual Property
Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company
and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual
properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Insurance</U>.
Except as set forth on Schedule 3.1(p), the Company and the Subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries
are engaged. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q)&nbsp;<U>Transactions
With Affiliates and Employees</U>. Except as set forth on Schedule 3.1(r), none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with
the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing
for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee
or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is
an officer, director, trustee, stockholder, member or partner, in each case in excess of US$120,000 other than for (i) payment of salary
bonus or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee
benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r)&nbsp;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002, as amended (&ldquo;<U>SOX</U>&rdquo;), that are effective as of the date hereof, and any
and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the
Closing Date. Except as disclosed in the Registration Statement, the Prospectus and the SEC Reports, the Company and each of its Subsidiaries
maintains a system of internal accounting controls sufficient to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with GAAP, including that (i) transactions are executed
in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation
of financial statements in conformity with GAAP and to maintain asset and liability accountability, (iii) access to assets or incurrence
of liabilities is permitted only in accordance with management&rsquo;s general or specific authorization and (iv) the recorded accountability
for assets and liabilities is compared with the existing assets and liabilities at reasonable intervals and appropriate action is taken
with respect to any difference. Except as disclosed in the Registration Statement, the Prospectus and the SEC Reports, the Company and
the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed
by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time
periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness
of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently
filed Annual Report on Form 20-F under the Exchange Act (such date, the &ldquo;Evaluation Date&rdquo;). The Company presented in its most
recently filed Annual Report on Form 20-F under the Exchange Act and disclosed in the Registration Statement and the Prospectus, the conclusions
of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation
Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined
in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect,
the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s)&nbsp;<U>Certain
Fees</U>. Other than the compensation payable to the Placement Agent pursuant to the terms of the Placement Agency Agreement and as set
forth in Schedule 3.1(s) and the Prospectus Supplement relating to the placement of the Securities, no brokerage or finder&rsquo;s fees
or commissions are or will be payable by the Company or any Subsidiary or Affiliate of the Company to any broker, financial advisor or
consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction
Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other
Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t)&nbsp;<U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u)&nbsp;<U>Registration
Rights</U>. Except as set forth Schedule 3.1(u), no Person has any right to cause the Company or any Subsidiary to effect the registration
under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Listing
and Maintenance Requirements</U>. The Ordinary Shares are registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Ordinary
Shares under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Except as set forth in Schedule 3.1(v), the Company has not, in the 12 months preceding the date hereof, received notice from any Trading
Market on which the Ordinary Shares are or have been listed or quoted to the effect that the Company is not in compliance with the listing
or maintenance requirements of such Trading Market. Except as disclosed in the Registration Statement and the Prospectus, the Company
has no reason to believe that it will not in the foreseeable future continue to be in compliance with all such listing and maintenance
requirements of such Trading Market The Ordinary Shares are currently eligible for electronic transfer through the Depository Trust Company
or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such
other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w)&nbsp;<U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its jurisdiction
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)&nbsp;<U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement.
The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and
correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not misleading. There are no documents required
to be filed with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant
to the Securities Act or (y) will not be filed pursuant to Section 4.4 hereof. There are no contracts or other documents required to be
described in the Prospectus or the Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which
have not been described or filed as required. The press releases disseminated by the Company during the twelve months preceding the date
of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when
made, not misleading. The statistical and market-related data included in the Prospectus and Prospectus Supplement, if any, are based
on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate or represent the Company&rsquo;s
good faith estimates that are made on the basis of data derived from such sources. The Company has obtained all consents required for
the inclusion of such statistical and market-related data in the Prospectus and Prospectus Supplement. No forward-looking statement (within
the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained in the Prospectus or Prospectus Supplement
has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. The Company acknowledges and agrees
that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y)&nbsp;<U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
prior offerings by the Company for purposes of the Securities Act, any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z)&nbsp;<U>Solvency</U>.
Except as disclosed in the Prospectus, based on the consolidated financial condition of the Company as of the Closing Date, after giving
effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s
assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital
to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all
of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of
its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts
as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). Except as disclosed in
the Prospectus, the Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization
or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one (1) year from the Closing Date. The Prospectus
sets forth as of the date of this Agreement and as of the Closing Date, respectively, all outstanding secured and unsecured Indebtedness
of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments, except as set forth in <U>Schedule 3.1(z)</U>.
For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in
excess of Fifty Thousand Dollars ($50,000) (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties,
endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected
in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for
deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess
of One Hundred Thousand Dollars ($100,000) due under leases required to be capitalized in accordance with GAAP. Neither the Company nor
any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa)&nbsp;<U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Effect, the Company and its Subsidiaries each (i) has made or filed , or secured all extensions for the filing of, all applicable
United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any
jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount,
shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate
for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
or of any Subsidiary know of no basis for any such claim. The provisions for taxes payable, if any, shown on the financial statements
filed with or as part of the Registration Statement, Prospectus and Prospectus Supplement are sufficient for all accrued and unpaid taxes,
whether or not disputed, and for all periods to and including the dates of such consolidated financial statements. The term &ldquo;taxes&rdquo;
mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise,
profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property,
windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest and
any penalties, additions to tax, or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means all returns, declarations,
reports, statements, and other documents required to be filed in respect to taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb)&nbsp;<U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign
or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)
failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the
Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA. The Company has taken
commercially reasonable steps to ensure that its accounting controls and procedures are designed to cause the Company to comply in all
material respects with the FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc)&nbsp;<U>Accountants</U>.
The Company&rsquo;s independent registered public accounting firms are set forth in the Prospectus. To the knowledge of the Company, each
such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) Enrome LLP shall express its
opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending on March
31, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd)&nbsp;<U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee)&nbsp;<U>Acknowledgement
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for&nbsp;<U>Sections 3.2(f)</U>&nbsp;and&nbsp;<U>4.13</U>&nbsp;hereof), it is understood and acknowledged by the Company that: (i) none
of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or
short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities
for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation,
Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may
negatively impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Ordinary Shares, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Warrant Shares deliverable with respect to the Securities are being determined, and (z) such hedging activities
(if any) could reduce the value of the existing shareholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any
of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff)&nbsp;<U>Regulation
M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf (other than the Placement Agent, as to which no
representation is made) has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation
of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased,
or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation
for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation
paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg)&nbsp;<U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;), the United Nations Security Council (&ldquo;<U>UNSC</U>&rdquo;),
the European Union (&ldquo;<U>EU</U>&rdquo;), His Majesty&rsquo;s Treasury (&ldquo;<U>HMT</U>&rdquo;), or other relevant sanctions authority
(collectively, &ldquo;Sanctions&rdquo;), nor located, organized or resident in a country or territory that is the subject of Sanctions
(including, without limitation, the Russian Federation, Burma/Myanmar, Cuba, Iran, Libya, North Korea, Sudan and Syria). The Company will
not, directly or indirectly, use the proceeds of the Offering, or lend, contribute or otherwise make available such proceeds to any Subsidiary
or affiliated entity, joint venture partner or other Person to fund or facilitate any activities or business of or with any Person or
in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions; or in any other manner that
will result in a violation of Sanctions by any Person (including any Person participating in the Offering, whether as placement agent,
advisor, investor or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)&nbsp;<U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) <U>Bank Holding
Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as
amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a
bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj)&nbsp;<U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
United States federal and state and foreign money laundering statutes and applicable rules and regulations thereunder (collectively, the
&ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company
or any Subsidiary, threatened.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk) <U>Environmental
Laws</U>. The Company and its Subsidiaries (including the VIEs) (i) are in compliance with all federal, state, local and foreign laws
relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface
or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants,
or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;);
(ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i),
(ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll)&nbsp;<U>Share
Option Plans</U>. Each share option granted by the Company under the Company&rsquo;s share option plan was granted (i) in accordance with
the terms of the Company&rsquo;s share option plan and (ii) with an exercise price at least equal to the fair market value of the Ordinary
Shares on the date such share option would be considered granted under GAAP and applicable law. No share option granted under the Company&rsquo;s
share option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice
to knowingly grant, share options or awards prior to, or otherwise knowingly coordinate the grant of share options or awards with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm)&nbsp;<U>Cybersecurity</U>.
There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information
technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers,
vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;)
that would reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect and (i) the Company and the
Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in,
any material security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance
with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory
authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection
of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the
aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable
safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security
of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent
with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nn)&nbsp;<U>Compliance
with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years were, in material
compliance with all applicable state, federal and foreign data privacy and security laws and regulations, (collectively, the &ldquo;<U>Privacy
Laws</U>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to
ensure compliance with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure,
handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); (iii) the Company provides accurate notice
of its applicable Policies to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and (iv)
applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating to its subject
matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy Laws.
&ldquo;<U>Personal Data</U>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph,
social security number, bank information, or customer or account number; any information which would qualify as &ldquo;personally identifying
information&rdquo; under the FTC, as amended; (iii) &ldquo;personal data&rdquo; as defined by Measures for Cybersecurity Review (2021);
and (iv)any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection
or analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures
made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the
execution, delivery and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither
the Company nor the Subsidiaries (i) to the knowledge of the Company, has received written notice of any actual or potential liability
of the Company or the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws;
(ii) is currently conducting or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to
any regulatory request or demand pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any court
or arbitrator or governmental or regulatory authority that imposed any obligation or liability under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(oo) <U>Foreign
Issuer</U>. The Company is a &ldquo;foreign private issuer&rdquo; as defined in Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp) <U>PFIC Status</U>.
Based on the past and projected composition of its income and assets, and the valuation of its assets, including goodwill, the Company
does not expect to be a &ldquo;passive foreign investment company&rdquo; (&ldquo;<U>PFIC</U>&rdquo;) as defined in Section 1297 of the
United States Internal Revenue Code of 1986, as amended, for its current taxable year or in the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(qq) <U>Payments
in Foreign Currency</U>. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package, and the Prospectus, under
the laws and regulations of the British Virgin Islands and the PRC, (i) subject to solvency, none of the Company nor any of its Subsidiaries
is prohibited, directly or indirectly, from (A) paying any dividends or making any other distributions on its share capital, (B) making
or repaying any loan or advance to the Company or any other Subsidiary or (C) transferring any of its properties or assets to the Company
or any other Subsidiary; and (ii) all dividends and other distributions declared and payable upon the share capital of the Company or
any of its Subsidiaries (A) may be converted into United States dollars, that may be freely transferred out of such entity&rsquo;s jurisdiction
of incorporation, without the consent, approval, authorization or order of, or qualification with, any court or governmental agency or
body in such entity&rsquo;s jurisdiction of incorporation or tax residence; and (B) are not and will not be subject to withholding, value
added or other taxes under the currently effective laws and regulations of such entity&rsquo;s jurisdiction of incorporation, without
the necessity of obtaining any consents, approvals, authorizations, orders, registrations, clearances or qualifications of or with any
court or governmental agency or body having jurisdiction over such entity, except as, in each case, disclosed in the Registration Statement,
the Time of Sale Disclosure Package, and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(rr) <U>Critical
Accounting Policies</U>. The statements set forth under the heading &ldquo;Critical Accounting Estimates&rdquo; contained in the Form
20-F and incorporated by reference to the section entitled &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and
Results of Operations&rdquo; contained in or incorporated by reference in the Registration Statement, the Time of Sale Disclosure Package
and the Prospectus, accurately and fully describes in all material respects: (A) accounting policies which the Company believes are the
most important in the portrayal of the financial condition and results of operations of the Company and the Subsidiaries on a consolidated
basis and which require management&rsquo;s most difficult, subjective or complex judgments (&ldquo;Critical Accounting Policies&rdquo;);
(B) judgments and uncertainties affecting the application of Critical Accounting Policies; and (C) explanation of the likelihood that
materially different amounts would be reported under different conditions or using different assumptions. Senior management has reviewed
and agreed with the selection, application and disclosure of Critical Accounting Policies. The section entitled &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; in the Registration Statement, the Time of Sale Disclosure
Package and the Prospectus, accurately and fully describes: (x) all material trends, demands, commitments, events, uncertainties and risks,
and the potential effects thereof, that the Company believes would materially affect liquidity and are reasonably likely to occur; and
(y) all material off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the financial
condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources
of the Company and the Subsidiaries on a consolidated basis. There are no outstanding guarantees or other contingent obligations of the
Company or the Subsidiaries that could reasonably be expected to have a Material Adverse Effect. All governmental tax waivers from national
and local governments of the PRC and other local and national PRC tax relief, concession and preferential treatment obtained by the Company
or the Subsidiaries are valid, binding and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ss) <U>Open Source
Software</U>. Except as described in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, or as would not
reasonably be expected to, singly or in the aggregate, have a Material Adverse Effect: (i) the Company and the Subsidiaries use and have
used any and all software and other materials distributed under a &ldquo;free,&rdquo; &ldquo;open source,&rdquo; or similar licensing
model (including but not limited to the MIT License, Apache License, GNU General Public License, GNU Lesser General Public License and
GNU Affero General Public License) (&ldquo;<U>Open Source Software</U>&rdquo;) in compliance with all license terms applicable to such
Open Source Software; and (ii) neither the Company nor any of its Subsidiaries uses or distributes or has used or distributed any Open
Source Software in any manner that requires or has required (A) the Company or any of Subsidiaries to permit reverse engineering of any
software code or other technology owned by the Company or any of its Subsidiaries or (B) any software code or other technology owned by
the Company or any of its Subsidiaries to be (1) disclosed or distributed in source code form, (2) licensed for the purpose of making
derivative works or (3) redistributed at no charge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(tt) <U>Foreign
Tax Compliance</U>. Except as otherwise disclosed in the Time of Sale Disclosure Package and the Prospectus, no transaction, stamp, capital
or other issuance, registration, transaction, transfer or withholding taxes or duties are payable in the PRC, Hong Kong, the British Virgin
Islands or the Cayman Islands to any PRC, Hong Kong or British Virgin Islands taxing authority in connection with the issuance, sale and
delivery of the Securities, and the delivery of the Securities to or for the account of the Investors; provided that, in respect of the
British Virgin Islands, the documents in connection therewith remain outside of the British Virgin Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(uu) <U>Compliance
with PRC Oversea Investment and Listing Rules and Regulations</U>. Except as otherwise disclosed in the Time of Sale Disclosure Package
and the Prospectus, the Company and Subsidiaries have taken reasonable steps to cause the Company&rsquo;s shareholders, directors and
officers that is, or directly or indirectly controlled by, a PRC resident or citizen, to comply with any applicable rules and regulations
of relevant PRC government agencies (including but not limited to the Ministry of Commerce, the National Development and Reform Commission,
the China Securities Regulatory Commission (&ldquo;<U>CSRC</U>&rdquo;) , and the State Administration of Foreign Exchange (&ldquo;<U>SAFE</U>&rdquo;)
relating to such persons&rsquo; shareholding with the Company (collectively, the &ldquo;PRC Oversea Investment and Listing Rules and Regulations&rdquo;),
including, without limitation, taking reasonable steps to require each such person that is, or is directly or indirectly owned or controlled
by, a PRC resident or citizen to complete any registration, to timely report material changes, and other procedures required under any
applicable PRC Oversea Investment and Listing Rules and Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vv) <U>M&amp;A
Rules</U>. The Company is aware of and has been advised as to the content of the Rules on Mergers and Acquisitions of Domestic Enterprises
by Foreign Investors jointly promulgated by the Ministry of Commerce, the State Assets Supervision and Administration Commission, the
State Tax Administration, the State Administration of Industry and Commerce, the CSRC and SAFE on August 8, 2006 and amended in 2009 (the
&ldquo;<U>M&amp;A Rules</U>&rdquo;), in particular the relevant provisions thereof that purport to require offshore special purpose vehicles
formed for the purpose of obtaining a stock exchange listing outside of the PRC and controlled directly or indirectly by companies or
natural persons of the PRC, to obtain the approval of the CSRC prior to the listing and trading of their securities on a stock exchange
located outside of the PRC; the Company has received legal advice specifically with respect to the M&amp;A Rules from its PRC counsel
and based on such legal advice, the Company confirms with the Placement Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) Except as disclosed
in the Registration Statement, the Time of Sale Disclosure Package, and the Prospectus, the issuance and sale of the Securities, the listing
and trading of the Securities on the Trading Market, and the consummation of the transactions contemplated by this Agreement are not and
will not be, as of the date hereof, at the Closing Date, materially affected by the M&amp;A Rules or any official clarifications, guidance,
interpretations or implementation rules in connection with or related to the M&amp;A Rules as amended as of the date hereof (collectively,
the &ldquo;M&amp;A Rules and Related Clarifications&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) Except as disclosed
in the Registration Statement, the Time of Sale Disclosure Package, and the Prospectus, as of the date hereof, the M&amp;A Rules and Related
Classifications did not and do not require the Company to obtain the approval of the CSRC prior to the issuance and sale of the Securities,
the listing and trading of the Securities on the Trading Market, or the consummation of the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ww) <U>Securities
Offering and Listing Rules</U>. For the purposes of this Agreement, &ldquo;<U>CAC</U>&rdquo; means the Cyberspace Administration of China;
&ldquo;CSRC Archive Rules&rdquo; means the Provisions on Strengthening Confidentiality and Archives Administration of Overseas Securities
Offering and Listing by Domestic Companies (&#20851;&#20110;&#21152;&#24378;&#22659;&#20869;&#20225;&#19994;&#22659;&#22806;&#21457;&#34892;&#35777;&#21048;&#21644;&#19978;&#24066;&#30456;&#20851;&#20445;&#23494;&#21644;&#26723;&#26696;&#31649;&#29702;&#24037;&#20316;&#30340;&#35268;&#23450;)
issued by the CSRC, Ministry of Finance of the PRC, National Administration of State Secrets Protection of the PRC, and National Archives
Administration of the PRC (effective from March 31, 2023), as amended, supplemented or otherwise modified from time to time; &ldquo;CSRC
Filing Rules&rdquo; means the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (&#22659;&#20869;&#20225;&#19994;&#22659;&#22806;&#21457;&#34892;&#35777;&#21048;&#21644;&#19978;&#24066;&#31649;&#29702;&#35797;&#34892;&#21150;&#27861;)
and supporting guidelines issued by the CSRC (effective from March 31, 2023), as amended, supplemented or otherwise modified from time
to time; &ldquo;<U>CSRC Filings</U>&rdquo; means any letters, filings, correspondences, communications, documents, responses, undertakings
and submissions in any form, including any amendments, supplements and/or modifications thereof, made or to be made to the CSRC, relating
to or in connection with the offering pursuant to the CSRC Filing Rules and other applicable rules and requirements of the CSRC; &ldquo;<U>CSRC
Rules</U>&rdquo; means the CSRC Filing Rules and the CSRC Archive Rules; &ldquo;<U>Revised Cybersecurity Review Measures</U>&rdquo; means
the Cybersecurity Review Measures, effective from February 15, 2022, promulgated by the CAC, together with certain other PRC governmental
authorities (&#12298;&#32593;&#32476;&#23433;&#20840;&#23457;&#26597;&#21150;&#27861;&#12299;). The Company represents and warrants to
the Placement Agent that the Offering or the listing of the Ordinary Shares on the Trading Market has fully complied with the requirements
of the CSRC Rules and the Revised Cybersecurity Review Measures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xx) <U>Compliance
with Rules of Trading Market</U>. On or prior to the Closing Date, the Company shall have taken all actions required pursuant to Nasdaq
Rule 5615(a)(3) to duly and validly rely on the exemption for foreign private issuers from applicable rules and regulations of the Nasdaq
by adopting the home country practice (the &ldquo;Home Country Practice&rdquo;) in connection with the transactions contemplated hereunder
(including an exemption from any Nasdaq rules that would otherwise require seeking shareholder approval in respect of such transactions).
The Company&rsquo;s practices in connection with the transactions contemplated hereunder are not prohibited by its home country&rsquo;s
laws Company has elected to be governed by home country rules, such that Nasdaq Listing Rule 5635(d) will not apply to Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(yy) <U>Outbound
Investment Representations and Warranties</U>. The Company is not a &ldquo;covered foreign person&rdquo; under 31 C.F.R. &sect; 850.209.
Furthermore, Company does not currently engage, and has no intention to engage, in any &ldquo;covered activity&rdquo; or &ldquo;covered
transaction&rdquo; (as defined in 31 C.F.R. &sect;&sect; 850.208 and 850.210) that would result in a &ldquo;notifiable transaction&rdquo;
or a &ldquo;prohibited transaction&rdquo; (as defined in 31 C.F.R. &sect; 850.217 and 850.224), or that would otherwise violate, or cause
Purchaser to violate, any &ldquo;Outbound Investment Law.&rdquo; For purposes of this Agreement, &ldquo;Outbound Investment Law&rdquo;
refers to any legal requirement related to the &ldquo;Outbound Investment Regulations&rdquo; (31 C.F.R. &sect;&sect; 850.101&ndash;850.904)
and Executive Order 14105.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;<U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date of this Agreement and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they
shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Incorporation,
Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in
good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability
company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and
otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which
it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will
constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i)
as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto), and the SEC Reports including the Prospectus and, has been afforded, (i) the opportunity to ask such questions
as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the
offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its
financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment;
and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort
or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees
that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with
respect to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made
or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired
non-public information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance
of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary
to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received
a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material pricing terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons
party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners,
legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for
the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Ownership
of Company Securities</U>. Except as disclosed in writing to the Company as of the date of this Agreement, no Purchaser, any of its Affiliates,
or any other Persons whose beneficial ownership of Ordinary Shares would be aggregated with the Purchaser&rsquo;s for purposes of Section
13(d) of the Exchange Act and the rules and regulations promulgated thereunder, including any &ldquo;group&rdquo; of which the Purchaser
is a member, directly or indirectly owns, beneficially or otherwise (including solely with respect to an economic interest), any of the
outstanding Ordinary Shares, or any other share capital, options, warrants, derivative securities, rights or any other securities (including
any securities convertible into, exchangeable for or that represent the right to receive securities) of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Sanctioned
Persons; BSA/PATRIOT Act</U>. Purchaser is not owned or controlled by or acting on behalf of (in connection with this Agreement), a Sanctioned
Person. Purchaser is not an institution that accepts currency for deposit and that (i) has no physical presence in the jurisdiction in
which it is incorporated or in which it is operating and (ii) is unaffiliated with a regulated financial group that is subject to consolidated
supervision (a &ldquo;<U>Shell Bank</U>&rdquo;) or providing banking services to a Shell Bank. Purchaser represents that if it is a financial
institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.), as amended by the USA PATRIOT Act of 2001 and its implementing
regulations (collectively, the &ldquo;<U>BSA/PATRIOT Act</U>&rdquo;), that Purchaser maintains policies and procedures reasonably designed
to comply with applicable obligations under the BSA/PATRIOT Act. Purchaser also represents that, to the extent required by applicable
law, it maintains, either directly or through the use of a third-party administrator, policies, and procedures reasonably designed for
the screening of any investors in the Purchaser against Sanctions-related lists of blocked or restricted persons. Purchaser further represents
and warrants that (A) the funds held by Purchaser and used to purchase the Securities were not directly or indirectly derived from or
related to any activities that may contravene U.S. federal, state, or non-U.S. anti-money laundering, anti-corruption, or Sanctions laws
and regulations or activities that may otherwise be deemed criminal and (B) any returns from the Purchaser&rsquo;s investment will not
be used to finance any illegal activities. For purposes of this Agreement, &ldquo;<U>Sanctioned Person</U>&rdquo; means at any time any
person or entity with whom dealings are restricted, prohibited, or sanctionable under any Sanctions (as defined below), including as a
result of being: (I) listed on any Sanctions-related list of designated or blocked or restricted persons; (II) that is a national of,
the government of, or any agency or instrumentality of the government of, or resident in, or organized under the laws of, a country or
territory that is the target of comprehensive Sanctions from time to time (as of the date of this Agreement, Cuba, Iran, North Korea,
Syria, and the Crimea region); or (III) a relationship of ownership, control, or agency with any of the foregoing. &ldquo;<U>Sanctions</U>&rdquo;
means those trade, economic and financial sanctions laws, regulations, embargoes, and restrictive measures (in each case having the force
of law) administered, enacted, or enforced from time to time by (1) the United States (including without limitation the U.S. Department
of the Treasury, Office of Foreign Assets Control, the U.S. Department of State, and the U.S. Department of Commerce), (2) the European
Union and enforced by its member states, (3) the United Nations, and (4) the United Kingdom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Non-cooperative
Jurisdiction</U>. Purchaser is not owned or controlled by or acting on behalf of (in connection with this Agreement), a person or entity
resident in, or whose funds used to purchase the Securities are transferred from or through, a country, territory, or entity that (i)
has been designated as non-cooperative with international anti-money laundering or counter terrorist financing principles or procedures
by the United States or by an intergovernmental group or organization, such as the Financial Action Task Force, of which the United States
is a member; (ii) is the subject of an advisory issued by the Financial Crimes Enforcement Network of the U.S. Department of the Treasury;
or (iii) has been designated by the Secretary of the Treasury under Section 311 of the USA PATRIOT Act as warranting special measures
due to money laundering concerns (any such country or territory, a &ldquo;<U>Non-cooperative Jurisdiction</U>&rdquo;), or an entity or
individual that resides or has a place of business in, or is organized under the laws of, a Non-cooperative Jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>ERISA</U>.
If Purchaser is an employee benefit plan that is subject to Title I of the Employee Retirement Income Security Act of 1974, as amended
(&ldquo;<U>ERISA</U>&rdquo;), a plan, an individual retirement account or other arrangement that is subject to section 4975 of the Code
or an employee benefit plan that is a governmental plan (as defined in section 3(32) of ERISA), a church plan (as defined in section 3(33)
of ERISA), a non-U.S. plan (as described in section 4(b)(4) of ERISA), or other plan that is not subject to the foregoing but may be subject
to provisions under any other federal, state, local, non-U.S., or other laws or regulations that are similar to such provisions of ERISA
or the Code, or an entity whose underlying assets are considered to include &ldquo;plan assets&rdquo; of any such plan, account or arrangement
subject to the fiduciary or prohibited transaction provisions of ERISA or section 4975 of the Code, Purchaser represents and warrants
that the acquisition and holding of the Securities will not result in a non-exempt prohibited transaction under ERISA or Section 4975
of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the representations
contained in this&nbsp;<U>Section 3.2</U>&nbsp;shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s
representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document
or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions
contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation
or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">4.1&nbsp;<U>Warrant Shares</U>.
If all or any portion of the Pre-Funded Warrants are exercised at a time when there is an effective registration statement to cover the
issuance or resale of the Warrant Shares or if the Pre-Funded Warrants are exercised via cashless exercise, the Warrant Shares issued
pursuant to any such exercise shall be issued free of all legends. If at any time following the date hereof the Registration Statement
(or any subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available
for the sale or resale of the Warrant Shares, the Company shall immediately notify the holders of the Pre-Funded Warrants in writing that
such registration statement is not then effective and thereafter shall promptly notify such holders when the registration statement is
effective again and available for the sale or resale of the Warrant Shares (it being understood and agreed that the foregoing shall not
limit the ability of the Company to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable federal and
state securities laws). The Company shall use best efforts to keep a registration statement (including the Registration Statement) registering
the issuance or resale of the Warrant Shares effective during the term of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;<U>Furnishing of
Information</U>. Until the earliest of the time that (i) no Purchaser owns Securities or (ii) the Pre-Funded Warrants have expired, the
Company covenants to&nbsp;<FONT STYLE="background-color: white">use its best efforts to&nbsp;</FONT>timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&nbsp;<U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of
any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval
is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4&nbsp;<U>Securities Laws
Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions
contemplated hereby, and (b) file a Current Report on Form 6-K, including the Transaction Documents as exhibits thereto, with the SEC
within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers
that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of
its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the
Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance
of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement,
whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees,
Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates
on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms that each Purchaser shall
be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each Purchaser shall consult
with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor
any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company,
with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release
of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case
the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding
the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with
the SEC or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal
securities law in connection with the filing of final Transaction Documents with the SEC and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted
under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5&nbsp;<U>Shareholder Rights
Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is
an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6&nbsp;<U>Non-Public Information</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be
disclosed pursuant to&nbsp;<U>Section 4.4</U>, the Company covenants and agrees that neither it, nor any other Person acting on its behalf
will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes,
material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed
with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not
have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees
or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or
Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable
law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the SEC on a Current Report on Form
6-K or shall issue a press release containing such material non-public information. The Company understands and confirms that each Purchaser
shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7&nbsp;<U>Use of Proceeds</U>.
The Company shall use the net proceeds from the sale of the Securities hereunder as described in the Prospectus, for working capital purposes
and other general corporate purposes, and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s
debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption
of any Ordinary Shares or Ordinary Share Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA
or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8&nbsp;<U>Indemnification
of Purchasers</U>. Subject to the provisions of this&nbsp;<U>Section 4.8</U>, the Company will indemnify and hold each Purchaser and its
directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role
of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within
the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents,
members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless to the fullest
extent permitted by applicable law from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses,
including all judgments, amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that
any such Purchaser Party may suffer or incur as a result of or relating to (i) any breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement or in the other Transaction Documents, (ii) any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement or Prospectus or by any omission or alleged omission to state therein
a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading (other
than untrue statements or alleged untrue statements in, or omissions or alleged omissions from, information relating to a Purchaser Party
furnished in writing by or on behalf of such Purchaser Party expressly for use in the Registration Statement or Prospectus), or (iii)
any Proceeding instituted against the Purchaser Parties in any capacity (including a Purchaser Party&rsquo;s status as an investor), or
any of them or their respective Affiliates, by the Company or any shareholder of the Company who is not an Affiliate of such Purchaser
Party, arising out of or relating to any of the transactions contemplated by the Transaction Documents. For avoidance of doubt, the indemnification
provided herein is intended to and shall also cover, direct claims brought by the Company against the Purchaser Parties; provided, however,
that such indemnification shall not cover any loss, claim, damage or liability to the extent it is finally judicially determined to be
attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser
Party in any Transaction Document or any conduct by a Purchaser Party which is finally judicially determined to constitute fraud, gross
negligence or willful misconduct. If any Proceeding shall be brought against any Purchaser Party in respect of which indemnity may be
sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and, except with respect to direct
claims brought by the Company, the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such Proceeding and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent
that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such Proceeding there is, in the reasonable opinion of counsel
to the applicable Purchaser Party (which may be internal counsel), a material conflict on any material issue between the position of the
Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses
of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement for any settlement
by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed.
In addition, if any Purchaser Party takes actions to collect amounts due under any Transaction Documents or to enforce the provisions
of any Transaction Documents, then the Company shall pay the cost incurred by such Purchaser Party for such collection, enforcement or
action, including, but not limited to, attorney&rsquo;s fees and disbursements. The indemnification and other payment obligations required
by this&nbsp;<U>Section 4.8</U>&nbsp;shall be made by periodic payments of the amount thereof during the course of the investigation,
defense, collection, enforcement or action, as and when bills are received or are incurred; provided, that if any Purchaser Party is finally
judicially determined not to be entitled to indemnification or payment under this&nbsp;<U>Section 4.8</U>, such Purchaser Party shall
promptly reimburse the Company for any payments that are advanced under this sentence. The indemnity agreements contained herein shall
be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company
may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9&nbsp;<U>Reservation of
Ordinary Shares</U>. As of the date of this Agreement, the Company has reserved and the Company shall continue to reserve and keep available
at all times, free of preemptive rights, in its authorized and unissued share capital a sufficient number of Ordinary Shares for the purpose
of enabling the Company to issue the Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants, including
but not limited to, a number of Ordinary Shares sufficient to honor the issuance of the maximum number of Ordinary Shares issuable assuming
exercise in full of the Pre-Funded Warrants pursuant to the terms of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10&nbsp;<U>Listing of Shares</U>.
The Company hereby agrees to use best efforts to maintain the listing or quotation of the Shares and Warrant Shares on each Trading Market
on which any Ordinary Shares are currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of
the Shares and Warrant Shares on such Trading Markets and promptly secure the listing of all of the Shares and Warrant Shares on such
Trading Markets. The Company further agrees, if the Company applies to have the Ordinary Shares traded on any other Trading Market, it
will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all
of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take
all action reasonably necessary to continue the listing and trading of its Ordinary Shares on a Trading Market and will comply in all
material respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The
Company agrees to maintain the eligibility of the Ordinary Shares for electronic transfer through The Depository Trust Company or another
established clearing corporation, including, without limitation, by timely payment of fees to The Depository Trust Company or such other
established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11&nbsp;<U>Subsequent Equity
Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) From the date
hereof until thirty (30) days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement
to issue or announce the issuance or proposed issuance of any Ordinary Shares or Ordinary Share Equivalents, or (ii) file any registration
statement or amendment or supplement thereto, other than with respect to the Registration Statement or a registration statement on Form
S-8, except for the Securities issued pursuant hereto or otherwise in connection with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) From the date
hereof until sixty (60) days after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect
any issuance by the Company or any of its Subsidiaries of Ordinary Shares or Ordinary Share Equivalents (or a combination of units thereof)
involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company (i) issues
or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional
Ordinary Shares either (A) at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies with
the trading prices of or quotations for the Ordinary Shares at any time after the initial issuance of such debt or equity securities,
or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of
such debt or equity security (other than in connection with a share split or share dividend or similar event) or upon the occurrence of
specified or contingent events directly or indirectly related to the business of the Company or the market for the Ordinary Shares or
(ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market
offering&rdquo;, whereby the Company may issue securities at a future determined price regardless of whether shares pursuant to such agreement
have actually been issued and regardless of whether such agreement is subsequently canceled. The Purchaser shall be entitled to obtain
injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) Notwithstanding
the foregoing, this&nbsp;<U>Section 4.11</U>&nbsp;shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12&nbsp;<U>Equal Treatment
of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to
amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered
to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to
each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as
a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13&nbsp;<U>Certain Transactions
and Confidentiality</U>. Each Purchaser, severally and not jointly, covenants that neither it nor any Affiliate acting on its behalf or
pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company&rsquo;s securities
during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in&nbsp;<U>Section 4.4</U>. Each Purchaser, severally
and not jointly, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company
pursuant to the initial press release as described in&nbsp;<U>Section 4.4</U>, such Purchaser will maintain the confidentiality of the
existence and terms of this transaction. Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the
contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that
it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this
Agreement are first publicly announced pursuant to the initial press release as described in&nbsp;<U>Section 4.4</U>, (ii) no Purchaser
shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities
laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in&nbsp;<U>Section 4.4</U>&nbsp;and (iii) no Purchaser shall have any duty of confidentiality or duty not to
trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates, or agent, including, without limitation, the Placement Agent after the issuance of the initial press release as described
in&nbsp;<U>Section 4.4</U>. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby
separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge
of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set
forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14&nbsp;<U>Exercise Procedures</U>.
The form of Notice of Exercise included in the Pre-Funded Warrants sets forth the totality of the procedures required of the Purchasers
in order to exercise the Pre-Funded Warrants. No additional legal opinion, other information or instructions shall be required of the
Purchasers to exercise their Pre-Funded Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be
required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in
order to exercise the Pre-Funded Warrants. The Company shall honor exercises of the Pre-Funded Warrants and shall deliver Warrant Shares
in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15&nbsp;<U>Lock-Up Agreements</U>.
The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the
lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement
breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms
of such Lock-Up Agreement.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE V.<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1&nbsp;<U>Termination</U>.
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5th) Trading Day following the date hereof;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that no such termination
will affect the right of any party hereto to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;<U>Fees and Expenses</U>.
Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any
fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser),
stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3&nbsp;<U>Entire Agreement</U>.
The Transaction Documents, together with the exhibits and schedules thereto, and the Prospectus and the Prospectus Supplement, contain
the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings,
oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4&nbsp;<U>Notices</U>. Any
and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be
deemed given and effective on the earliest of: (i) the time of transmission, if such notice or communication is delivered via facsimile
at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30
p.m. (New York, NY time) on a Trading Day, (ii) the next Trading Day after the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York, NY time) on any Trading Day, (iii) the second (2nd) Trading
Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party
to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages
attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the SEC pursuant to a Report
on Form 6-K or by issuing a press release containing such material non-public information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5&nbsp;<U>Amendments; Waivers</U>.
No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of
an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Units based on the Subscription Amounts
hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement
of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts
a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be
required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any amendment
effected in accordance with this&nbsp;<U>Section 5.5</U>&nbsp;shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6&nbsp;<U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7&nbsp;<U>Successors and
Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8&nbsp;<U>Third-Party Beneficiaries</U>.
The Placement Agent shall be a third-party beneficiary of the representations and warranties of the Company in&nbsp;<U>Section 3.1</U>&nbsp;and
the representations and warranties of the Purchasers in&nbsp;<U>Section 3.2</U>. This Agreement is intended for the benefit of the parties
hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by,
any other Person, except as otherwise set forth in&nbsp;<U>Section 4.8</U>&nbsp;and this&nbsp;<U>Section 5.8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9&nbsp;<U>Governing Law</U>.
All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service
of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law. If any party shall commence an Proceeding to enforce any provisions
of the Transaction Documents, then, in addition to the obligations of the Company under&nbsp;<U>Section 4.8</U>, the prevailing party
in such Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such Proceeding. The Company hereby appoints Puglisi &amp; Associates,
850 Library Avenue, Suite 204, Newark, DE 19711, (302) 738-6680 as its agent for service of process in New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10&nbsp;<U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for the applicable statute
of limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11&nbsp;<U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature page were an original
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12&nbsp;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13&nbsp;<U>Rescission and
Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the
other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the
Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw,
in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that in the case of a rescission of an
exercise of a Pre-Funded Warrant, the applicable Purchaser shall be required to return any Ordinary Shares subject to any such rescinded
exercise notice concurrently (if such shares were delivered to the applicable Purchaser) with the return to such Purchaser of the aggregate
exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant
to such Purchaser&rsquo;s Pre-Funded Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14&nbsp;<U>Replacement of
Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15&nbsp;<U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Proceeding for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17&nbsp;<U>Independent Nature
of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. The
Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not
because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained
in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and
the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18&nbsp;<U>Liquidated Damages</U>.
The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing
obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding
the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall
have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19&nbsp;<U>Saturdays, Sundays,
Holidays, etc.</U>&nbsp;If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20&nbsp;<U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and Ordinary Shares in any Transaction Document shall be subject to adjustment for reverse and forward share splits, share
dividends, share combinations and other similar events with respect to the Ordinary Shares and Pre-Funded Warrants that occur after the
date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21&nbsp;<U>Sales During
Pre-Settlement Period</U>. Notwithstanding anything herein to the contrary, if at any time on or after the time of execution of this Agreement
by the Company and an applicable Purchaser, through, and including the time immediately prior to the Closing (the &ldquo;<U>Pre-Settlement
Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of any Shares to be issued hereunder to such Purchaser at
the Closing (collectively, the &ldquo;<U>Pre-Settlement Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any
additional required actions by such Purchaser or the Company), be deemed to be unconditionally bound to purchase, and the Company shall
be deemed unconditionally bound to sell, such Pre-Settlement Shares to such Purchaser at the Closing; provided, that the Company shall
not be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase price of such
Pre-Settlement Shares hereunder; and provided further that the Company hereby acknowledges and agrees that the forgoing shall not constitute
a representation or covenant by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any Shares
to any Person and that any such decision to sell any Shares by such Purchaser shall be made, in the sole discretion of such Purchaser,
at the time such Purchaser elects to effect any such sale, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.22&nbsp;<B><U>WAIVER OF
JURY TRIAL</U>.&nbsp;<U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>China SXT Pharmaceuticals, Inc. </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for Notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">178 Taidong Rd North, Taizhou</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jiangsu Province</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">People&rsquo;s Republic of China</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Feng Zhou</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 59%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feng Zhou</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Feng Zhou</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">E-Mail: fzhou@sxtchina.com</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Chief Executive Officer </FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Telephone Number: N/A</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Loeb &amp; Loeb LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">2206-19 Jardine House</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">1 Connaught Place</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Central, Hong Kong SAR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Lawrence S. Venick, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email: lvenick@loeb.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>SIGNATURE PAGE TO SECURITIES
PURCHASE AGREEMENT</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: Sabby Volatility Warrant Master
Fund, Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signature of Authorized Signatory of Purchaser:
<U>/s/ Robert Grundstein&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: Chief Operating
Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory: _________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile Number of Authorized Signatory: __________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser (and delivery of the Pre-Funded Warrants):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Applicable Securities to Purchaser (if not
same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares: (if applicable) _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pre-Funded Warrants: (if applicable) _________________
Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Lock-Up Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(see attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Pre-Funded Warrant</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(see attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 35; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ea027250601ex10-2_chinasxt.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center"><B>PLACEMENT AGENCY AGREEMENT</B></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">January 9, 2026</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">Univest Securities, LLC</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">75 Rockefeller Plaza, Suite 18C</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif">New York, NY 10019</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif">Ladies and Gentlemen:</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">Subject to the terms and conditions
of this agreement (this &ldquo;<B>Agreement</B>&rdquo;) and the Transaction Documents (as defined below), China SXT Pharmaceuticals, Inc.,
a BVI business company incorporated in the British Virgin Islands (the &ldquo;<B>Company</B>&rdquo;), hereby agrees to offer and sell
up to an aggregate of approximately $15,000,000 of securities directly to various investors (each, an &ldquo;<B>Investor</B>&rdquo; and
collectively, the &ldquo;<B>Investors</B>&rdquo;) through Univest Securities, LLC, as placement agent (the &ldquo;<B>Placement Agent</B>&rdquo;),
consisting of class A ordinary shares of the Company, no par value per share (the &ldquo;<B>Ordinary Shares</B>&rdquo;), and/or pre-funded
Ordinary Share purchase warrant to purchase one Ordinary Share in lieu thereof (each, a &ldquo;<B>Pre-Funded Warrant</B>&rdquo; and collectively,
the &ldquo;<B>Pre-Funded Warrants</B>&rdquo;) as the applicable Investor may elect. The Ordinary Shares underlying the Pre-Funded Warrants
are referred to as the &ldquo;<B>Warrant Shares</B>.&rdquo; The Ordinary Shares offered and sold in this Offering (as defined below) is
defined as the &ldquo;<B>Shares</B>.&rdquo; The Shares, the Pre-Funded Warrants and the Warrant Shares are collectively referred to as
the &ldquo;<B>Securities</B>.&rdquo; The documents executed and delivered by the Company and the Investors in connection with the Offering
(as defined below), including, without limitation, a securities purchase agreement to be entered into between the Company and each Investor
(the &ldquo;<B>Purchase Agreement</B>&rdquo;), shall be collectively referred to herein as the &ldquo;<B>Transaction Documents</B>.&rdquo;
The purchase price to the Investors for each Share is $0.15 and the exercise price for each Share issuable upon exercise of each Pre-Funded
Warrant is $0.001.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">Notwithstanding anything herein
to the contrary, in the event that the Placement Agent determines that any of the terms provided for hereunder do not comply with a Financial
Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;) rule, including but not limited to FINRA Rule 5110, then the Company shall
agree to amend this Agreement in writing upon the request of the Placement Agent to comply with any such rules; provided that any such
amendments shall not provide for terms that are less favorable to the Company than the terms of this Agreement or terms that are adverse
to the Company.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">The Company hereby confirms
its agreement with the Placement Agent as follows:</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 1. Agreement to Act as Placement Agent</B>.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(a) On the basis of the representations,
warranties and agreements of the Company herein contained, and subject to all the terms and conditions of this Agreement, the Placement
Agent shall be the exclusive placement agent in connection with the offering and sale by the Company of the Securities pursuant to the
Company&rsquo;s registration statement on Form F-3 (File No. 333- 291428) (the &ldquo;<B>Registration Statement</B>&rdquo;) with the terms
of such offering (the &ldquo;<B>Offering</B>&rdquo;) to be subject to market conditions and negotiations between the Company, the Placement
Agent and the prospective Investors. The Placement Agent will act on a best efforts basis and the Company agrees and acknowledges that
there is no guarantee of the successful placement of the Securities, or any portion thereof, in the prospective Offering. Under no circumstances
will the Placement Agent or any of its Affiliates (as defined below) be obligated to underwrite or purchase any of the Securities for
its own account or otherwise provide any financing. The Placement Agent shall act solely as the Company&rsquo;s agent and not as principal.
The Placement Agent shall have no authority to bind the Company with respect to any prospective offer to purchase Securities and the Company
shall have the sole right to accept offers to purchase Securities and may reject any such offer, in whole or in part. Subject to the terms
and conditions hereof, payment of the purchase price for, and delivery of, the Securities shall be made at one closing (the &ldquo;<B>Closing</B>&rdquo;
and the date on which the Closing occurs, the &ldquo;<B>Closing Date</B>&rdquo;). As used in this agreement, &ldquo;Affiliate&rdquo; means
any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with
a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 33.75pt; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 33.75pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 33.75pt; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">As compensation for services
rendered, on the Closing Date, the Company shall pay to the Placement Agent the following:</P>



<P STYLE="margin: 0pt 0 0pt 33.75pt; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 33.75pt; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 33.75pt">(i) a cash fee
equal to seven percent (7%) of the aggregate gross proceeds received by the Company from the sale of the Securities (the &ldquo;<B>Cash
Fee</B>&rdquo;);</P>

<P STYLE="margin: 0pt 0 0pt 33.75pt; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 33.75pt; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 33.75pt">(ii) a non-accountable
expense reimbursement in an amount equal to half percent (0.5%) of the gross proceeds of the Offering; and&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 33.75pt; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 33.75pt; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 33.75pt">(iii) reimbursement
of the Placement reasonable travel and out-of-pocket expenses, including legal counsel fees and disbursements, not to exceed an aggregate
of One Hundred Thousand Dollars ($100,000), subject to compliance with FINRA Rule 5110(f)(2)(D).</P>

<P STYLE="margin: 0pt 0 0pt 33.75pt; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(b) The term of the Placement
Agent&rsquo;s exclusive engagement shall begin on the date hereof and continue until January 9, 2026 at 9am ET. Unless otherwise provided
under this Agreement, the provisions concerning the Company&rsquo;s obligation to pay any fees actually earned pursuant to&nbsp;<U>Section
1(a)</U>&nbsp;hereof and to pay or reimburse the Placement Agent for any expenses and legal fees incurred in accordance with&nbsp;<U>Section
6</U>&nbsp;hereof, the Company&rsquo;s obligations contained in the indemnification provisions, and the provisions concerning indemnification
and contribution contained herein will survive any expiration or termination of this Agreement for any reason. All fees and expense payments
or reimbursements due to the Placement Agent shall be paid by the Company to the Placement Agent on or before the Termination Date (in
the event such fees and expenses are earned or owed as of the Termination Date). Furthermore, the Company agrees that during the Placement
Agent&rsquo;s engagement hereunder, all inquiries from prospective U.S. investors and with respect to the Offering will be referred to
the Placement Agent. Additionally, the Company represents, warrants and covenants that no brokerage or finder&rsquo;s fees or commissions
are or will be payable by the Company or any subsidiary of the Company to any broker, financial advisor or consultant, finder, placement
agent, investment banker, bank or other third-party with respect to the Offering. The Placement Agent agrees, not to use any confidential
information concerning the Company provided to the Placement Agent by the Company for any purposes other than those contemplated under
this Agreement. Starting from the date of this Agreement, without the Placement Agent&rsquo;s consent, neither the Company nor any of
its agents shall, in any manner contact, solicit or transact with any investors that have been contacted by and through the Placement
Agent. The Company shall not in any way whatsoever circumvent or attempt to circumvent the Placement Agent and shall not enter into direct
or indirect offers, negotiations or transactions with any investors contacted and revealed by the Placement Agent.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">The services provided by the
Placement Agent hereunder are solely for the benefit of the Company and are not intended to confer any rights upon any persons or entities
not a party hereto (including, without limitation, security holders, employees or creditors of the Company) as against the Placement Agent
or its directors, officers, agents and employees.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 2. Representations, Warranties and
Covenants of the Company</B>. Each of the representations and warranties (together with any related disclosure schedules thereto) and
covenants made by the Company to the Investors in the Purchase Agreements in connection with the Offering is hereby incorporated herein
by reference into this Agreement (as though fully restated herein) and is, as of the date of this Agreement and as of the Closing Date,
hereby made to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that:</P>



<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Securities Law
Filings</U>. The Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) the Registration Statement
under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), which was originally filed on November 10, 2025
and originally became effective on December 1, 2025, for the registration of the Securities under the Securities Act. Following the determination
of pricing among the Company and the prospective Investors introduced to the Company by the Placement Agent, the Company will file with
the SEC pursuant to Rules 424(b) and 430B under the Securities Act, and the rules and regulations (the &ldquo;<B>Rules and Regulations</B>&rdquo;)
of the SEC promulgated thereunder, a supplement to such registration statement and a base prospectus contained therein relating to the
placement of the Securities, their respective pricings and the plan of distribution thereof and will advise the Placement Agent of all
further information (financial and other) with respect to the Company required to be set forth therein. Such registration statement, at
any given time, including the exhibits thereto filed at such time, as amended at such time, is hereinafter called the &ldquo;<B>Registration
Statement</B>&rdquo;; such prospectus in the form in which it appears in the Registration Statement at the time of effectiveness is hereinafter
called the &ldquo;<B>Base Prospectus</B>&rdquo;; and the supplemented form of prospectus, in the form in which it will be filed with the
SEC pursuant to Rules 424(b) and/or 430B (including the Base Prospectus as it may be amended or supplemented) is hereinafter called the
&ldquo;<B>Prospectus Supplement</B>.&rdquo; If the Company files any registration statement pursuant to Rule 462(b) of the Securities
Act Rules and Regulations, then after such filing, the term &ldquo;Registration Statement&rdquo; shall include such registration statement
filed pursuant to Rule 462(b). Any reference in this Agreement to the Registration Statement, the Registration Statement, the Base Prospectus
or the Prospectus Supplement shall be deemed to refer to and include the documents incorporated by reference therein (the &ldquo;<B>Incorporated
Documents</B>&rdquo;), if any, which were or are filed under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;),
at any given time, as the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment,&rdquo;
or &ldquo;supplement&rdquo; with respect to the Registration Statement, the Base Prospectus or the Prospectus Supplement shall be deemed
to refer to and include the filing of any document under the Exchange Act after the date of this Agreement, or the issue date of the Base
Prospectus or the Prospectus Supplement, as the case may be, deemed to be incorporated therein by reference. All references in this Agreement
to financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo;
&ldquo;referenced,&rdquo; &ldquo;set forth,&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the Base Prospectus or the Prospectus
Supplement (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and
other information which is or is deemed to be incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus
Supplement, as the case may be. As used in this paragraph and elsewhere in this Agreement, &ldquo;<B>Time of Sale Disclosure Package</B>&rdquo;
means the Base Prospectus, any securities purchase agreement between the Company and the Investors, the final terms of the Offering provided
to the Investors (orally or in writing) and any issuer free writing prospectus as defined in Rule 433 of the Securities Act (each, an
&ldquo;<B>Issuer Free Writing Prospectus</B>&rdquo;), if any, that the parties hereto shall hereafter expressly agree in writing to treat
as part of the Time of Sale Disclosure Package. The term &ldquo;<B>any Prospectus</B>&rdquo; shall mean, as the context requires, the
Base Prospectus, the Prospectus Supplement, and any supplement to either thereof. The Company has not received any notice that the SEC
has issued or intends to issue a stop order suspending the effectiveness of the Registration Statement or the use of the Base Prospectus
or any Prospectus Supplement or intends to commence a Proceeding (as defined below) for any such purpose. &ldquo;Proceeding&rdquo; means
any action, suit, inquiry, notice of violation, proceeding or investigation affecting the Company, any subsidiary or any of their respective
properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county,
local or foreign).</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Assurances</U>.
The Registration Statement, as amended, (and any further documents to be filed with the SEC) contains all exhibits and schedules as required
by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied
in all material respects with the Securities Act and the applicable Rules and Regulations and did not contain any untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.
The Base Prospectus and the Prospectus Supplement, each as of its respective date, complies or will comply in all material respects with
the Securities Act and the applicable Rules and Regulations. Each of the Base Prospectus and the Prospectus Supplement, as amended or
supplemented, did not and will not contain as of the date thereof any untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The
Incorporated Documents, when they were filed with the SEC, conformed in all material respects to the requirements of the Exchange Act
and the applicable Rules and Regulations promulgated thereunder, and none of such documents, when they were filed with the SEC, contained
any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein (with respect to
Incorporated Documents incorporated by reference in the Base Prospectus or the Prospectus Supplement), in light of the circumstances under
which they were made not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising
after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is
required to be filed with the SEC. Except for this Agreement and the Transaction Documents, there are no documents required to be filed
with the SEC in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities
Act or (y) will not be filed within the requisite time period. Except for this Agreement and the Transaction Documents, there are no contracts
or other documents required to be described in the Base Prospectus or the Prospectus Supplement, or to be filed as exhibits or schedules
to the Registration Statement, which have not been described or filed as required.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Offering Materials</U>.
Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to the Closing Date,
any offering material in connection with the offering and sale of the Securities other than the Time of Sale Disclosure Package.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Subsidiaries</U>.
All of the direct and indirect Subsidiaries of the Company and their respective jurisdictions of incorporation are set forth in the SEC
Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear
of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid,
non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Organization and
Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own
and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation
nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter
documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation
or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect
on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken
as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its
obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;Material Adverse Effect&rdquo;) and no Proceeding has
been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s shareholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party has
been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof,
will constitute the valid and binding obligations of the Company enforceable against the Company in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, liquidation, possessory liens, rights of set off,
merger, consolidation, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights
generally as well as applicable international sanctions, (ii) as limited by laws relating to the statutory limitation of the time within
which proceedings may be brought or availability of specific performance, injunctive relief or other equitable remedies, (iii) insofar
as indemnification and contribution provisions may be limited by applicable law and (iv) that such obligations (a) may not be given effect
to by a British Virgin Islands court if and to the extent they constitute the payment of an amount which is in the nature of a penalty
and (b) may not be given effect by a British Virgin Islands court to the extent that they are to be performed in a jurisdiction outside
the British Virgin Islands and such performance would be illegal under the laws of that jurisdiction.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>No Conflicts</U>.
The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the
issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not
(i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation,
bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse
of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company
or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse
of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or
other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary
is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation,
order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is
subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary
is bound or affected; except in the case of clause (ii), such as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Filings, Consents
and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any
filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with
the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to
Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement (iii) application(s) to each applicable
Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby and such filings
as are required to be made under applicable state securities laws (collectively, the &ldquo;Required Approvals&rdquo;).</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Issuance of the
Securities; Registration</U>. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company. The Pre-funded
Warrants are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will constitute valid
and legally binding obligations of the Company, enforceable against the Company in accordance with their terms. The Warrant Shares are
duly authorized and, when issued in accordance with the terms of the Pre-funded Warrants against payment therefor as provided therein,
will be validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company. The Company has reserved from
its duly authorized share capital the maximum number of Ordinary Shares issuable pursuant to this Agreement and the Pre-funded Warrants
(without taking into account any limitations on the exercise of the Pre-funded Warrants set forth therein). The Company has prepared and
filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on December 1, 2025,
including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration
Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement
or suspending or preventing the use of the Prospectus has been issued by the SEC and no Proceedings for that purpose have been instituted
or, to the knowledge of the Company, are threatened by the SEC. The Company, if required by the rules and regulations of the SEC, shall
file the Prospectus with the SEC pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective,
at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform
in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and
the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued
and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and
will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the Registration
Statement eligible to use Form F-3. The Company is eligible to use Form F-3 under the Securities Act and it meets the transaction requirements
as set forth in General Instruction I.B.1 of Form F-3 with respect to the aggregate market value of the Shares.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">Any &ldquo;issuer free writing
prospectus&rdquo; (as defined in Rule 433 under the Securities Act) relating to the Securities is hereafter referred to as an &ldquo;<U>Issuer
Free Writing Prospectus</U>.&rdquo; Any reference herein to the Prospectus shall be deemed to refer to and include the documents incorporated
by reference therein as of the date of filing thereof; and any reference herein to any &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo;
with respect to the Prospectus shall be deemed to refer to and include (i) the filing of any document with the SEC incorporated or deemed
to be incorporated therein by reference after the date of filing of such Prospectus and (ii) any such document so filed.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">All references in this Agreement
to the Registration Statement, the Prospectus, or any Issuer Free Writing Prospectus, or any amendments or supplements to any of the foregoing,
shall be deemed to include any copy thereof filed with the SEC on EDGAR.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth Prospectus. The number of Ordinary Shares owned beneficially,
and of record, by Affiliates of the Company as of the date hereof is set forth in the Prospectus. Except as set forth in the Registration
Statement, the Prospectus and the Prospectus Supplement, the Company has not issued any Ordinary Shares or other shares of capital stock
since the filing of its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock
options under the Company&rsquo;s stock option plans, the issuance of Ordinary Shares to employees pursuant to the Company&rsquo;s employee
stock purchase plans and pursuant to the conversion and/or exercise of Ordinary Share Equivalents outstanding as of the date of the most
recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set forth on Schedule 3.1(g),
there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any Ordinary Shares or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional Ordinary Shares or Ordinary Share Equivalents or capital
stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue Ordinary Shares
or other securities to any Person (other than the Purchasers) and will not result in a right of any holder of Company securities to adjust
the exercise, conversion, exchange or reset price under any of such securities. Except as set forth on Schedule 3.1(g), there are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the
Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. All of the outstanding Ordinary Shares and any other shares of capital stock of the Company are duly
authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and
none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.
No further approval or authorization of any shareholder, the Board of Directors or others is required for the issuance and sale of the
Securities. There are no shareholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s Ordinary
Shares or other shares of capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the
Company&rsquo;s shareholders.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>SEC Reports; Financial
Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date
hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including
the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus Supplement, being
collectively referred to herein as the &ldquo;SEC Reports&rdquo;) on a timely basis or has received a valid extension of such time of
filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports
complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC
Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Additionally,
any further documents so filed and incorporated by reference in the Prospectus and Prospectus Supplement, when such documents are filed
with the Commission, will conform in all material respects to the requirements of the Exchange Act and the applicable rules and regulations,
as applicable, and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
therein, in light of the circumstances under which they were made not misleading. No post-effective amendment to the Registration Statement
reflecting any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental change
in the information set forth therein is required to be filed with the Commission. The Company has not been an issuer subject to Rule 144(i)
under the Securities Act. As of their respective dates, the financial statements of the Company included in the SEC Reports the Registration
Statement and the Prospectus complied in all material respects with applicable accounting requirements and the rules and regulations of
the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with
United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;GAAP&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements and documents described
in the Registration Statement, the Prospectus, the Prospectus Supplement, and the SEC Reports conform in all material aspects to the descriptions
thereof contained therein and there are no agreements or other documents required by the Securities Act and the rules and regulations
thereunder to be described in the Registration Statement, the Prospectus, the Prospectus Supplement, or the SEC Reports or to be filed
with the Commission as exhibits to the Registration Statement, that have not been so described or filed. Each agreement or other instrument
(however characterized or described) to which the Company is a party or by which it is or may be bound or affected and (i) that is referred
to in the Registration Statement, the Prospectus, the Prospectus Supplement, or the SEC Reports, or (ii) is material to the Company&rsquo;s
business (each, a &ldquo;Material Agreement&rdquo;), has been duly authorized and validly executed by the Company, is in full force and
effect in all material respects and is enforceable against the Company and, to the Company&rsquo;s knowledge, the other parties thereto,
in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws
affecting creditors&rsquo; rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under
the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief
may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefore may be brought. No Material
Agreement has been assigned by the Company, and neither the Company nor, to the best of the Company&rsquo;s knowledge, any other party
is in default thereunder and, to the best of the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the
giving of notice, or both, would constitute a default thereunder that has had or that could reasonably be expected to result in a Material
Adverse Effect. To the best of the Company&rsquo;s knowledge, performance by the Company of the material provisions of the Material Agreements
will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency
or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation,
those relating to environmental laws and regulations. The other financial and statistical information included in the SEC Reports, the
Registration Statement and the Prospectus present fairly, in all material respects, the information included therein and have been prepared
on a basis consistent with that of the financial statements that are included in the SEC Reports the Registration Statement and the Prospectus
and the books and records of the respective entities presented therein.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Material Changes;
Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within the SEC
Reports, the Registration Statement, the Prospectus and the Prospectus Supplement, (i) there has been no event, occurrence or development,
including changes generally affecting the Company&rsquo;s or Subsidiaries&rsquo; industries, that has had or that could reasonably be
expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than
(A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of
cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company
stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Securities contemplated by this Agreement or as set forth on Schedule 3.1(i), no event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries
or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least 1 Trading Day prior to the date that this representation is made. Other than as set forth in the SEC Reports, the Company has
not: (i) issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or
paid any dividend or made any other distribution on or in respect of its capital stock.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Litigation</U>.
Except as set forth in the Registration Statement, the Prospectus and on Schedule 3.1(j), there has not been, and to the knowledge of
the Company, there is not pending or contemplated, any action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;Action&rdquo;). None of the Actions set forth on Schedule 3.1(j), the Registration Statement, the Prospectus
and the Prospectus Supplement adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents
or the Securities, (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect
or (iii) are not expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof,
is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim
of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation
by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any
stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the
Exchange Act or the Securities Act.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Labor Relations</U>.
The Company and each of its Subsidiaries is, and has been, in material compliance with all applicable laws respecting labor, employment
and employment practices, terms and conditions of employment, wages and hours, including the classification of independent contractors
and has not received any notice from any governmental authority in Canada or any other country disputing such classification Except as
set forth in the SEC Reports, no labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the
Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that
their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and
foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Compliance</U>.
Except as set forth in the Registration Statement, the Prospectus, the Prospectus Supplement and Schedule 3.1(l), neither the Company
nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or
lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received
notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement
or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been
waived); (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority; or (iii) is or
has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign,
federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety
and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Regulatory Permits</U>.
The Company and the Subsidiaries possess all certificates, authorizations, approvals, orders, licenses and permits issued by the appropriate
federal, state, local or foreign regulatory authorities, or by any foreign, federal, state or local governmental, judicial or regulatory
authority necessary to conduct their respective businesses as described in the SEC Reports, the Registration Statement and the Prospectus
(each, a &ldquo;Material Permit&rdquo;), to own, lease and operate its properties and conduct their respective businesses as they are
now being conducted or, except as disclosed in the Registration Statement and the Prospectus, proposed to be conducted, in each case as
disclosed in the Registration Statement and the Prospectus, and each such Material Permit is valid, existing, in good standing and in
full force and effect, except in each case as would not have a Material Adverse Effect. Neither the Company nor any Subsidiary has received
any notice of investigation or proceedings relating to the revocation or modification of any Material Permit. The Company and each Subsidiary
are in compliance with the terms and conditions of all such Material Permits, except where the failure to so comply would not, individually
or in the aggregate, have a Material Adverse Effect. The disclosures in the Registration Statement concerning the effects of federal,
state, local and all foreign regulation on the business of the Company and its Subsidiaries as currently contemplated are correct in all
material respects.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(q)&nbsp;<U>Title to Assets</U>.
The Company and the Subsidiaries have good and marketable title in fee simple to or have valid and marketable rights to lease or otherwise
use all real property and all personal property owned or used by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance except where
the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(r)&nbsp;<U>Intellectual Property</U>.
The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary
or required for use in connection with their respective businesses as described in the SEC Reports, the Registration Statement and the
Prospectus and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;Intellectual Property Rights&rdquo;).
The SEC Reports set forth all of the Intellectual Property Rights that the Company and its Subsidiaries own or have the rights to use.
Neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has
expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this
Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within
the SEC Reports, the Registration Statement and the Prospectus, a written notice of a claim or otherwise has any knowledge that the operation
of their respective businesses violate or infringe upon the intellectual property rights of any Person, except as could not have or reasonably
be expected to have a Material Adverse Effect. . To the knowledge of the Company, all such Intellectual Property Rights are enforceable
and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have
taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where
failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(s)&nbsp;<U>Insurance</U>.
Except as set forth in the SEC Reports, the Company and the Subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries
are engaged. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
without a significant increase in cost.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(t)&nbsp;<U>Transactions With
Affiliates and Employees</U>. Except as set forth on Schedule 3.1(r), none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with
the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing
for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee
or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is
an officer, director, trustee, stockholder, member or partner, in each case in excess of US$120,000 other than for (i) payment of salary
bonus or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee
benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(u)&nbsp;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002, as amended (&ldquo;<U>SOX</U>&rdquo;), that are effective as of the date hereof, and any
and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the
Closing Date. Except as disclosed in the Registration Statement, the Prospectus and the SEC Reports, the Company and each of its Subsidiaries
maintains internal control over financial reporting (as such term is defined in Rule 13a-l5(f) under the Exchange Act) that is effective
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP, including that (i) transactions are executed in accordance with management&rsquo;s general or specific
authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and
to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance with
management&rsquo;s general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared with
the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any difference. Except as
disclosed in the Registration Statement, the Prospectus and the SEC Reports, the Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules
and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company
and the Subsidiaries as of the end of the period covered by the most recently filed Annual Report on Form 20-F under the Exchange Act
(such date, the &ldquo;Evaluation Date&rdquo;). The Company presented in its most recently filed Annual Report on Form 20-F under the
Exchange Act and disclosed in the Registration Statement and the Prospectus, the conclusions of the certifying officers about the effectiveness
of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have
been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its
Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting
of the Company and its Subsidiaries.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Certain Fees</U>.
Other than the compensation payable to the Placement Agent pursuant to the terms of the Placement Agency Agreement and as set forth in
the Prospectus Supplement relating to the placement of the Securities, no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Company or any Subsidiary or Affiliate of the Company to any broker, financial advisor or consultant, finder, placement
agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers
shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type
contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(w)&nbsp;<U>Investment Company</U>.
The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate
of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct
its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the Investment Company
Act of 1940, as amended.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(x)&nbsp;<U>Registration Rights</U>.
Except as set forth herein and in the SEC Reports, no Person has any right to cause the Company or any Subsidiary to effect the registration
under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(y)&nbsp;<U>Listing and Maintenance
Requirements</U>. The Ordinary Shares are registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken
no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Ordinary Shares
under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Except as set forth in the Registration Statement, the Prospectus and the Prospectus Supplement, the Company has not, in the 12 months
preceding the date hereof, received notice from any Trading Market on which the Ordinary Shares are or have been listed or quoted to the
effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. Except as disclosed
in the Registration Statement and the Prospectus, the Company has no reason to believe that it will not in the foreseeable future continue
to be in compliance with all such listing and maintenance requirements of such Trading Market The Ordinary Shares are currently eligible
for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in
payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic
transfer.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(z)&nbsp;<U>Application of
Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its jurisdiction
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(aa)&nbsp;<U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement.
The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and
correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not misleading. There are no documents required
to be filed with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant
to the Securities Act or (y) will not be filed pursuant to Section 4.4 hereof. There are no contracts or other documents required to be
described in the Prospectus or the Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which
have not been described or filed as required. The press releases disseminated by the Company during the twelve months preceding the date
of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when
made, not misleading. The statistical and market-related data included in the Prospectus and Prospectus Supplement, if any, are based
on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate or represent the Company&rsquo;s
good faith estimates that are made on the basis of data derived from such sources. The Company has obtained all consents required for
the inclusion of such statistical and market-related data in the Prospectus and Prospectus Supplement. No forward-looking statement (within
the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained in the Prospectus or Prospectus Supplement
has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. The Company acknowledges and agrees
that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(bb)&nbsp;<U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
prior offerings by the Company for purposes of the Securities Act, any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(cc)&nbsp;<U>Solvency</U>.
Except as disclosed in the Prospectus, based on the consolidated financial condition of the Company as of the Closing Date, after giving
effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s
assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital
to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all
of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of
its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts
as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). Except as disclosed in
the Prospectus, the Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization
or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one (1) year from the Closing Date. The Prospectus
sets forth as of the date of this Agreement and as of the Closing Date, respectively, all outstanding secured and unsecured Indebtedness
of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments, except as set forth in <U>Schedule 3.1(z)</U>.
For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in
excess of Fifty Thousand Dollars ($50,000) (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties,
endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected
in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for
deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess
of One Hundred Thousand Dollars ($100,000) due under leases required to be capitalized in accordance with GAAP. Neither the Company nor
any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(dd)&nbsp;<U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i) has made or filed , or secured all extensions for the filing of, all applicable United States
federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction
to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment
of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any
Subsidiary know of no basis for any such claim. The provisions for taxes payable, if any, shown on the financial statements filed with
or as part of the Registration Statement, Prospectus and Prospectus Supplement are sufficient for all accrued and unpaid taxes, whether
or not disputed, and for all periods to and including the dates of such consolidated financial statements. The term &ldquo;taxes&rdquo;
mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise,
profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property,
windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest and
any penalties, additions to tax, or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means all returns, declarations,
reports, statements, and other documents required to be filed in respect to taxes.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(ff)&nbsp;<U>Foreign Corrupt
Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person
acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment
or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law, or (iv) violated in any material respect any provision of FCPA. The Company has taken commercially reasonable
steps to ensure that its accounting controls and procedures are designed to cause the Company to comply in all material respects with
the FCPA.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(gg)&nbsp;<U>Accountants</U>.
The Company&rsquo;s independent registered public accounting firms are set forth in the Prospectus. To the knowledge of the Company, each
such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) Enrome LLP shall express its
opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending on March
31, 2026.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(hh)&nbsp;<U>Regulation M
Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf (other than the Placement Agent, as to which no
representation is made) has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation
of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased,
or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation
for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation
paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;), the United Nations Security Council (&ldquo;<U>UNSC</U>&rdquo;),
the European Union (&ldquo;<U>EU</U>&rdquo;), His Majesty&rsquo;s Treasury (&ldquo;<U>HMT</U>&rdquo;), or other relevant sanctions authority
(collectively, &ldquo;Sanctions&rdquo;), nor located, organized or resident in a country or territory that is the subject of Sanctions
(including, without limitation, the Russian Federation, Burma/Myanmar, Cuba, Iran, Libya, North Korea, Sudan and Syria). The Company will
not, directly or indirectly, use the proceeds of the Offering, or lend, contribute or otherwise make available such proceeds to any Subsidiary
or affiliated entity, joint venture partner or other Person to fund or facilitate any activities or business of or with any Person or
in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions; or in any other manner that
will result in a violation of Sanctions by any Person (including any Person participating in the Offering, whether as placement agent,
advisor, investor or otherwise).</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(jj)&nbsp;<U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(kk) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended
(the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;).
Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity
that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(ll)&nbsp;<U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable United States federal
and state and foreign money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering
Laws</U>&rdquo;), and no Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;(mm)&nbsp;<U>Certificates</U>.
Any certificate signed by an officer of the Company and delivered to the Placement Agent shall be deemed to be a representation and warranty
by the Company to the Placement Agent as to the matters set forth therein.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(nn)&nbsp;<U>Reliance</U>.
The Company acknowledges that the Placement Agent will rely upon the accuracy and truthfulness of the foregoing representations and warranties
and hereby consents to such reliance.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(oo)&nbsp;<U>Forward-Looking
Statements</U>. No forward-looking statements (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) contained in the Time of Sale Disclosure Package has been made or reaffirmed without a reasonable basis or has been disclosed other
than in good faith.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(pp)&nbsp;<U>Statistical or
Market-Related Data</U>. Any statistical, industry-related and market-related data included or incorporated by reference in the Time of
Sale Disclosure Package, are based on or derived from sources that the Company reasonably and in good faith believes to be reliable and
accurate, and such data agree with the sources from which they are derived.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(qq)&nbsp;<U>FINRA Affiliations</U>.
There are no affiliations with any firm that is a member of the FINRA participating in the Offering among the Company&rsquo;s officers,
directors or, to the knowledge of the Company, any 5% or greater shareholder of the Company.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(rr)&nbsp;<U>Board of Directors</U>.
The Company&rsquo;s Board of Directors is comprised of the persons identified as directors of the Company in the SEC Reports or in the
Base Prospectus or the Prospectus under the section titled &ldquo;Management.&rdquo; The qualifications of the persons serving as board
members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder
applicable to the Company and the rules of the Trading Market. At least one member of the Board of Directors qualifies as a &ldquo;financial
expert&rdquo; as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules of the Trading
Market. In addition, at least a majority of the persons serving on the Board of Directors qualify as &ldquo;independent&rdquo; as defined
under the rules of the Trading Market.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(ss)&nbsp;<U>Cybersecurity</U>.
There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information
technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers,
vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<B>IT Systems and Data</B>&rdquo;)
that would reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect and (i) the Company and the
Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in,
any material security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance
with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory
authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection
of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the
aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable
safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security
of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent
with industry standards and practices.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(tt)&nbsp;<U>Compliance with
Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years were, in material compliance
with all applicable state, federal and foreign data privacy and security laws and regulations (collectively, the &ldquo;<B>Privacy Laws</B>&rdquo;);
(ii) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to ensure compliance
with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling and analysis
of Personal Data (as defined below) (the &ldquo;<B>Policies</B>&rdquo;); (iii) the Company provides accurate notice of its applicable
Policies to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and (iv) applicable Policies
provide accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating to its subject matter, and do not
contain any material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy Laws. &ldquo;<B>Personal
Data</B>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph, social security
number, bank information, or customer or account number; (ii) any information which would qualify as &ldquo;personally identifying information&rdquo;
under the FTC, as amended; (iii) &ldquo;personal data&rdquo; as defined by Measures for Cybersecurity Review (2021); and (iv) any other
piece of information that allows the identification of such natural person, or his or her family, or permits the collection or analysis
of any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures made or contained
in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the execution, delivery
and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company nor the
Subsidiaries (i) to the knowledge of the Company, has received written notice of any actual or potential liability of the Company or the
Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws; (ii) is currently
conducting or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to any regulatory request
or demand pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any court or arbitrator or governmental
or regulatory authority that imposed any obligation or liability under any Privacy Law.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(uu) <U>Environmental Laws</U>.
The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection
of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances
or wastes (collectively, the &ldquo;<B>Hazardous Materials</B>&rdquo;) into the environment, or otherwise relating to the manufacture,
processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations,
codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations,
issued, entered, promulgated or approved thereunder (&ldquo;<B>Environmental Laws</B>&rdquo;); (ii) have received all permits licenses
or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance
with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply
could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(vv) <U>Foreign Issuer</U>.
The Company is a &ldquo;foreign private issuer&rdquo; as defined in Rule 405 under the Securities Act.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(ww) <U>PFIC Status</U>. Based
on the past and projected composition of its income and assets, and the valuation of its assets, including goodwill, the Company does
not expect to be a &ldquo;passive foreign investment company&rdquo; (&ldquo;<B>PFIC</B>&rdquo;) as defined in Section 1297 of the United
States Internal Revenue Code of 1986, as amended, for its current taxable year or in the foreseeable future.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(xx) <U>Payments in Foreign
Currency</U>. Except as disclosed in the Base Prospectus, the Time of Sale Disclosure Package, and the Prospectus, under the laws and
regulations of the British Virgin Islands and the PRC, (i) subject to solvency, none of the Company nor any Subsidiaries is prohibited,
directly or indirectly, from (A) paying any dividends or making any other distributions on its share capital, (B) making or repaying any
loan or advance to the Company or any Subsidiary or (C) transferring any of its properties or assets to the Company or any Subsidiary;
and (ii) all dividends and other distributions declared and payable upon the share capital of the Company or any Subsidiaries (A) may
be converted into United States dollars, that may be freely transferred out of such entity&rsquo;s jurisdiction of incorporation, without
the consent, approval, authorization or order of, or qualification with, any court or governmental agency or body in such entity&rsquo;s
jurisdiction of incorporation or tax residence; and (B) are not and will not be subject to withholding, value added or other taxes under
the currently effective laws and regulations of such entity&rsquo;s jurisdiction of incorporation, without the necessity of obtaining
any consents, approvals, authorizations, orders, registrations, clearances or qualifications of or with any court or governmental agency
or body having jurisdiction over such entity, except as, in each case, disclosed in the Base Prospectus, the Time of Sale Disclosure Package,
and the Prospectus.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(yy) <U>Critical Accounting
Policies</U>. The statements set forth under the heading &ldquo;Critical Accounting Estimates&rdquo; contained in Form 20-F and incorporated
by reference to the section entitled &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo;,
contained in or incorporated by reference in the Base Prospectus, the Time of Sale Disclosure Package and the Prospectus, accurately and
fully describes in all material respects: (A) accounting policies which the Company believes are the most important in the portrayal of
the financial condition and results of operations of the Company and the Subsidiaries on a consolidated basis and which require management&rsquo;s
most difficult, subjective or complex judgments (the &ldquo;<B>Critical Accounting Policies</B>&rdquo;); (B) judgments and uncertainties
affecting the application of Critical Accounting Policies; and (C) explanation of the likelihood that materially different amounts would
be reported under different conditions or using different assumptions. Senior management has reviewed and agreed with the selection, application
and disclosure of Critical Accounting Policies. The section entitled &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition
and Results of Operations&rdquo; contained in or incorporated by reference into the Base Prospectus, the Time of Sale Disclosure Package
and the Prospectus, accurately and fully describes: (x) all material trends, demands, commitments, events, uncertainties and risks, and
the potential effects thereof, that the Company believes would materially affect liquidity and are reasonably likely to occur; and (y)
all material off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the financial condition,
changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources of the
Company and the Subsidiaries on a consolidated basis. There are no outstanding guarantees or other contingent obligations of the Company
or the Subsidiaries that could reasonably be expected to have a Material Adverse Effect. All governmental tax waivers from national and
local governments of the PRC and other local and national PRC tax relief, concession and preferential treatment obtained by the Company
or the Subsidiaries are valid, binding and enforceable.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(zz) <U>Open Source Software</U>.
Except as described in the Base Prospectus, the Time of Sale Disclosure Package and the Prospectus, or as would not reasonably be expected
to, singly or in the aggregate, have a Material Adverse Effect: (i) the Company and any Subsidiaries use and have used any and all software
and other materials distributed under a &ldquo;free,&rdquo; &ldquo;open source,&rdquo; or similar licensing model (including but not limited
to the MIT License, Apache License, GNU General Public License, GNU Lesser General Public License and GNU Affero General Public License)
(the &ldquo;<B>Open Source Software</B>&rdquo;) in compliance with all license terms applicable to such Open Source Software; and (ii)
neither the Company nor any Subsidiaries uses or distributes or has used or distributed any Open Source Software in any manner that requires
or has required (A) the Company or any Subsidiaries to permit reverse engineering of any software code or other technology owned by the
Company or any Subsidiaries or (B) any software code or other technology owned by the Company or any Subsidiaries to be (1) disclosed
or distributed in source code form, (2) licensed for the purpose of making derivative works or (3) redistributed at no charge.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(aaa) <U>Foreign Tax Compliance</U>.
Except as otherwise disclosed in the Time of Sale Disclosure Package and the Prospectus, no transaction, stamp, capital or other issuance,
registration, transaction, transfer or withholding taxes or duties are payable in the PRC, Hong Kong, the British Virgin Islands to any
PRC, Hong Kong or British Virgin Islands taxing authority in connection with the issuance, sale and delivery of the Securities, and the
delivery of the Securities to or for the account of the Investors; provided that, in respect of the British Virgin Islands, the documents
in connection therewith remain outside of the British Virgin Islands.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(bbb) <U>Compliance with PRC
Oversea Investment and Listing Rules and Regulations</U>. Except as otherwise disclosed in the Time of Sale Disclosure Package and the
Prospectus, the Company and Subsidiaries have taken reasonable steps to cause the Company&rsquo;s shareholders, directors and officers
that is, or directly or indirectly controlled by, a PRC resident or citizen, to comply with any applicable rules and regulations of relevant
PRC government agencies (including but not limited to the Ministry of Commerce, the National Development and Reform Commission, the China
Securities Regulatory Commission (the &ldquo;<B>CSRC</B>&rdquo;) , and the State Administration of Foreign Exchange (&ldquo;<B>SAFE</B>&rdquo;)
relating to such persons&rsquo; shareholding with the Company (collectively, the &ldquo;<B>PRC Oversea Investment and Listing Rules and
Regulations</B>&rdquo;), including, without limitation, taking reasonable steps to require each such person that is, or is directly or
indirectly owned or controlled by, a PRC resident or citizen to complete any registration, to timely report material changes, and other
procedures required under any applicable PRC Oversea Investment and Listing Rules and Regulations.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(ccc) <U>M&amp;A Rules</U>.
The Company is aware of and has been advised as to the content of the Rules on Mergers and Acquisitions of Domestic Enterprises by Foreign
Investors jointly promulgated by the Ministry of Commerce, the State Assets Supervision and Administration Commission, the State Tax Administration,
the State Administration of Industry and Commerce, the CSRC and SAFE on August 8, 2006 and amended in 2009 (the &ldquo;<B>M&amp;A Rules</B>&rdquo;),
in particular the relevant provisions thereof that purport to require offshore special purpose vehicles formed for the purpose of obtaining
a stock exchange listing outside of the PRC and controlled directly or indirectly by companies or natural persons of the PRC, to obtain
the approval of the CSRC prior to the listing and trading of their securities on a stock exchange located outside of the PRC; the Company
has received legal advice specifically with respect to the M&amp;A Rules from its PRC counsel and based on such legal advice, the Company
confirms with the Placement Agent:</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(i) Except as disclosed in
the Registration Statement, the Time of Sale Disclosure Package, and the Prospectus, the issuance and sale of the Securities, the listing
and trading of the Securities on the Trading Market, and the consummation of the transactions contemplated by this Agreement are not and
will not be, as of the date hereof, at the Closing Date, materially affected by the M&amp;A Rules or any official clarifications, guidance,
interpretations or implementation rules in connection with or related to the M&amp;A Rules as amended as of the date hereof.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(ii) Except as disclosed in
the Registration Statement, the Time of Sale Disclosure Package, and the Prospectus, as of the date hereof, the M&amp;A Rules and Related
Classifications did not and do not require the Company to obtain the approval of the CSRC prior to the issuance and sale of the Securities,
the listing and trading of the Securities on the Trading Market, or the consummation of the transactions contemplated by this Agreement.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(ddd) <U>Securities Offering
and Listing Rules</U>. For the purposes of this Agreement, &ldquo;<B>CAC</B>&rdquo; means the Cyberspace Administration of China; &ldquo;<B>CSRC
Archive Rules</B>&rdquo; means the Provisions on Strengthening Confidentiality and Archives Administration of Overseas Securities Offering
and Listing by Domestic Companies (&#20851;&#20110;&#21152;&#24378;&#22659;&#20869;&#20225;&#19994;&#22659;&#22806;&#21457;&#34892;&#35777;&#21048;&#21644;&#19978;&#24066;&#30456;&#20851;&#20445;&#23494;&#21644;&#26723;&#26696;&#31649;&#29702;&#24037;&#20316;&#30340;&#35268;&#23450;)
issued by the CSRC, Ministry of Finance of the PRC, National Administration of State Secrets Protection of the PRC, and National Archives
Administration of the PRC (effective from March 31, 2023), as amended, supplemented or otherwise modified from time to time; &ldquo;<B>CSRC
Filing Rules</B>&rdquo; means the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (&#22659;&#20869;&#20225;&#19994;&#22659;&#22806;&#21457;&#34892;&#35777;&#21048;&#21644;&#19978;&#24066;&#31649;&#29702;&#35797;&#34892;&#21150;&#27861;)
and supporting guidelines issued by the CSRC (effective from March 31, 2023), as amended, supplemented or otherwise modified from time
to time; &ldquo;<B>CSRC Filings</B>&rdquo; means any letters, filings, correspondences, communications, documents, responses, undertakings
and submissions in any form, including any amendments, supplements and/or modifications thereof, made or to be made to the CSRC, relating
to or in connection with the offering pursuant to the CSRC Filing Rules and other applicable rules and requirements of the CSRC; &ldquo;<B>CSRC
Rules</B>&rdquo; means the CSRC Filing Rules and the CSRC Archive Rules; &ldquo;<B>Revised Cybersecurity Review Measures</B>&rdquo; means
the Cybersecurity Review Measures, effective from February 15, 2022, promulgated by the CAC, together with certain other PRC governmental
authorities (&#12298;&#32593;&#32476;&#23433;&#20840;&#23457;&#26597;&#21150;&#27861;&#12299;). The Company represents and warrants to
the Placement Agent that the Offering or the listing of the Ordinary Shares on the Trading Market has fully complied with the requirements
of the CSRC Rules and the Revised Cybersecurity Review Measures.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(eee)&nbsp;<U>Share Option
Plans</U>. Each share option granted by the Company under the Company&rsquo;s share option plan was granted (i) in accordance with the
terms of the Company&rsquo;s share option plan and (ii) with an exercise price at least equal to the fair market value of the Ordinary
Shares on the date such share option would be considered granted under GAAP and applicable law. No share option granted under the Company&rsquo;s
share option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice
to knowingly grant, share options or awards prior to, or otherwise knowingly coordinate the grant of share options or awards with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 3. Delivery and Payment</B>.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Closing for the
Offering</U>. Delivery of and payment for the Ordinary Shares and Pre-Funded Warrants shall be made at or around 11:00 a.m., Eastern time,
on the first (1st) Trading Day following the date of the Purchase Agreement (or the second (2nd) Trading Day following the date of the
Purchase Agreement if the Purchase Agreement is signed on a day that is not a Trading Day or after 4:00 p.m. (New York, NY time) and before
midnight (New York, NY time) on a Trading Day). The Closing shall take place remotely by electronic transfer of the Closing documentation.
On the Closing Date, the Company shall issue such amount of shares and/or pre-funded warrants sold pursuant to the Purchase Agreement
directly to the accounts designated by the Placement Agent for the applicable Investors and payment shall be made by the Investors by
wire transfer to the Company. At the Closing, the Securities which the Company shall deliver to each Investor shall consist of the following,
as applicable: (i) the number of Shares and/or Pre-Funded Warrants purchased by such Investor. Subject to the terms and conditions hereof,
at the Closing, payment of the purchase price for the Shares and/or Pre-funded Warrants sold pursuant to the Purchase Agreement shall
be made by federal funds wire transfer, against delivery of the Shares (with the Pre-Funded Warrants to follow as provided in the previous
sentence), and such Securities shall be registered in such name or names and shall be in such denominations, as the Placement Agent may
request. Deliveries of the documents with respect to the purchase of the Securities, if any, shall be made remotely by electronic transfer;
provided, however, that the Company shall be deemed to have satisfied its obligations with respect to the delivery of the Pre-Funded Warrants
by making available a PDF copy of the executed Pre-Funded Warrants at the Closing and delivering the originals thereof within five (5)
Trading Days of the Closing. All actions taken at the Closing shall be deemed to have occurred simultaneously.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Payment for the
Shares and/or Pre-funded Warrants</U>. The Shares and/or Pre-funded Warrants are being sold to the Investors at the public offering price
as set forth in the Prospectus. The purchase of the Shares and/or Pre-funded Warrants by each of the Investors shall be evidenced by the
receipt of funds in the account designated by the Company and the Placement Agent and execution of a Purchase Agreement by each such Investor
and the Company.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Delivery of the
Shares and the Pre-Funded Warrants</U>. Delivery of the Shares shall be made through the facilities of The Depository Trust Company unless
the Placement Agent shall otherwise instruct. Delivery of the Pre-Funded Warrants shall be made as set forth in&nbsp;<U>Section 3(a)</U>&nbsp;above.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 4. Covenants and Agreements of the
Company</B>. The Company further covenants and agrees with the Placement Agent as follows:</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Registration Statement
Matters</U>. During the Prospectus Delivery Period (as defined below), the Company will advise the Placement Agent promptly after it receives
notice thereof of the time when any amendment to the Registration Statement has been filed or becomes effective or any supplement to the
Prospectus has been filed and will furnish the Placement Agent with copies thereof. During the Prospectus Delivery Period, the Company
will file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the SEC pursuant
to Section 13(a), 14 or 15(d) of the Exchange Act subsequent to the date of any Prospectus Supplement. During the Prospectus Delivery
Period, the Company will advise the Placement Agent, promptly after it receives notice thereof (i) of any request by the SEC to amend
the Registration Statement or to amend or supplement any Prospectus Supplement or for additional information, and (ii) of the issuance
by the SEC of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or any
order directed at any Incorporated Document, if any, or any amendment or supplement thereto or any order preventing or suspending the
use of the Base Prospectus or the Prospectus Supplement or any other prospectus supplement or any amendment or supplement thereto or any
post-effective amendment to the Registration Statement, of the suspension of the qualification of the Securities for offering or sale
in any jurisdiction, of the institution or threatened institution of any Proceeding for any such purpose, or of any request by the SEC
for the amending or supplementing of the Registration Statement or the Prospectus Supplement or for additional information. The Company
shall use its best efforts to prevent the issuance of any such stop order or prevention or suspension of such use. If the SEC shall enter
any such stop order or order or notice of prevention or suspension at any time, the Company will use its best efforts to obtain the lifting
of such order at the earliest possible moment, or will file a new registration statement and use its best efforts to have such new registration
statement declared effective as soon as practicable. Additionally, the Company agrees that during the Prospectus Delivery Period, it shall
comply with the provisions of Rules 424(b), 430A, 430B and 430C, as applicable, under the Securities Act, including with respect to the
timely filing of documents thereunder, and will use its reasonable efforts to confirm that any filings made by the Company under such
Rule 424(b) are received in a timely manner by the SEC. The Company covenants and agrees to update the Prospectus Supplement to include
all information required to be included therein, including with respect to any SEC Reports that are filed subsequent to the date of the
Prospectus Supplement, for the period beginning on the effective date of the Registration Statement and ending on the date on which no
Warrants (including any Pre-Funded Warrants) are outstanding.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Blue Sky Compliance</U>.
The Company will cooperate with the Placement Agent and the Investors in endeavoring to qualify or register the Offering under the securities
laws of applicable jurisdictions (United States and foreign) as the Placement Agent and the Investors may reasonably request and will
make such applications, file such documents, and furnish such information as may be reasonably required for that purpose, provided the
Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction
where it is not now so qualified or required to file such a consent, and&nbsp;<U>provided further</U>&nbsp;that the Company shall not
be required to produce any new disclosure statement or take such action as is necessary for the Offering to be made pursuant to an available
exemption from qualification or registration in applicable jurisdictions. During the Prospectus Delivery Period, the Company will, from
time to time, prepare and file such statements, reports and other documents as are or may be required to continue such qualifications
in effect. During the Prospectus Delivery Period, the Company will advise the Placement Agent promptly of the suspension of the qualification
or registration of (or any such exemption relating to) the Securities for offering, sale or trading in any jurisdiction or any initiation
or threat of any Proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification, registration
or exemption, the Company shall use its best efforts to obtain the withdrawal thereof at the earliest possible moment.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Amendments and
Supplements to the Prospectus Supplement and Other Matters</U>. The Company will comply with the Securities Act and the Exchange Act,
and the rules and regulations of the SEC thereunder, so as to permit the completion of the distribution of the Securities as contemplated
in this Agreement, the Incorporated Documents and the Prospectus Supplement. If during the period in which a prospectus is required by
law to be delivered in connection with the distribution of Securities contemplated by the Incorporated Documents or the Prospectus Supplement
(the &ldquo;<B>Prospectus Delivery Period</B>&rdquo;), any event shall occur as a result of which, in the judgment of the Company or in
the opinion of the Placement Agent or Placement Agent&rsquo;s Counsel, it becomes necessary to amend or supplement the Incorporated Documents
or the Prospectus Supplement in order to make the statements therein, in the light of the circumstances under which they were made, as
the case may be, not misleading, or if it is necessary at any time to amend or supplement the Incorporated Documents or the Prospectus
Supplement or to file under the Exchange Act any Incorporated Document to comply with any law, the Company will promptly prepare and file
with the SEC, and furnish at its own expense to the Placement Agent and to dealers, an appropriate amendment to the Registration Statement
or supplement to the Registration Statement, the Incorporated Documents or the Prospectus Supplement that is necessary in order to make
the statements in the Incorporated Documents and the Prospectus Supplement as so amended or supplemented, in the light of the circumstances
under which they were made, as the case may be, not misleading, or so that the Registration Statement, the Incorporated Documents or the
Prospectus Supplement, as so amended or supplemented, will comply with law. Before amending the Registration Statement or supplementing
the Incorporated Documents or the Prospectus Supplement in connection with the Offering, the Company will furnish the Placement Agent
with a copy of such proposed amendment or supplement and will not file any such amendment or supplement to which the Placement Agent reasonably
objects.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Copies of any
Amendments and Supplements to the Prospectus Supplement</U>. The Company will furnish the Placement Agent, without charge, during the
period beginning on the date hereof and ending on the Closing Date of the Offering, as many copies of the Prospectus Supplement and any
amendments and supplements thereto, as the Placement Agent may reasonably request.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Free Writing Prospectus</U>.
The Company covenants that it will not, unless it obtains the prior written consent of the Placement Agent, make any offer relating to
the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &ldquo;<B>Free Writing Prospectus</B>&rdquo;
(as defined in Rule 405 of the Securities Act) required to be filed by the Company with the SEC or retained by the Company under Rule
433 of the Securities Act. In the event that the Placement Agent expressly consents in writing to any such Free Writing Prospectus (a
&ldquo;<B>Permitted Free Writing Prospectus</B>&rdquo;), the Company covenants that it shall (i) treat each Permitted Free Writing Prospectus
as an Issuer Free Writing Prospectus, and (ii) comply with the requirements of Rule 164 and 433 of the Securities Act applicable to such
Permitted Free Writing Prospectus, including in respect of timely filing with the SEC, legending and record keeping. Notwithstanding anything
herein to the contrary, in no event shall the Company make any offer or communication relating to the Offering which meets the definition
of a &ldquo;Free Writing Prospectus&rdquo; while the Company is an &ldquo;ineligible issuer&rdquo; (as such terms are defined in Rule
405 of the Securities Act) or otherwise in contravention of the Securities Act and the Rules and Regulations thereunder.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Transfer Agent</U>.
The Company will maintain, at its expense, a registrar and transfer agent for the Ordinary Shares.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Earnings Statement</U>.
As soon as practicable and in accordance with applicable requirements under the Securities Act, but in any event not later than 12 months
after the Closing Date, the Company will make generally available to its security holders and to the Placement Agent an earnings statement,
that satisfies the provisions of Section 11(a) and Rule 158 under the Securities Act.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Periodic Reporting
Obligations</U>. During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the SEC and the Trading Market
all reports and documents required to be filed under the Exchange Act within the time periods and in the manner required by the Exchange
Act.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Additional Documents</U><I>.&nbsp;</I>The
Company will enter into any subscription, purchase or other customary agreements as the Placement Agent or the Investors deem necessary
or appropriate to consummate the Closing in connection with the Offering, all of which will be in form and substance reasonably acceptable
to the Placement Agent and the Investors. The Company agrees that the Placement Agent may rely upon, and each is a third-party beneficiary
of, the representations and warranties, and applicable covenants, set forth in any Transaction Document including the Purchase Agreement
entered into with Investors in connection with the Offering.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>No Manipulation
of Price</U><I>.&nbsp;</I>The Company will not take, directly or indirectly, any action designed to cause or result in, or that has constituted
or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities of the Company.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Acknowledgment</U>.
The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit and use of the Board of
Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement Agent&rsquo;s prior
written consent.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Announcement of
Offering</U>. The Company acknowledges and agrees that the Placement Agent may, subsequent to the Closing, make public its involvement
with the Offering.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Reliance on Others</U>.
The Company confirms that it will rely on its own counsel and accountants for legal and accounting advice.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Research Matters</U><FONT STYLE="font-variant: small-caps">.</FONT>&nbsp;By
entering into this Agreement, the Placement Agent provides no promise, either explicitly or implicitly, of favorable or continued research
coverage of the Company and the Company hereby acknowledges and agrees that the Placement Agent&rsquo;s selection as the placement agent
for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agent&rsquo;s providing favorable or any research
coverage of the Company. In accordance with FINRA Rule 2711(e), the parties acknowledge and agree that the Placement Agent has not directly
or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change research, a rating or
a price target, to the Company or inducement for the receipt of business or compensation.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Subsequent Equity
Sales</U>.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(i) From the date
hereof until thirty (30) days after the Closing Date (the &ldquo;<B>Prohibition Period</B>&rdquo;), the Company shall not issue, enter
into any agreement to issue or announce the issuance or proposed issuance of any Ordinary Shares or Ordinary Share Equivalents, except
for the Securities issued pursuant hereto.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(ii) From the date
hereof until sixty (60) days after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect
any issuance by the Company of Ordinary Shares or Ordinary Share Equivalents (or a combination of units thereof) involving a Variable
Rate Transaction. &ldquo;<B>Variable Rate Transaction</B>&rdquo; means a transaction in which the Company (i) issues or sells any debt
or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional Ordinary Shares
either (A) at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies with the trading prices
of or quotations for the Ordinary Shares at any time after the initial issuance of such debt or equity securities, or (B) with a conversion,
exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security
or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for
the Ordinary Shares or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line
of credit whereby the Company may issue securities at a future determined price regardless of whether shares pursuant to such agreement
have actually been issued and regardless of whether such agreement is subsequently canceled. The Placement Agent shall be entitled to
obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect
damages.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(iii) Notwithstanding
the foregoing,&nbsp;<U>Sections 4(p)(i)</U>&nbsp;and&nbsp;<U>(ii)</U>&nbsp;shall not apply in respect of an Exempt Issuance. An &ldquo;<B>Exempt
Issuance</B>&rdquo; means the issuance of (A) Ordinary Shares or options or other securities to employees, officers, directors or consultants
of the Company pursuant to any employee benefit plan, equity incentive plan or other employee compensation plan existing on the date hereof
or any share or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (B) Ordinary
Shares issued upon the exercise or exchange of or conversion of any Securities issued pursuant to the Purchase Agreement or Prospectus
Supplement or this Agreement and/or other securities exercisable or exchangeable for or convertible into Ordinary Shares issued and outstanding
on the date of this Agreement provided that such securities have not been amended since the date of this Agreement to increase the number
of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection
with share splits or combinations or anti-dilution provisions contained therein as disclosed in the SEC Reports and the Prospectus Supplement)
or to extend the term of such securities, or securities issuable in connection with a transaction involving the Company and existing shareholders
in which the Company offers the existing shareholders the option to exchange their Ordinary Shares for other securities of the Company,
(C) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the
Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration
rights that require or permit the filing of any registration statement in connection therewith during the Prohibition Period in&nbsp;<U>Section
4(p)(i)</U>&nbsp;herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is,
itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company
and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities, (D) the issuance of the Securities in the Offering, (E) an &ldquo;at-the-market&rdquo; offering as defined in Rule 415 under
the Securities Act, including, without limitation, sales made directly on the Trading Market, on any other existing trading market for
the Ordinary Shares or to or through a market maker; or (F) Ordinary Shares or Ordinary Shares Equivalents issued in private placement
offerings provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144).</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&ldquo;Persons&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(q)&nbsp;<U>Termination for
Cause</U>. Notwithstanding anything herein to the contrary, this Agreement may be terminated by the Company for &ldquo;<B>Cause</B>,&rdquo;
which shall mean a material breach by the Placement Agent of this Agreement or a material failure by the Placement Agent to provide the
services as contemplated by this Agreement.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(r)&nbsp;<U>Securities Laws
Disclosure; Publicity</U>. The Company shall (i) issue a press release disclosing the material terms of the transactions contemplated
hereby at the date and time agreed upon by the Company and the Placement Agent, and (ii) file a Report on Form 6-K, including the Transaction
Documents as exhibits thereto, with the SEC within the time required by the Exchange Act. From and after the issuance of such press release,
the Company represents that it shall have publicly disclosed all material, non-public information delivered by the Company or any of its
Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, in connection with the transactions contemplated
by the Transaction Documents. The Company and the Placement Agent shall consult with each other in issuing any other press releases with
respect to the transactions contemplated hereby.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 5. Conditions of the Obligations of
the Placement Agent</B>. The obligations of the Placement Agent hereunder shall be subject to the accuracy of the representations and
warranties on the part of the Company set forth in&nbsp;<U>Section 2</U>&nbsp;hereof, in each case as of the date hereof and as of the
Closing Date as though then made, to the timely performance by each of the Company of its covenants and other obligations hereunder, and
to each of the following additional conditions:</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Reserved</U></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Compliance with
Registration Requirements; No Stop Order; No Objection from FINRA</U>. Each Prospectus Supplement (in accordance with Rule 424(b)) and
Free Writing Prospectus if any, shall have been duly filed with the SEC, as appropriate; no stop order suspending the effectiveness of
the Registration Statement or any part thereof shall have been issued and no Proceeding for that purpose shall have been initiated or
threatened by the SEC; no order preventing or suspending the use of the Prospectus Supplement shall have been issued and no Proceeding
for that purpose shall have been initiated or threatened by the SEC; no order having the effect of ceasing or suspending the distribution
of the Securities or any other securities of the Company shall have been issued by any securities commission, securities regulatory authority
or stock exchange and no Proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of the Company,
contemplated by any securities commission, securities regulatory authority or stock exchange; all requests for additional information
on the part of the SEC shall have been complied with; and FINRA shall have raised no objection to the fairness and reasonableness of the
placement terms and arrangements.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Corporate Proceedings</U>.
All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement and the Prospectus Supplement,
and the registration, sale, and delivery of the Securities, shall have been completed or resolved in a manner reasonably satisfactory
to the Placement Agent&rsquo;s Counsel, and such counsel shall have been furnished with such papers and information as it may reasonably
have requested to enable such counsel to pass upon the matters referred to in this&nbsp;<U>Section 5</U>.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>No Material Adverse
Change</U>. Subsequent to the execution and delivery of this Agreement and prior to the Closing Date, in the Placement Agent&rsquo;s reasonable
judgment after consultation with the Company, there shall not have occurred any material adverse change or development involving a prospective
material adverse change in the condition or the business activities, financial or otherwise, of the Company from the latest dates as of
which such condition is set forth in the Registration Statement and Prospectus Supplement (each, a &ldquo;<B>Material Adverse Change</B>&rdquo;).</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Opinions of Counsel
for the Company</U>. The Placement Agent shall have received on the Closing Date the written opinion of US counsel, BVI counsel and PRC
counsel to the Company, dated as of the Closing Date and addressed to the Placement Agent, including, without limitation, a negative assurance
letter addressed to the Placement Agent and, in form and substance satisfactory to the Placement Agent.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Officers&rsquo;
Certificate</U>. The Placement Agent shall have received on the Closing Date, a certificate of the Company, dated as of the Closing Date
and which may be relied upon by the Placement Agent, signed by the Chief Executive Officer of the Company, in his or her capacity as Chief
Executive Officer only, in a form satisfactory to the Placement Agent, to the effect that:</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(i) The representations
and warranties of the Company in this Agreement are true and correct in all material respects (except such representations and warranties
which are qualified by materiality or by Material Adverse Effect, which shall be true and correct in all respects), as if made on and
as of the Closing Date, and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed
or satisfied at or prior to the Closing Date;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(ii) No stop order
suspending the effectiveness of the Registration Statement or the use of the Prospectus Supplement has been issued and no Proceedings
for that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities Act; no order
having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company has been issued by
any securities commission, securities regulatory authority or stock exchange in the United States and no Proceedings for that purpose
have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange in the United States;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(iii) When the Registration
Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such certificate, the Registration
Statement and the Incorporated Documents, if any, when such documents became effective or were filed with the SEC, and the Prospectus
Supplement contained all material information required to be included therein by the Securities Act and the Exchange Act and the applicable
rules and regulations of the SEC thereunder, as the case may be, and in all material respects conformed to the requirements of the Securities
Act and the Exchange Act and the applicable rules and regulations of the SEC thereunder, as the case may be, and the Registration Statement
and the Incorporated Documents, if any, and the Prospectus Supplement, did not and do not include any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading (provided, however, that the preceding representations and warranties contained in this paragraph
(iii) shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished in writing to
the Company by the Placement Agent expressly for use therein) and, since the effective date of the Registration Statement, there has occurred
no event required by the Securities Act and the rules and regulations of the SEC thereunder to be set forth in the Incorporated Documents
which has not been so set forth; and</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(iv) Subsequent
to the respective dates as of which information is given in the Registration Statement, the Incorporated Documents and the Prospectus
supplement, there has not been: (i) any Material Adverse Change; (ii) any transaction that is material to the Company and the Subsidiaries
taken as a whole, except transactions entered into in the ordinary course of business; (iii) any obligation, direct or contingent, that
is material to the Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred
in the ordinary course of business; (iv) any material change in the share capital (except changes thereto resulting from the exercise
of outstanding share options or warrants) or outstanding indebtedness of the Company or any Subsidiary; (v) any dividend or distribution
of any kind declared, paid or made on the share capital of the Company; or (vi) any loss or damage (whether or not insured) to the property
of the Company or any Subsidiary which has been sustained or will have been sustained which has a Material Adverse Effect.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Reserved</U>.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Secretary&rsquo;s
Certificate</U>. The Placement Agent shall have received on the Closing Date, a certificate of the Company, dated as of the Closing Date
and which may be relied upon by the Placement Agent, signed by the secretary of the Company, certifying, among others, (i) that Company&rsquo;s
second amended and restated memorandum and articles of association, and all amendments thereto, is true and complete, has not been modified
and is in full force and effect; (ii) that the resolutions of the Company&rsquo;s Board of Directors relating to the Offering are in full
force and effect and have not been modified; (iii) that each of the Company and its Subsidiaries is in good standing under the laws of
the jurisdiction of its incorporation or organization; (iv) as to the accuracy and completeness of all correspondence between the Company
or its counsel and the SEC; and (v) as to the incumbency of the officers of the Company, in a form reasonably acceptable to the Placement
Agent.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Exchange Act Registration
and Stock Exchange Listing</U>. The Ordinary Shares (including the Shares and the Warrant Shares) shall be registered under the Exchange
Act and shall be listed on the Trading Market, and the Company shall not have taken any action designed to terminate, or likely to have
the effect of terminating, the registration of the Ordinary Shares under the Exchange Act or delisting or suspending from trading the
Ordinary Shares from the Trading Market, nor shall the Company have received any information suggesting that the SEC or the Trading Market
is contemplating terminating such registration or listing.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Lock-Up Agreement</U>.
On or prior to the date of this Agreement, the Company shall also have furnished to the Placement Agent a letter substantially in the
form of&nbsp;<U>Exhibit A</U>&nbsp;hereto (the &ldquo;<B>Lock-Up Agreement</B>&rdquo;) from each executive officer, director and five
percent (5%) shareholder of the Company addressed to the Placement Agent. The Company will use its best efforts to enforce the terms of
each Lock-Up Agreement and will issue stop-transfer instructions to the transfer agent for the Ordinary Shares with respect to any transaction
or contemplated transaction that would constitute a breach of or default under the applicable Lock-Up Agreement.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Additional Documents</U>.
On or before the Closing Date, the Placement Agent and Placement Agent&rsquo;s Counsel shall have received such information and documents
as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the Securities as contemplated
herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions
or agreements, herein contained.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">If any condition specified in
this&nbsp;<U>Section 5</U>&nbsp;is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Placement
Agent by notice to the Company at any time on or prior to the Closing Date, which termination shall be without liability on the part of
any party to any other party, except that&nbsp;<U>Section 1 </U>(Agreement to Act as Placement Agent),&nbsp;<U>Section 6</U>&nbsp;(Payment
of Fees and Expenses),&nbsp;<U>Section 7</U>&nbsp;(Indemnification and Contribution) and&nbsp;<U>Section 8</U>&nbsp;(Representations and
Indemnities to Survive Delivery) shall at all times be effective and shall survive such termination.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 6. Payment of Fees and Expenses</B>.
Subject to compliance with FINRA Rule 5110(f)(2)(D), the Company agrees to pay all reasonable costs, fees and expenses incurred by the
Company in connection with the performance of its obligations hereunder and in connection with the transactions contemplated hereby, including,
without limitation: (i) payment to the Placement Agent of its Cash Fee, non-accountable expense allowance, and reimbursement of legal
and other out-of-pocket fees, costs and expenses of up to One Hundred Thousand Dollars ($100,000), (ii) all expenses incident to the issuance,
delivery and qualification of the Securities (including all printing and engraving costs); (iii) all fees and expenses of the registrar
and transfer agent of the Ordinary Shares; (iv) all necessary issue, transfer and other stamp taxes in connection with the issuance and
sale of the Securities; (v) all fees and expenses of the Company&rsquo;s counsel, registered independent public accounting firm and other
advisors; (vi) all costs and expenses incurred in connection with the preparation, printing, filing, shipping and distribution of the
Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts), the Base Prospectus,
the Prospectus Supplement and each supplement, if any, and all amendments and supplements thereto, and this Agreement; (vii) all filing
fees, reasonable attorneys&rsquo; fees and expenses incurred by the Company in connection with qualifying or registering (or obtaining
exemptions from the qualification or registration of) all or any part of the Securities for offer and sale under the state securities
or blue sky laws or the securities laws of any other country; (viii) RESERVED; (ix) the fees and expenses associated with including the
Shares and Warrant Shares on the Trading Market; (x) RESERVED; (xi) RESERVED; and (xii) all other fees, costs and expenses referred to
in Part II of the Registration Statement.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 7. Indemnification and Contribution</B>.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(a) The Company agrees to
indemnify and hold harmless the Placement Agent, its Affiliates and each Person controlling the Placement Agent, and the directors, officers,
agents and employees of the Placement Agent, their respective affiliates and each such controlling person (the Placement Agent, and each
such entity or person, an &ldquo;<B>Indemnified Person</B>&rdquo;) to the fullest extent permitted by applicable law from and against
any losses, claims, damages, judgments, assessments, costs and other liabilities (collectively, the &ldquo;<B>Liabilities</B>&rdquo;),
and shall reimburse each Indemnified Person for all fees and expenses (including the reasonable fees and expenses of one counsel for all
Indemnified Persons, except as otherwise expressly provided herein) (collectively, the &ldquo;<B>Expenses</B>&rdquo;) as they are incurred
by an Indemnified Person in investigating, preparing, pursuing or defending any Proceedings, whether or not any Indemnified Person is
a party thereto, (i) caused by, or arising out of or in connection with, any untrue statement or alleged untrue statement of a material
fact contained in the Registration Statement, any Incorporated Document, or the Prospectus Supplement or by any omission or alleged omission
to state therein a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not
misleading (other than untrue statements or alleged untrue statements in, or omissions or alleged omissions from, information relating
to an Indemnified Person furnished in writing by or on behalf of such Indemnified Person expressly for use in the Registration Statement,
any Incorporated Document, or the Prospectus Supplement) or (ii) otherwise arising out of or in connection with advice or services rendered
or to be rendered by any Indemnified Person pursuant to this Agreement, the transactions contemplated thereby or any Indemnified Person&rsquo;s
actions or inactions in connection with any such advice, services or transactions;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that, in
the case of clause (ii) only, the Company shall not be responsible for any Liabilities or Expenses of any Indemnified Person that are
finally judicially determined to have resulted solely from such Indemnified Person&rsquo;s (x) gross negligence or willful misconduct
in connection with any of the advice, actions, inactions or services referred to above or (y) use of any offering materials or information
concerning the Company in connection with the offer or sale of the Securities in the Offering which were not authorized for such use by
the Company and which use constitutes gross negligence or willful misconduct. The Company also agrees to reimburse each Indemnified Person
for all Expenses as they are incurred in connection with enforcing such Indemnified Person&rsquo;s rights under this Agreement.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(b) Upon receipt by an Indemnified
Person of actual notice of an Proceeding against such Indemnified Person with respect to which indemnity may be sought under this Agreement,
such Indemnified Person shall promptly notify the Company in writing; provided that failure by any Indemnified Person so to notify the
Company shall not relieve the Company from any liability which the Company may have on account of this indemnity or otherwise to such
Indemnified Person, except to the extent the Company shall have been prejudiced by such failure. The Company shall, if requested by the
Placement Agent, assume the defense of any such Proceeding including the employment of counsel reasonably satisfactory to the Placement
Agent, which counsel may also be counsel to the Company. Any Indemnified Person shall have the right to employ separate counsel in any
such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified
Person unless: (i) the Company has failed promptly to assume the defense and employ counsel or (ii) the named parties to any such Proceeding
(including any impeded parties) include such Indemnified Person and the Company, and such Indemnified Person shall have been advised in
the reasonable opinion of counsel that there is an actual conflict of interest that prevents the counsel selected by the Company from
representing both the Company (or another client of such counsel) and any Indemnified Person; provided that the Company shall not in such
event be responsible hereunder for the fees and expenses of more than one firm of separate counsel for all Indemnified Persons in connection
with any Proceeding or related Proceedings, in addition to any local counsel. The Company shall not be liable for any settlement of any
Proceeding effected without its written consent (which shall not be unreasonably withheld). In addition, the Company shall not, without
the prior written consent of the Indemnified Person (which shall not be unreasonably withheld), settle, compromise or consent to the entry
of any judgment in or otherwise seek to terminate any pending or threatened Proceeding in respect of which indemnification or contribution
may be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise, consent or termination
includes an unconditional release of each Indemnified Person from all Liabilities arising out of such Proceeding for which indemnification
or contribution may be sought hereunder. The indemnification required hereby shall be made by periodic payments of the amount thereof
during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is due and payable.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(c) In the event that the
foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the Company shall contribute
to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect (i) the relative
benefits to the Company, on the one hand, and to the Placement Agent and any other Indemnified Person, on the other hand, of the matters
contemplated by this Agreement or (ii) if the allocation provided by the immediately preceding clause is not permitted by applicable law,
not only such relative benefits but also the relative fault of the Company, on the one hand, and the Placement Agent and any other Indemnified
Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate, as well as any other relevant
equitable considerations; provided that in no event shall the Company contribute less than the amount necessary to ensure that all Indemnified
Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of fees actually received by the Placement
Agent pursuant to this Agreement. For purposes of this paragraph, the relative benefits to the Company, on the one hand, and to the Placement
Agent on the other hand, of the matters contemplated by this Agreement shall be deemed to be in the same proportion as (a) the total value
paid or contemplated to be paid to or received or contemplated to be received by the Company in the transaction or transactions that are
within the scope of this Agreement, whether or not any such transaction is consummated, bears to (b) the fees paid to the Placement Agent
under this Agreement. Notwithstanding the above, no person guilty of fraudulent misrepresentation within the meaning of Section 11(f)
of the Securities Act, as amended, shall be entitled to contribution from a party who was not guilty of fraudulent misrepresentation.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(d) The Company also agrees
that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for
or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement, the transactions
contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services or transactions
except for Liabilities (and related Expenses) of the Company that are finally judicially determined to have resulted solely from such
Indemnified Person&rsquo;s gross negligence or willful misconduct in connection with any such advice, actions, inactions or services.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(e) The reimbursement, indemnity
and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement and shall remain in full
force and effect regardless of any termination of, or the completion of any Indemnified Person&rsquo;s services under or in connection
with, this Agreement.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 8. Representations and Indemnities
to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other statements of the Company or any
person controlling the Company, of its officers, and of the Placement Agent set forth in or made pursuant to this Agreement will remain
in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent, the Company, or any of its or their
partners, officers or directors or any controlling person, as the case may be, and will survive delivery of and payment for the Securities
sold hereunder and any termination of this Agreement. A successor to the Placement Agent, or to the Company, its directors or officers
or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution and reimbursement agreements contained
in this Agreement.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 9. Notices</B>. All communications
hereunder shall be in writing and shall be overnight, next business day delivery, hand delivered or e-mailed and confirmed to the parties
hereto as follows:</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify">If to the Placement Agent to the address
set forth above, attention: Yi (Edric) Guo, Chief Executive Officer, e-mail: yguo@univest.us.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">If to the Company:</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">China SXT Pharmaceuticals, Inc.</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">178 Taidong Rd North, Taizhou</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">Jiangsu Province</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">People&rsquo;s Republic of China</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">Attention: Feng Zhou</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">Email: fzhou@sxtchina.com</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif"><I>With a copy (which shall not constitute notice) to:</I></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">Loeb &amp; Loeb LLP<BR>
Attention: Lawerence Venick</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-family: Times New Roman, Times, Serif">Email: lvenick@loeb.com</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">Any party hereto may change
the address for receipt of communications by giving written notice to the others.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 10. Successors</B>. This Agreement
will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and directors and controlling
persons referred to in <U>Section 7</U> hereof, and to their respective successors, and personal representative, and no other person will
have any right or obligation hereunder.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 11. Partial Unenforceability</B>. The
invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability
of any other section, paragraph or provision hereof. If any section, paragraph or provision of this Agreement is for any reason determined
to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to
make it valid and enforceable.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 12. Governing Law Provisions; Exclusive
Jurisdiction</B>. This Agreement and the transactions contemplated hereby shall be governed as to validity, interpretation, construction,
effect and in all other respects by the internal laws of the State of New York, without regard to the conflict of laws principles thereof.
Each of the Placement Agent and the Company: (i) agrees that any legal suit, action or Proceeding arising out of or relating to this Agreement
and/or the transactions contemplated hereby shall be instituted exclusively in the New York Supreme Court, County of New York, or in the
United States District Court for the Southern District of New York, (ii) waives any objection which it may have or hereafter to the venue
of any such suit, action or Proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New
York, and the United States District Court for the Southern District of New York in any such suit, action or Proceeding. Each of the Placement
Agent and the Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action
or Proceeding in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New
York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address shall be deemed in every
respect effective service of process upon the Company, in any such suit, action or Proceeding, and service of process upon the Placement
Agent mailed by certified mail to the Placement Agent&rsquo;s address shall be deemed in every respect effective service process upon
the Placement Agent, in any such suit, action or Proceeding. If either party shall commence an action or Proceeding to enforce any provision
of this Agreement, then the prevailing party in such action or Proceeding shall be reimbursed by the other party for its reasonable attorney&rsquo;s
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or Proceeding.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify"><B>Section 13. General Provisions</B>.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(a) This Agreement and the
Transaction Documents together constitute the entire agreement of the parties to this Agreement and supersedes all prior written or oral
and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof. Notwithstanding anything
herein to the contrary, the Engagement Agreement by and between the Company and the Placement Agent dated January 8, 2026 (the &ldquo;<B>Engagement
Agreement</B>&rdquo;) shall continue to be effective, including but not limited to <U>Section 4</U> therein, and the terms therein shall
continue to survive and be enforceable by the Placement Agent in accordance with its terms, provided that, in the event of a conflict
between the terms of the Engagement Agreement and this Agreement, the terms of this Agreement shall prevail. This Agreement may be executed
in two or more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were
upon the same instrument. This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition
herein (express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. Section headings
herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">(b) The Company acknowledges
that in connection with the Offering of the Securities: (i) the Placement Agent has acted at arm&rsquo;s length, is not an agent of, and
owes no fiduciary duties to the Company or any other person, (ii) the Placement Agent owes the Company only those duties and obligations
set forth in this Agreement and (iii) the Placement Agent may have interests that differ from those of the Company. The Company waives
to the full extent permitted by applicable law any claims it may have against the Placement Agent arising from an alleged breach of fiduciary
duty in connection with the Offering of the Securities.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">[<I>The remainder of this page has been intentionally
left blank.</I>]</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">If the foregoing is in accordance
with your understanding of our agreement, please sign below whereupon this instrument, along with all counterparts hereof, shall become
a binding agreement in accordance with its terms.</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-family: Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>China
    SXT Pharmaceuticals, Inc.</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Feng Zhou</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feng
    Zhou</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Chief
    Executive Officer</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
    and agreed to as of the date first written above:</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Univest
    Securities, LLC</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Yi (Edric) Guo</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yi
    (Edric) Guo</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</P>

<P STYLE="text-align: center; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[<I>Signature Page to
Placement Agency Agreement</I>]</P>



<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center"><B><U>Exhibit A</U></B></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">Form of Lock-Up Agreement</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">(see attached)</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ea027250601ex99-1_chinasxt.htm
<DESCRIPTION>PRESS RELEASE DATED JANUARY 9, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 95px; width: 200px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>China
SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TAIZHOU,
China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the &ldquo;Company&rdquo;), today announced that
it has entered into a definitive agreement with a single investor for the purchase and sale of an aggregate of 66,666,666 Class A ordinary
shares of the company, no par value per share (the &ldquo;Shares&rdquo;) &nbsp;(or pre-funded warrants in lieu thereof), at a purchase
price of $0.15 per share in a registered direct offering. The purchase price for each pre-funded warrant is identical to the purchase
price for each Share, less the exercise price of $0.001 per share.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate gross proceeds to the Company of this offering are expected to be approximately $10 million. The transaction is expected to
close on or about January 12, 2026, subject to the satisfaction of customary closing conditions.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Univest
Securities, LLC is acting as the sole placement agent.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registered direct offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-291428) previously filed
by the Company with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) and became effective on December 1, 2025. A final
prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be
available on the SEC&rsquo;s website located at&nbsp;http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying
prospectus may be obtained, when available, by contacting Univest Securities, LLC at&nbsp;info@univest.us, or by calling +1 (212) 343-8888.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities
in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of such jurisdiction. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying
base prospectus will be filed by the Company and, upon filing, can be obtained at the SEC&rsquo;s website at&nbsp;www.sec.gov.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
China SXT Pharmaceuticals Inc.</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founded
in 2005 and headquartered in Taizhou City, Jiangsu Province, China, China SXT Pharmaceuticals, Inc. is an innovative pharmaceutical company
focusing on the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces, which is a type of Traditional
Chinese Medicine that has been processed to be ready for use. For more information, please visit&nbsp;www.sxtchina.com.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and
uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes
may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking
statements by words or phrases such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;aim,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo;
&ldquo;is/are likely to&rdquo; or other similar expressions. The Company undertakes no obligation to update forward-looking statements
to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the
Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations
will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results
and encourages investors to review other factors that may affect its future results in the Company&rsquo;s registration statement and
in its other filings with the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>China
SXT Pharmaceuticals Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feng
Zhou, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;fzhou@sxtchina.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ^ / # 2(  A$! Q$!_\0
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M1]G3IQJSJ+!N4:[A"E.-24XPG",))N2V7TK1117F'K!1110 45\Q?M'?M@_
MC]D^TTC4OCCX@\1^&-)UFUU&]@UK3/A[X^\7Z+96NEO;1WDVMZOX0\.:YI^@
M(ANX3&=9N+$3IYLD.^."9HV_LP?MD?LZ_MD:#XI\3?LZ_$"/X@:)X+UJT\/^
M([V/0_$&AC3]6OK!=3MK4Q>(-+TN:X\RR=9O-MHY85Y1G#@K7IO)LW66_P!L
M?V9C_P"R5*,'F?U6L\ ISJ.E"$L4E*C&<JB=.,)2A*4E91>[\I9[DCS3^PUF
MV7?VSR2J+*?KE%9BZ<*:K3J+!MQKRA&DU4E.,9P4'=R6J7T_17YK?$[_ (*Y
M?L'?!CQ/JO@[XJ?%CQ!X#\1:1?ZGI]Q8>)OA)\6]*%S-H]Y)8WTVDW5UX*CM
M-9L8[B(B/4-*GO+*>-XIH9WAFB=_T6T76-.\0Z-I.OZ1<"[TG7-,L-8TNZ"2
M1BYT[4[6*]LK@1RJDL8FMIXI DB)(N[:ZJP(!CLES?+*.&Q&8Y7C\#A\:I/!
MU\7A:U"CBU&$)R>&JS7LZZC"I3E)TISY8SBW:]D9?GN29M7Q>&RO-LNS'$X!
MQCCL/@\91Q%?!RE.=.*Q5*F_:4'*=.I"*JP@Y2A)*]KO3HHHKS#U0HHHH **
M** /YQ?^"ZW[>OQ3^&T_PU_87_9FU>_T?XR_M Q:;_PF'B'0+I[3Q'HWA+Q3
MKG_")>%O".@:A;NMSH^K>/M;%]#J&JV[0WVG^'M.GCLY8VU8W$'ZF?L!_L%_
M"/\ 81^"OA_P+X.T/2K_ .)&HZ9:7WQ:^*<MG%-XH\>^,;F))]8N+C5YT:_B
M\/6EZ\MMX?T1)4M+'3XHI98IM3N+^^NOYL/C+.WQ*_X.4O!6G>(2)[+PQ\7O
MA59:;;7'SP10>!OA-9^(=,CCC?*B.35H&OM@&U[J:24@O(37]GM?L''4?]6N
M#^!.&,N_V:EG>14N+>(*M)\E3-LPQ]7EP=/%U(<LZ^&R[#+DPN&J2E0I3<JJ
MH^U?M#\0\/)+BOCCQ%XMS/\ VJMD'$57@OAJC67M*639;EM'GQM3!4I\U.AB
M\SQ5ZF+Q5.$,15IJ-)UE27LWXG^T5\#_  -^T5\&?B%\(_B!X3T+QCHOB_PM
MK>EV^G:]:6\\-IJ]SIUQ%I&JV-S-')+I6IZ;J#6UY8:M9F*[L+B&.X@D5DY^
M(O\ @E/^R=\9_P!D7]AK1?@'\6#H'A[XF6'B[XB:PUSX9UF+Q'IEM;>(]>DO
M]*O$O[>WM$EG>V(>>$1!H7.QB2,#]2:@NEF>UN4MVV7#V\RP/G;LF:-A$V[!
MQM<J<X.,9P>E?G-#/LQHY)B>'8U(2RS%YI@,VG3JQG4=+&8"EB*%.='FJNG2
MIU:>*E]:@J+=?V5%SE^[5_U'$<.Y97S_  O$\J4XYM@LHS')85:,H4U6P.8U
M<-7JPKN-)5:M2C4PL/JDY5[8?VM90C^\=OG;Q-%KO@NUCO?&/QX\/>$[*9BD
M5WXFU'3-!M97&,K'<:I>6L3L-PRJN2,C(Y%6?#^F>*?%FGKJWA7XV:1XFTIW
M:--3\/W-CK.GM(H!:-;W3KFYMF=0REE$A8!@2,$5^5/[ ?\ P24B\-Z+\0?B
M/_P4>\.>$OVG/VB_&'CG5GTO6/B)XFU7XTZ!X<^'R6UJ-*M-+M_&-K'I=MJF
MHWTVJ7.I2#1VEM;:/3;*RGM[:!H6_/7Q]H%M_P $V_\ @N5^S_X _9C>[^'W
MP6_:>3X:6WCCX.Z1>7D/@ VWQ$\0Z_X#U:.RT"2>2QMDT_6](MO%NA&")#HV
MHFZLK!H-,GDLZ^_PG#.59KCL[R7)>(J>8YKD^3YCF]+&1R+ 4\@S:.4X2&-Q
MV&P.)6(GF5.U!U%AL7BL,J.(JT)QE1HQE"3_ #;&\69QDV79!GV?\,5<KR?/
M,\RO)*N!EQ%F57B/)I9SC*F R_%9AAGA8975OB(TGBL'@\4ZV'I5X2C7KS4H
M+^G"X\+>/K-UCN_BU!:R.I=$N$B@=T!P659959E!!!8 C/&<U);^$/B'=HTE
MK\54N8U8JTEO DR*P )5FCD90P!!()! (.,&OE3_ (*8?LI_ ;X[_LU?&WQ[
M\2?A]I.N?$+X:? GXFZG\/?'8DOK'Q1X/O=%\.ZKXEL)-&U.PNK:6*)-8LH;
MF:VF$UM<@R13Q212NA_!3_@B1^S?\2/VOOV1?B%\._&'QB\5_#S]F.#XWZMJ
M'C[P_P##/7]2T7XK?&3Q+<>#/"*GPAX@\;N9KCPC\*-)L5LKJ]TGP\/[8\9:
MI>W,%_?Z;INGI'>\>4</8+-.$LPXIJY[2RZ&3YGEN79IA\3P_AJ\%_:,<15A
M4R^IA<1*OC:OLZ,84L+4HX253$3DJF(H8:E.N^[.N)<?E'&F6<(4N'J^:3SS
M*<US3*,5A>)<50F_[,EAZ52EF=+&8:-# 455KN=;%TJ^-C3PT(NEAL1BJL,.
MOZ<-#GU'Q/J5[HWAK]H+PMXAU?30YU'2M#UC1]6U*P$;B-S>V-A?7%U:A)"(
MW,\485R%.&.*U]<T7Q?X8TZ;6/$OQGTWP]I%L5%QJNN36FDZ= 7.$$U]?W%O
M;1%SPH>5=QX&37\GO_!7;]C+X1_\$L/%?[*?[3'[$W_"7_"3Q-<^.M=L=8L8
M/&WB37;>]OO"EGI/B+3[W[9X@U'4M5:+6+9M4T7Q)I5Q?7.C:GIURB/I\9\[
MS_VPLO\ @FYHO[<.FZ)\<_\ @H=XS\3?%[6_&NAZ9XB\'? 7P+XU\6>"/V?_
M ((Z#KFGP7^GZ%X9T[0+_1]>\9^*(K.X@/B/Q[XDOA/K&H^;%::9:Z7;6,8[
M<PX:R/!99D7$O^LTWPUG:QU*FZG#&$7$/]H9=B(T,3@Z.64L9+ SI\LEB'C:
M^9T</1I.-.4*]>I3@N#+>*L_S#-^(>%/]54N*\@>75JJI<78Q\-?V;FF%EB,
M+CJ^;5<##,(5'.,L,L!A\IKXFM54JL:F'P]*K4?Z(Z%H_B[Q3IT6L>&?C1IG
MB/2)V=(-4T*>SU?3IGC($BQ7VGW%Q;2,A(#JDI*D@,!FK,_AKQU;2M!<_%VU
MMYE"EH9Q!%*H<94M')*K@,.5) !'(R*_F)_X)TZ-JG[#_P#P6V^,W[#WPP\4
M>(KCX ^)M,\7)#X1UO5;C4+6T2P^'VG?%/PCJ+1.5MY/$/A^.:[\,-K4<$-U
MJ.E7=P+TRR,I3]%/^"Z?[+'P*UW]C;X\_M,S> M-LOCSX,TSP!<:1\3]+GU#
M3O$[6=MXQ\.>'!I-]<V=Y!#?Z8^C:I=69M;N"54!BDC*2PQNLXWA2A@>+LAX
M>GG"JY;Q1@LDQ^39K1R#!/$*EG[A#!+'Y?5Q--472J.<,5]7Q59I*,Z,9ISB
MJR_C+$YAP5Q'Q+2R25+->$<PS_+L]R:OQ)CUAG6X<52>.>79G1PE5UU6I1A4
MPGUC"48R;G3K3@U"3_6.;PUX[MK"?5;CXNVL&EVT,EQ<ZE,(8K"W@A!,T\]X
M\JV\4,05C)))(J( =S#!JIX(?4_%5U%J7AOXW^'?'.E:7J%L-6C\-ZGIFMV^
MU9-[V5S/I=W=QVTD\:.H65E<@,0#M-?@;_P2[_8?A_;4_8#^! _:A\>^,-9_
M9[\-R>/K7X?? /P'XQ\1>#]$\57W_"P_$\VL>//C1X@T:[LO$?BO6_[5DO--
M\)^&;/4['P_X8T2SAO&.HZKJ]T;/XU_X**_LP3?\$5OCY\ /VL_V'_$'BKPA
M\._&6OZAH/BGX::EXCU36M&DU308[;6-0\):C+?S2W>O>#O'/ADZA"EIKT^I
M:EHFL:4^HV&IQS26/V+MPO!65X[B#,^#*/%-*7%%'$9IA,NI_P"K="GDV+Q&
M7K$2C@:^9O%?6,/CL31H3;E0P57!X:NW0^L8F=&K4?!B^/<WR_AK*..Z_"%>
M/".(PV3XS,ZO^M5>IGF"PV92PT9YA0RE83ZMB<OPM;$4THU\?2QV*PZ^L/"X
M6%>E27]7/[7=E:ZC^RE^TS8WT$5U:7/P!^,$5Q;S(LD4L;?#[Q!E'1@58' Z
MC@@$<@5^$O\ P;,QSW'[('[045M<?9KF?XWR1P76-QMYY/ASX76*XQQGRI&6
M3'?;BOVL^,?CW1OBG^PM\5?B9X=8MH'Q"_94\=>-=&+.)&&F>)_A-JNM62.Z
MJH:2.WO8XY"%4>8K?*.@_F3_ ."%W[,WBW]JW]EGXM_#;Q3\4?$_P\_9IM_C
M+'J'C_PQ\+-;O/"WQ'^,7B2;P/X?BA\)^)/&EJAN_#?PLTFP2TO-0TGP^T6L
M>,=3NWMK[4=.TS3$BOCA?"TY>%_'^$S'%K+*-#BWA+ZW6JT*N)G0EAO[1A6I
MTL'2<9XG%RJ4G0I8=5*$:E1-5L11H4ZM1+B[&58^+OAKC<LP;S:OB>#.,W@J
M-+$4<+#$1Q:RRI0JU<=64H87!QI5HXBMB?9UYTZ4HNCAJ^(JTJ9_4)HMU?>(
MM5N- \/_ +0WA/7M=LA(;W1M&UK1M4U:U\D[9C<Z=8W\]Y (FXD,L*;#PV#7
M9?\ "#?$[_HIDO\ X!-_C7\V'_!4'_@CY\%_V3O@'J/[87[#D_CSX*?$?X"W
MVC>*?$%OI/Q \5ZJVJ>'&U:SL+WQ#I>K:YJNH:_I7B7PY=7EKJ^ZVU4Z;J&F
M0:C;7.G-*8I*_9;_ ()C?MFW/[6?[#'@?X]_$:[L[7Q?X5L_$GA3XNZG%&D%
MG)XB^'09-8\2?9H-RVL>N:&-.\33VT4:1V\NI3PVT*6Z0K7B9SD%"EPY@^+.
M&\S6<Y15S1Y)CZ..R+"9;F>6YI*DJV&IU</0KXZA6PV-IN^&K4:[ESVISBY/
M3Z#(N),15XIQO!G%64RR+.J.4+/\NKY?Q%C<URG-<HC4='%5*.*Q&'R_$4,3
M@*J:Q5"O04?9IU8225G]3:QH'C3P[IUSK'B#XQ6.A:39H)+S5-8>VTS3K5"0
MH>YOKV>"V@0L0 TLJ@D@9R:S/"\6N>-[.74?!?QX\/>+]/@E$$]]X7U'3-?L
MX9B"1#+=:3>7<$<I )$;N'(!., U^ O[ OB:?_@L9^V1^T#^T)^T5:2^+_V:
M?V=KO2-"_9]_9]UMY+OX8VFJ>*+W6#H_BOQ=X6D9M%\7>)H_#7A]]4U%]=M;
MV'^U/$%M'!&FG:-8VHG_ ."Q7AO1/^";7CW]EG]MS]C[PWHOP3\3R_$&_P#A
M_P#%;P=\.=-M/!_P^^*WA.WTA?$=II'B_P &Z!#8^';V66STG6]+>_.G)?,+
M^UOEN4O])L+F'TX<%S7$6%X*Q&94Z7%N*P4*_L8Y3E\\GPF95LNJ9IA\DQ6+
M=58Z6)EAX1HXC&X?#O!X7&58472KTJ=:NO*J<=P?#.+X]PV65:O!6#Q\\/[>
M>=9I#/<;E=#-*>48G/L'@E1>7QPL,5.5;#8#$XE8[&8*C.LJN'K5*.'?]"OQ
MBTRX3]G/XN:1KURFMS-\'OB-9ZG<3PJ8M16;PAK<<XFA<,K1RQ.8WC<%73(8
M$$BOY[/^#7K_ )-\_:<_[+!X._\ 5?65?T!>-_&&F?$/]ECQAX^T4,-'\;_
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M_:][^T!IT^E*P!E-MI_@7QC)JS1GJ%6*>V$F.#N0'J!7FW_!+;XF_M_? ?\
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&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "; 48# 2(  A$! Q$!_\0
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M:WVMU]._RN%%%% 6?9_<_P#(****!76NJTWU6GKKI\[!1110,**** "BBB@
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M'^!/V>/A1X7^'7P[L)[71K/1Q?ZMJY19/$_B_P 3Z\&/B#XE>(=99<Z_X_\
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M2]%_L[QUK^DK#H?@?6]*\;ZX51O'FA+\'=9UKPJ/^$K,L?@Z,[UP[ Q_Q?\
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M*<XI\W$G$TL9A)KAF4<.ZCI5J*Q2G!QJ1]C*,5/F492C+E=S^Y3XQ?'?X;?
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M'?\ X+M_\H[/B=_V-OP>_P#5H_#ROG^(/^1;+_LG-?\ %SK?^]ZZGZAX,?\
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M$#CSC_BW((J-.7$?#5/@_%RE?$*7LJF&F\+4AB:=1S@Z+PT:BNHQJ./,T_\
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M+^)Y4J?"_#/$\J$*E*->C&G0C*O4G.E.G1IRQ$).G[-SY)2C$^G/V8_V%/\
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M%SR?B[\#& ]A\:_#8//U(_.O0_\ @H5^VYH'["W[/]M\6'\*ZAXS\2ZKJZ>
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MW#&;-\-VR7B?A_B62XF4WPU/EES-58TXSJ.$G!*:49-\SCRWDC^$G]K+P/\
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M054L@4D?R=>%]"_9?L_VSM1T3QK>>)]1_9(TKXA^)[,:]X5O=</B"_\ !/\
M;&O_ /"#:P6\/ >*BF[^Q &\)@'&"0.0/Z>?$/\ P;>? 2;XA:?XB\/_ !O^
M,/A+P+_:Q+:$^D>#_$?B1-,*DC1]"UK_ (1@+H:Y'S?\)5X5\7D="RYS7Z8?
M#?\ X)%?\$]?A9#87WAW]FKP+J=]IRM?:/JGC@:Q\1&&ID$?VTH\?>(?%7A]
M6'7.0P.2"" *_(LRX,XLS_&1QF+ROA?)80FG"[G5E*,))14ES-)N,8RLU'5[
MI69_H5P!](OP<\">$:O#O"7%_BIQO6XCX4E0K\.*5#!QX7Q-6,G4K4JO(FJW
MM:LW&I%UE!J,G3G*$E+\/O"7_!;/]BO]E#P8/!'[%/['WCX>&FNT,C:G>>#_
M (<>&->=>6\9:QXVT,^,/B7KNOG&W/BM-S@DG#@-7]&'[&'[1D'[5'[.GPW^
M/*^"=2\"MXYT<WDOA?5VU9O^$?E&LZUHI32-:\0>'?"#Z[H$J:2)$\4+'L\8
M(5.%4Q*^7KW_  3K_87\9WQO]<_9"_9QU/6 "?[5O/@IX.;53C)QK6MGPX3R
M.B@G/N:^M?#?A_2?#.D:1X:TVPTVTL-.TD6>DVFE+_9^FV&FZ,P_L31]%&1V
M.2>B@<#: I^XR3+>(L'BFLVS2+RB,4HQIJ,5=*UM+-+3W4GM;U/Y4\6>/_";
MBO*,IGP=PIQ5D?&;XDJ2XJXIXJXGJ<1U.)%)-Q4'+9N3?,VXJ+37DNFKG?$&
MI:5H.DZA>:HQ4Z;HYO-7(T?5]2(TS0\G(_L$%21@D J1QR,9KHJSM2F_LW_3
MB./T_P /\?SKZV5K2ZJSLWK=6=OPLS\(P=WF$>5-R=1-*-[R?/'1./O7>UT[
MJ^CT/R2_9=_:"^*GQ'^+7@WPKX<\#?V7\&M.\7_%+1M)\5VGA#1?#W@4?![P
M,/'F@^!=(\$_\(^WBMM!\0^*?^$V^%2#PM\51X-./A)\3 -GCH#P8OZ_5^,7
M[,A_9W\5_MD>*?%'P0^.WCU?&Y'CU?B/\'QX>UAO#>N^&/[#\ G0]'T/6OB$
MGBWQ-X \.^$_$GCC1O% /PG\8>$/!?C/QIKWB5BC+X3=8_V=K@R__=G:V\OA
M:?5]NVWR1]EXA8>2S2$9974R3DX8@TJL:D6GRT[S49O3VCO/F2BFYR:W=RBB
MBO0/@ELNNBU[Z+7YA1110,****3V?H_R8"8Y)SUQQZ?2OQU_X+N7 '_!-;XR
MJ<9;QA\'O7@CXT?#\]?7Z<=STK]BZ_&G_@O3<BU_X)J?'%B>=0UGX96N/7_B
MY?@*+_W$9Y]/7BOG^*=,@S9ZJW#,FFD[\ZBVFK+62DHVZWMV/V;P'2Q7C?X5
M8'&14HSXLX9C.+:BI4ZE:$*JN[+6G.HG=V;LFU='\RWAW_@OQ^W[X=\.6&A-
MK?PPU0Z7I(LQX@U?X>::?%&N,/\ F,:Q_P (_P")_"/AF/H!MC\'HO8CT]2B
M_P""_O\ P4;>\\MO!_PGVZKHPO=)TK_A5_C8-HFEZ#HHU[7=:T5U\3;V\.MX
M<4>)R2QXT @G%?S[6C-'?6P;D7'3CH/0'!.,8QDG\*_K1^%>N_M+^*OV1?"]
MW\#_ (#_  ]_9M^)5W^SQ\,[;X=>/]8^$'@[4_B7\=&^%>CZ_HNA?\(/XUU_
MQ#X471G\5?"$ZWX9\#^%)/"'BWQG$K^*),^#O OBCP3XS\:?SSPUF7$>;?VF
MO]:N*(>SMRJ-VM$T^5M)1:44EK'FT5VTK_[%^/WAK]'_ ,'?]5\9'PBX0XAJ
M\3\12]LN)N(%P\^'E)1G>I1I*5?$T)2JU)3Y:=5P@W;W)^[\N:Q_P6E_X*#Z
M[X.N/&_Q$^"/P7\0?#/2ETW66U;XC?!CQD/#:Z7KNM:_X$T+6-%UF3XC,F[Q
M3XCT;6?#0.T@#0_$F2RG;7/_  4_X+%_\%$?BS\0_#?PI^"GA#X/W_B7Q:/#
M7AVVTO1_A/INFA=)0C1M%;6S'XHR?#?A7^V=S%/E\((2#O5V4^1?\%"_%G[4
MW@GX>_#SP5\0?VAO$GQ$LOC]\)/AIXQ\0^ O%GP,TKX$-\.8M&UGQOKVB:2?
MA;H87Q/\/_$C>(]6UB-O$OBSPCX2_P"$O\E4#^,1X1*^#(/^",4^D7/[2^H>
M%]6&I6/BCQ.WPQOO"NK ZTNGZ-?^!OC%X%\0:YH^L?V F[0O#[^'C'\,P?%A
MC\'/XQU_PSX)!=_%PCDZEF'$*XERC)EQ5Q.XMQYG:$93M:32DHOFNFTG*<^6
M32:C9GS3X#\(Y^!7&/BO/PHX4=6+K2X7I<,RQ&(X;IRA4G3C.MA\]J0DI1E'
MFQ$J6'I2JTZ;JTI352BU[;\;/^"S'_!1/X1_$75?A?\ &3P_\!=/\=^ +E;;
M5=+U?X=Z;J;:'J+J'5M"UW0O$_BYTR&!ZJPS@XYKRCPC_P %W?VF?"?B)O%]
MI\-OV=;C6FR-S_"F2SQ_NZYI$GA?Q& ,'J,8Z9KZ;_:/_8H\=?MZ?M]_'/2=
M>U=OAIX3^&FC[=#\9>'/AS\1OC-IFN>%M!3Q^==;7M:T-@R>/H_$G@?68W'B
M=/"LGC :&O@CP)&RCPA)XP_%+]K/]GK5_P!EKXW:Q\(+Z;QGK%G:#3/$OA/5
MO&F@:Q\.=3\5:;KZ*NC^+1X*U_;XF\!E?$.D:YX6(\5QARFA^80$)KESS'\8
M99_:N,_M;B3^QWQ.U3]JX2;Y;J+E%QE+EYDE=0A3DTTK]/J/!KA;Z*7'F RG
MAG%\*<-QXWS3@U<4<5\,T(8FA2@IT.:<:-2G5A33FE*HJ%.K5J0ISIN5OBE^
MN6F?\'$7[9FHQZ-8Z9\#?V?;E])#W.CZ7I?@7XDZB0-%T?7"?[$1/B*J97P[
M'K8!V$@;ASN8'L8_^#B#]ISPOI5^_B+]G+X+Z7K7C/'B4:Q9^'/B)X=T[7!K
M7.AZWKGA]O$#KX\#^'-(&9/^$L7S"H16*QE5[[_@GA\(_A5^SGK?P"MF^$S?
M'W]KGXA>'].^/GPC\4?"%]73_A'/A!\4_AJV@O+^T/K6MKX5^&OA_P"'OAGQ
M"NK>&A_PBTOQ:;_A+=?ADB\$*\@?Q=\]?MY_'OX?>,_$?Q[\)_ML?L\ZC\./
MC_X&\/:;X0_9[\,^ ?BAI'C;3/"HUJ/7];T71]93X?>'O!WPS3P!X8D70&4^
M+$;XPK%KGAUR<^6/"/N/,>+L)E"QV+XKBI.*DHR2]U<CFE+W6D[<J44GS2:L
MK.Z_$\MX<^CMQ/XDO@OAKZ/57.,CAB)4W67$=>/$TIQQ'U=U*7#KJTJD^'X3
MC.=6M.5-TJ5"JY2<X\DO#?VCO^"R/[4_[97AZ/X->/+/P)H'PT\6^+?#-UJV
MF^ ?"&LCQ05\$ZYX>\0:)_Q.=<^(WBJ'<?$6A+AO+7Y%'S$\M_H : UTVGV3
M70 N6L-)+=@#C)X([_A@9]J_RP?@UX0OOB/\7_A?\/M)U0Z;K/BOXE^%/ .C
MWG3&I>-_&FB>'\>^3KV<]@..]?W<?\%!?VN/V@/A'\8OV7/V:/V=[SPEHGQ*
M^--GJ^M:MXBU;PF/B-J&@^%_ VB_\)!*-&\"CQ'X1&OZ_P")MNN+&QDPHT)X
MWB#^*!/X2]G@#B7&RP>;YQG4WG5FE&3>O*G91@E;W;R;44K*S<8JY\G].3P5
MX2R3B+PH\.O#/)>&LAC/A;B/B>K'FM"+<*4W7Q524I2ER0H>R=2I.3?(XN>S
MC^Q2@XYA!Y."#CC]:6 #+' R>IQR<8QD^U?RU>)?^"I/[;'PF\.?LES_ !7\
M!:%I/Q,\8:7\=?&WQ^\%2^!&\%>.;WX<_"T^(M>T8Z1#XY\2(/ 6O>+?AYX-
M\:S.)I&61]$>3P,J+&GA!OJSQ#_P56\6W7Q2\+>(K/P]-8_#+3/V(!^UGXZ\
M ZKI/@Z^U634M:TCQ!_8?@O1?''_  DA/A_Q+XG\0ZW\,%V?\(DXE&M[BR^8
MP7]'P_&.3XJTI<L&^6_NI22:3=VTG[JNI)RNFKZK4_A',? KQ&RK"99B*<.'
MJD<\4W%\-24U4E"?LXQG%3;;JRMR24:D)W:YHS]Q_OUW_KVJQ7X/?"[_ (+3
M>&_B)8_%[5M4_9T^+$%K\)OA'X:^*RZ1X2U32?BOXX\5Z=XU?P*?!>BZ+H/@
M'0 -!\1>*_#_ ,3M$\3QL%.SP;_PD[>.O^$03PF37TU^Q#_P4 TW]M>[_:!T
M1O@WJ'@'Q3\&_$6D^&?%I_X2W1/&?AS7O[;;7S(-%U[P^2K:]X7_ +#UA2HB
M1DRS;RS1^7Z%'B3A_$8J6%PN9ZQ@Y..NO+%N2UBNS337I?0^7S?PI\1,CPN8
MXS,>%99/#*9\.QXCG>/)-\1-1I234^6?/S1;E"51QYI<_)LOT_\ /]OT_P#K
MT>?UX_3_ .R/]*_F7_9/_P""@W[9/[2WQW\3?\5=\%_"7AKPN/BA_P +%^!/
MBGP@W@?XF?"7PMX&TC7AX(\9:+HVO^(QXE\>^(?^$C.@>&O'8)'@WP@%RB^$
M7\4@#D?V'_\ @I/^V]^V3X/^+NM#6OA+X TKX!?LX'Q+XQ\6^*_ >W3S\8M<
M\9:]KO@;6UT7P_XD&?AYX3^'.@ZP"-P?_A,?#V\$CQ2<>-3X]RF']G?4WS/.
M/:-IVT]ESW;NW9/D>ZB[Z6U/N\=]'#Q"R_!YIC<5+AEPR=\,KB2?.Y+A]\4>
MR7#B?N^\W[:DY*+K:RYGHFC^I;S_ &_3_P"O36+ 94 G(X)QD9YY]<5^(?\
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M\<]:\7? KQEX=\3_  @^*.F_"C1_"VE>)?!WB+5?'GCG6]9^+.@_V0NKA?\
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M[\!:]HV@-HFAZUXX\0?#;Q;XG\/>(?"OQ%36?%)'A3PC@_VXO_%;*5Y^Y/\
M@GE^SI\>?V4_ -E^S_XW\0^%/$GP8^&GPLTLZ1XUTQ=5/C;Q7\8O'?Q+\?\
MCKQRNCL/$6-!^'/PK\-ZOX'\+>"@?"/A.7QB9?$WC@XCVA?UHH(!X-&6\*93
ME6*>+PE]K/5NVCTMZMOHWO?<^8SOQ>XMX@RE<-YQ*^41XE_UDBEP^DN?EC"+
M517DHQ45&G&SA"/*U!62/YJ+S_@C_P#&W7M.UZ/Q#X@^$K:SXX_X*":?^U+\
M463Q'\2MNN?"XOK@T?P06/PZ5-?\1[O&?C0;6"^# 4\-8) <+D6W_!(O]I*P
M^#FBNOBCX*>(OC1IG[;X_:I\1?VMJ_Q'/PS\5:5HAUXGP5K.O)\-W\3:!N\1
M:WK.[;X1:/.N>)"N<DU_3=17.^%<H;;Y7S.^MWU;>UK;MOYONSZ->.W&V$PG
MU*.:KV?-S*"A%=(Q3NE=-4XPBEI;EC:SA%K\R/V._@5^US\$Y?!/@WXS?'+P
MG\</A[_PB/BB]\>>+-?LOB7>_%Y_C-XV\;-KFA:+X'UK7BOAG0/@QX4^'*'P
MOD@^,9/&#(0?!Z-@?IO117T>&P_U3"_5%IM9MN]EYO5O;KY'Y3G&88K/<6\W
MQ:BG=MJ$805VVV^6"A%.[>JC?6[;;=RBBBN@X HHHH **** "BBB@ HHHHLN
MR%9=E]R_R"BBBBR[+[D.R[+[E_D%%%%*R[+[E_D'GUUUZZ[Z[Z]==>MPHHHI
MV"RVLK=K*WW6"BBB@+)M.RNE9.RNEV3M=+R32\@HHHH'=]W][[6[]M/33;0*
M***!>73MT^X**** Z6Z+9=%Z+;\ HHHH#_._S[^OGOYA1110%WW?WL****+!
M^NX4444!;]/PV^[IVZ6"BBB@++LON7GY>;^]]W<HHHH%9=E]R_R"BBB@=WW?
MWO\ S"BBB@+!1110'ET[=/NV"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
1HH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
